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 Abstract 
Abstract 
 
Oil-based plastic production processes have given rise to several environmental problems and energy 
availability. Over the past 30 years, polyhydroxyalkanoates (PHA) have become one of the main 
sustainable alternatives to replace petroleum-base commodities. These biopolymers have superior features 
than synthetic plastics since they are produced from biobased sources and their intrinsic chemical 
composition make them biodegradable, biocompatible, and part of the carbon cycle of the earth. Although 
there is a vast knowledge base for synthesizing eco-friendly biopolymers, the industrial production of 
PHAs is still 5-10 more expensive to obtain than conventional plastics.  
Therefore, the present research addresses this critical issue by using Pseudomonas putida as a cell factory 
along with a systems biotechnology approach with the aim of enhancing the production of PHAs. First, it 
was shown that P. putida and related species are suitable as whole-cell biocatalyzers for the production of 
several value-added industrial compounds. To highlight differences among various nutrient limitations 
and their influence on PHA synthesis in P. putida KT2442, chemostat cultures were employed to perform 
well-controlled nutrient limitations. Strict nitrogen-limiting condition reached the highest PHA 
productivity in standard continuous cultivation ever reported. To gain insight into the PHA machinery, 
transcriptome, proteome, and metabolome analyses were employed to investigate the metabolic responses 
under such limiting conditions. Dual limitation showed different expression patterns in comparison to 
those observed under strict carbon- or nitrogen-limiting conditions. Energy metabolism, fatty acids 
metabolism, stress response, and proteins belonging to the transport system were the components of the 
cell which were highly affected by the imposed nutrient limitation. Driven by the systems biology 
approach, it was possible to increase the PHA accumulation under dual limitation, which shows to use the 
carbon source in the most efficient and economic manner among all tested conditions.  
In order to reduce the production costs for PHA synthesis, P. putida KT2440 and in silico-driven 
metabolically engineered strains were subjected to PHA-producing conditions using the inexpensive 
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carbon source glucose. Indeed, the created Δgcd mutant strain exhibited 60% increase in PHA 
accumulation as compared to the parental wild-type strain. The mutant maintained a high specific growth 
rate and exhibited an almost unaffected gene expression profile. To further develop an industrial-scale 
PHA production process, the P. putida strains were subjected to the industrial process of choice  the 
fed-batch cultivation. After the application of an exponential-feeding strategy for biomass synthesis, the 
PHA accumulation stage should be promoted by applying a pulse-feeding instead of a linear-feeding 
approach, which appears to be more appropriated for PHA synthesis in P. putida within high cell 
cultivations. In conclusion, the results described in this thesis have shown the strength of in silico 
modeling and integration of omics measurements to lead metabolic engineering works towards optimal 
performance of the cell and reengineering processes for the synthesis of polyhydroxyalkanoates. 
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 Zusammenfassung 
Zusammenfassung 
 
Die Produktion von Kunststoffen aus Erdöl ist mit erheblichen Umweltproblemen verbunden. Darüber 
hinaus stellt sich die Frage nach der zukünftigen Verfügbarkeit des nicht erneuerbaren Rohstoffs. 
Während der letzten 30 Jahre haben sich Polyhydroxyalkanoate (PHA) als nachhaltige Alternative zu 
Erdöl-basierten Produkten durchgesetzt. Im Gegensatz zu synthetischen Kunststoffen haben diese 
Biopolymere den Vorzug, dass ihre chemische Zusammensetzung sie biokompatibel und zugänglich für 
Biodegradation macht. Als Teil des natürlichen Kohlenstoffzyklus ist ihre Verwendung CO2-neutral. 
Trotz einer enormen Wissensbasis über die Synthese umweltfreundlicher Biopolymere ist die industrielle 
Produktion von PHA immer noch fünf bis zehnmal teurer als die herkömmlicher Kunststoffe. 
Die vorliegende Arbeit widmet sich diesem wichtigen Thema mit dem Ziel die Produktionsrate von PHAs 
durch einen systembiotechnologischen Ansatz in Pseudomonas putida als Zellfabrik zu steigern. Zunächst 
wurde gezeigt, dass lebende Zellen von P. putida und verwandter Spezies als Biokatalysatoren für die 
Herstellung verschiedener industriell relevanter Grundstoffe geeignet sind. Während kontinuierlicher 
Kultivierungen in der kontrollierten Umgebung eines Chemostats wurde der Einfluss verschiedener 
Nährstoff-Limitierungen auf den Stamm P. putida KT2442 sowie dessen Produktion von PHA 
untersucht. Unter strikter Stickstoff-Limitierung wurden die höchsten PHA-Konzentrationen erreicht, die 
bisher in kontinuierlichen Kulturen gemessen wurden. Um einen Einblick in die Biosynthese von PHA 
unter verschiedenen limitierenden Bedingungen zu erhalten, wurden Transkriptom-, Proteom- und 
Metabolom-Studien durchgeführt. Gleichzeitige Stickstoff- und Kohlenstoff-Limitierung zeigte dabei im 
Vergleich zu den einzelnen Limitierungen ein stark unterschiedliches Expressionsprofil. Unter den 
zellulären Komponenten, die am stärksten durch die Nährstoff-Limitierungen beeinflusst waren fanden 
sich der Energie-Metabolismus, der Fettsäure-Metabolismus, die Stressantwort sowie Bestandteile des 
Transportsystems. Mit Hilfe des Systembiologischen Ansatzes war es möglich, die PHA Biosynthese 
unter beiden Limitierungen zu erhöhen. Unter dieser Bedingung wurde die Kohlenstoffquelle am 
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effizientesten und ökonomischsten genutzt. Um die Produktionskosten für PHA weiter zu minimieren, 
wurden P. putida KT2440 und in silco abgeleitete Stämme unter Bedingungen kultiviert, die eine PHA-
Produktion mit der kostengünstigen Kohlenstoffquelle Glukose begünstigen. Der Stamm mit einer Δgcd-
Mutation zeigte eine um 60% erhöhte PHA-Akkumulation im Vergleich zum Wildtyp-Stamm. Dabei 
zeigte dieser Stamm eine hohe spezifische Wachstumsrate und ein Genexpressionsprofil, das durch die 
Mutation kaum beeinflusst wurde. Um die PHA-Produktion im Industrie-Maßstab weiterzuentwickeln 
wurde die P. putida-Stämme mit der Methode der Wahl aus der Industrie kultiviert – dem „Fed-batch 
Process“. Nach der Anwendung eines exponentiellen Fütterungsansatzes, um die Bildung von Biomasse 
zu optimieren sollte die Bildung von PHA über eine gepulste statt lineare Fütterungsstrategie angeregt 
werden. Diese stellte sich während der Hochdichte-Zellkultivierung als wesentlich geeigneter für die 
maximale PHA-Biosynthese heraus.  
Zusammenfassend zeigen die in dieser Arbeit vorgestellten Resultate die Stärke von in silco basierten 
Methoden der Integration  von „Omics“-Daten und Modellierung für die Optimierung von Stämmen für 
die Biosynthese von polyhydroxyalkanoaten. 
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CHAPTER I. General Introduction 
 
1.1 Background 
 
Increasing generation of petroleum-based commodities has given rise to sever energy and environmental 
problems. The U.S. Energy Information Administration (EIA) estimates that more than 4% of the 
worldwide oil consumption is used for plastic production, which reflects approximately a consumption 
rate of 155 million tons of petroleum annually. Biotechnological processes offer the potential to 
sustainable manufacturing such products, which benifits society and environment by reducing demands 
on fossil resources. Since the rapid increase and high fluctuation of the oil price in recent years (Fig.1), 
not only biofuel, but also the synthesis of renewable bio-derived polymers has advanced towards large-
scale production.  
 
 
 
 
 
 
 
 
 
 
Figure 1. Development of the crude oil prices per barrel (U.S. Energy Information Administration, 2012).  
 
Biopolymers can substitute oil-based plastics due to their similar physical and mechanical properties to 
conventional plastics. Among them, polyhydroxyalkanoates (PHAs) and polylactic acid (PLA) are 
promising biopolymers since they can be synthesized from several renewable feedstocks e.g., biomass, 
industrial wastes. PHAs comprise a large class of polyesters. These accumulate in the bacterial cell in 
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response to fluctuation of nutrient availability in the environment, specifically when carbon is in excess 
accompanied by the limitation of one or several inorganic nutrients such as nitrogen, phosphorus, oxygen, 
etc. There have been more than 150 different types of identified PHAs (Steinbüchel and Valentin 1995)  
which the number of newly identified PHAs has gone beyond expectation in the last decade. 
PHAs can be classified into two groups according to the length of the side chain (Hazer and Steinbüchel 
2007); (i) short-chain-length (scl), having an alkyl side chain up to two carbons, and (ii) medium-chain-
length (mcl), with an alkyl chain consisting of at least three carbons (Fig. 2). Several bacteria have the 
capability to naturally produce PHAs. Cupriavidus necator (formerly known as Ralstonia eutropha) and 
Alcaligenes latus synthesize scl-PHAs such as poly-(R)-3-hydroxybutyrate (PHB), and poly((R)-3-
hydroxybutyrate-co-(R)-3-hydroxyvalerate) (PHBV). Pseudomonas, belonging to the rRNA homology 
group I accumulate mcl-PHAs in the presence of fatty acids and sugars (Huijberts et al. 1994b). The 
monomer composition of the resulting mcl-PHA depends on many factors such as the supplied carbon 
source, cultivation conditions, and the affinity of the PHA synthase (PhaC) for the substrate (Steinbüchel 
and Valentin 1995).  
 
 
 
 
 
 
Figure 2. Chemical structure of various PHAs (Adapted from Chen and Chen 2010). 
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P. putida KT2440 and its rifampisin-resistant derivate KT2442 (Bagdasarian et al. 1981) have been used 
as laboratory workhorses to investigate PHA formation at the molecular level as well as the pathway 
organizations and their regulations. PHA precursors can be formed via the β-oxidation pathway, de novo 
fatty acid biosynthesis, and elongation of 3-hydroxyalkanoates by acetyl-CoA molecules (Huijberts et al. 
1994b). The substrates that activate each pathway for PHA formation in Pseudomonas are shown in 
Figure 3. Fatty acids are oxidized in several steps trough the β-oxidation route yielding several precursors 
towards the formation of (R)-3-hydrxyacyl-CoA the substrate of PHA polymerase (PhaC). When glucose 
or gluconate are employed as carbon sources the route of de novo fatty acid biosynthesis is active. The 
key enzyme to turn (R)-3-hydroxyacyl-ACP into (R)-3-hydrxyacyl-CoA was identified as a 3-
hydroxyacyl-ACP-CoA transacilase (PhaG) (Rehm et al. 1998).  
 
 
 
 
 
 
 
 
 
 
Figure 3. Linkages between PHA biosynthetic pathways in Pseudomonas putida KT2440. 
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The regulation of PHAs pathways has been extensively studied in the genus Pseudomonas. Besides PHA 
synthases (PhaC1 and PhaC2), the pha operon has two additional genes, phaZ and phaD. PhaZ is a 
depolimerase (lipase) which participates in the degradation process of the granule, releasing hydroxyacyl-
CoA derivates from PHAs (Luengo et al. 2003). An additional cluster, which also encodes genes related 
to PHAs synthesis, is located downstream of the pha operon (Fig. 3). PhaI and PhaF are phasins which 
participate in granule formation and localization within the cell (Galan et al. 2011; Prieto et al. 1999). 
Interestingly, PhaF plays a role as regulator since it seems to repress transcription of the polyester 
synthase gene (phaC1) and the transacylase gene (phaG) (Hoffmann and Rehm 2004). On the other hand, 
PhaF protein also has a structural function giving stabilization to the granule by creating a phospholipid 
monolayer between the hydrophobic polymer and the hydrophilic cytoplasm (Kessler and Witholt 2001).  
Recently, it was shown that P(I) and P(C1) are the most active promoters of the pha cluster (de Eugenio et 
al. 2010c). Their transcription explain the simultaneous production of PHA depolymerase and synthase. 
In the same study, phaD gene was proved to be a transcriptional regulator, which behaves as a carbon-
source-dependent activator of the pha cluster. An important external component of the PHA synthesis is 
the sigma factor σ54 encoded by rpoN. This regulates at the transcriptional level the PHA biosynthetic 
genes in P. aeruginosa when gluconate is the carbon source (Madison and Huisman 1999) whereas the 
pathway from fatty acid is completely σ54-independent (Timm and Steinbuhel 1992). The rpoN is also 
suggested as a negative regulator of phaF transcription. On the other hand, transcription of phaC1 in P. 
putida is not affected by this regulator (Hoffmann and Rehm 2004). The phosphoenolpyruvate-
carbohydrate transferase system in P. putida KT2440 has five enzymes. It was found that the genes 
encoding for the proteins EI
Ntr
, NP
r
, and EII
Ntr
, act in concert to modulate the accumulation of PHA 
(Velazquez et al. 2007). 
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1.2 Industrial production of PHAs 
The industrial production of PHAs began in the 80's when Biopol
®
 a copolymer made from PHBV 
was created by the British's Imperial Chemical Industry (Shah et al. 2008). A two-stage fermentation 
method was applied to obtain a high PHBV productivity. In 1992 the Boston-based company Metabolix 
(formerly known as Monsanto) purchased the rights to produce and commercialize Biopol
®
. Nowadays, 
Metabolix markets its PHA under the commercial name Mirel
®
 (Chen and Chen 2010). Microbial 
fermentation is the process of choice for industrial production of PHAs. As many bacteria naturally 
accumulate PHAs, high cell density fermentation processes were developed to reach PHB productivities 
up to 4.5 (g/L·h) in the presence of sugar (Table. 1). Nevertheless, only PHB and PHBV are obtained 
when C. necator, Bacillus spp, and A. latus are used as microbial factories. By applying metabolic 
engineering strategies, several heterolougus genes have been integrated into E. coli  the most employed 
industrial organism  to obtain different copolymers thus expanding the range of the mechanical as well 
as the physical properties of the synthesized polyester (Chen 2009).  
Table 1. Wild types and industrial bacterial strains for the production of scl-PHA. 
Strain DNA 
manipulation 
PHA 
type 
Productivity 
(g/L·h) 
C-source Reference 
Alcaligenes eutrophus NO PHB 3.14 Glucose Ryu et al. 1997 
Escherichia coli phbCAB PHB 3.2 Glucose Wang and Lee 1997 
Alcaligenes latus NO PHB 4.58 Sucrose Wang and Lee 1997 
Bacillus megaterium BA-019 NO PHB 1.27 Sugars Kulprescha 2009 
 
At present P. putida strains seems not to be used to produce mcl-PHA at industrial scale. In the research 
field vast information has been generated concerning pathway organization and fermentation strategies to 
obtain tailored-made mcl-PHAs. It is important to highlight that commercial processes for the production 
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of PHAs should have volumetric productivities ranging from 0.7 to 2.4 (g/L·h) (Huijberts et al. 1994b). 
As it is observed in Table 2 many fermentation strategies have achieved such productivity values, 
positioning P. putida as an appropriate industrial strain.  
 
Table 2. P. putida strains for the production of mcl-PHA. 
Strain Fermentation 
mode 
Productivity 
(g/L·h) 
C-source Reference 
P. putida GPo1 Continuous 1.06 Octane (Jung et al. 2001) 
P. putida KT2442 Fed-Batch 1.91 Oleic acid (Lee et al. 2000) 
P. putida KT2442 Fed-Batch 1.44 Nonanoic acid (Sun et al. 2007b) 
P. putida IPT046 Fed-Batch 0.80 Glucose + Fructose (Diniz et al. 2004) 
P. putida KT2442 Fed-Batch 0.68 Corn oil hydrolysate (Shang et al. 2008) 
 
PHA production has several drawbacks as compared to established oil-based plastic production, 
especially regarding the high cost associated with the synthesis of PHAs. To make them competitive 
against petrochemical polymers, the use of inexpensive carbon sources such as sugars, PHA-producer 
bacterial communities in waste water treatments, and systems metabolic engineering of natural producer, 
have been proposed as possible paths to overcome the high cost issue. The pricing for raw meterials 
contribute most among the costs in PHA production (Yamane 1993).Therefore, the straightforward 
approach is to select an appropriate carbon source. In this concern, P. putida species are efficient cell 
factories for such aim (Poblete-Castro et al. 2012a), since their versatility and robustness make them 
capable to catabolize a broad range of compounds as well as resisting adverse environmental conditions 
as high substrate toxicity, temperature, pH, among others. Inexpensive substrates have been already tested 
in different P. putida strains, where their metabolic repertoires funneled resources towards PHAs 
synthesis.  
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Table 3. Physical properties of different PHAs and polypropylene (PP). 
Polyester Tg (°C)
a
 Tm (°C)
b
 Cristallinity Elongation to break 
(%) 
Reference 
PHB 15 175 70 5 (Doi 1990) 
PHV 0 118 N.A. N.A. (Madison and Huisman 1999) 
PHBV -1 145 56 50 (Sudesh et al. 2000) 
P(3HO-3HH) -36 61 30 300 (Doi 1990) 
P3HD -37 72 N.A. 313 (Liu et al. 2011) 
PP -15 176 50 400 (Doi 1990) 
N.A. Data not available 
P(3HO-3HH): Poly(3-hydroxyoctanoate-co-3-hydroxyhexanoate), P3HD: Poly(3-hydroxydecanoate). 
a 
glass transition temperature 
b
 melting temperature 
 
All tested P. putida strains produced a heteropolymer in the presence of glycerol (Wang and Nomura 
2010), lignocellulosic-derivatives (Diniz et al. 2004), and residual oil from plant (Fuchtenbusch et al. 
2000). Due to structural differences, the physical properties mcl-PHA are quite different from PHB and 
other scl-PHA (Table. 3). In addition, by applying continuous cultivation the monomer composition of the 
produced PHA can be exactly defined (Hartmann et al. 2004). Furthermore, metabolic engineering of the 
β-oxidation reactions has allowed synthesizing different kind of homopolymers (Liu et al. 2011) as well 
as novel PHA containing thioester group in the side chain, making them suitable for further chemical 
modifications (Escapa et al. 2011a). Taking all together, mcl-PHAs have potentially a broader application 
range than scl-PHAs (Madison and Huisman 1999) as environmentally friendly polymers as well as 
functional biomaterials for the medical field (Kim et al. 2007). 
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1.3 Project Rationale 
The production of petroleum-based plastics has severe impacts on the environment in terms of soil and 
atmosphere quality, which are reflected by an increasing accumulation of non-degradable material in the 
ground as well as a rising global emission of greenhouse gases. Hence, the present work pursues the aims 
of developing metabolically engineered strains and efficient processes which enhance the production of 
feedstock bio-based polymer using Pseudomonas putida as a cell factory. As P. putida KT2440 and 
KT2442 are natural producers of one of the most promising biopolymers for plastic production e.g. 
PHAs, their metabolic network structure can be redesigned to systematically develop a superior strain.  
This work aims at exploring the metabolic response at transcriptome, proteome, and metabolome level, 
while P. putida KT2442 grows in decanoic acid, a well-known precursor for PHA synthesis. Using the 
chemostat, a valuable tool to perform well-controlled conditions, it is possible to achieve desirable 
nutrient limitations. In addition, continuous culture has been proved being a good system to achieve a 
high PHA productivity. Little is known concerning the metabolic response under the carbon-nitrogen 
limitation regime, and whether this condition is more similar to strict carbon limitation or strict nitrogen 
limitation is not yet clear. Furthermore, carbon-nitrogen limitation has been proposed as an extremely 
efficient process since the carbon source is utilized in the most economical manner. Therefore, based on 
the top-down approach we expect to find insights of the whole-cell metabolic response that drive us to 
devolope a more efficient process in order to increase the PHA productivity. 
The second goal is to develop an engineered P. putida strain based upon model-predictions, which target 
several genes that should increase the pool of acetyl-CoA towards PHA biosynthesis, using non-alkanoic 
substrates as carbon sources. This systematic analysis may provide a solid framework to optimize the 
production of PHA within the cell without severely impacting growth features. In order to investigate the 
microbial production of biopolymers, the developed strain and the parental strain (P. putida KT2440) will 
be subjected to different processes (batch and fed-batch). In addition, transcriptome analysis will be 
  
 9 
 Chapter I 
applied to cells from PHA-producing conditions to unravel more accurately the highly complex metabolic 
networks that govern the cell under PHA production and non-production conditions. 
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CHAPTER II. Industrial biotechnology of Pseudomonas putida and related species 
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Abstract 
Since their discovery many decades ago, Pseudomonas putida and related subspecies have been 
intensively studied with regard to their potential application in industrial biotechnology. Today, these 
gram-negative soil bacteria, traditionally known as well-performing xenobiotic degraders are becoming 
efficient cell factories for various products of industrial relevance including a full range of unnatural 
chemicals. This development is strongly driven by systems biotechnology, integrating systems metabolic 
engineering approaches with novel concepts from bioprocess engineering, including novel reactor designs 
and renewable feedstocks.  
 
Keywords 
Pseudomonas putida, cell factory, bio-catalysis, biofilm, systems metabolic engineering, synthetic 
biology, bioeconomy 
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2.1 Background 
Pseudomonas putida is a Gram-negative road-shaped bacterium occurring in various environmental 
niches, due to its metabolic versatility, and low nutritional requirements (Timmis 2002). Initiated by the 
pioneering discovery of its high capability to degrade rather recalcitrant and inhibiting xenobiotics, 
extensive biochemical analysis of this bacterium has been carried out in the recent years. In addition, P. 
putida shows a very high robustness against extreme environmental conditions such as high temperature, 
extreme pH or the presence of toxins or inhibiting solvents. Additionally, it is genetically accessible and 
grows fast with simple nutrient demand (Martins Dos Santos et al. 2004). Meanwhile, P. putida is 
successfully used for the production of bio-based polymers and a broad range of chemicals, far beyond its 
initial purpose for the degradation of various toxic compounds. The sequencing of its genomic repertoire 
(Nelson et al. 2002) and genome-wide pathway modeling (Puchalka et al. 2008) now provide novel 
possibilities to further engineer this bacterium into a flexible cell factory for bio-industrial application. 
Hereby, different species of P. putida vary to some extent in their genetic repertoire and phenotypic 
behavior creating a high range of industrial application possibilities. This review highlights fundamental 
aspects of the cellular physiology of P. putida together with recent achievements in systems biology and 
systems metabolic engineering.  
 
2.2 Carbon core metabolism of Pseudomonas putida   
Of particular interest for industrial application of P. putida are the central routes of carbon metabolism, 
receiving carbon from the various converging pathways of substrate utilization and supplying building 
blocks, cofactors and energy for the added-value products of interest. It is interesting to note that P. 
putida differs in key aspects from the generally much conserved central catabolic pathways of many other 
prokaryotic cells, making its pathway repertoire and usage quite unique (Figure 1). Its fast growth, high 
biomass yield and low maintenance demands are additional features important for industrial application 
(Table 1). 
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Figure 1. Metabolic pathways in the carbon core metabolism of Pseudomonas putida 
 
2.2.1 Substrate uptake 
In contrast to various other industrial microorganisms, including e.g. E. coli, C. glutamicum or B. subtilis, 
glucose is not the preferred carbon substrate for pseudomonads. In the presence of succinate and other 
intermediates of the tricarboxylic acid (TCA) cycle, carbon catabolic repression suppresses the 
assimilation of glucose (Wolff et al. 1991). It is interesting to note that also some of the mechanisms of 
substrate up-take vary from those of other bacteria. Differing from the typically observed 
phosphoenolpyruvate-carbohydrate phosphotransferase system (PTS), P. putida assimilates glucose by 
facilitated diffusion via the specific porin OprB. Concerning the use of industrial substrates, P. putida is 
capable to  use raw glycerol, a technical by-product from the biodiesel industry (Ciesielski et al. 2010). 
Naturally, it cannot grow on carbon five sugars such as D-xylose or L-arabinose, but has been recently 
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engineered towards utilization of these sugars (Meijnen et al. 2008; Meijnen et al. 2009), important as 
major constituents of lignocellulosic biomass (Lee 1997), 
 
Table 1. Physiological growth data of Pseudomonas putida KT2440 on glucose as carbon source. 
The data comprise maximum specific growth rate (µ), biomass yield (YX/S) and maintenance 
coefficient (mX) from batch as well as continuous culture. 
µ (h
-1
) YX/S  (g g
-1
) mX (mmol g
-1 
h
-1
) Reference 
a
0.81 - - (Sohn et al. 2010) 
a
0.73 
a
0.56 
b
0.062 (Ebert et al. 2011) 
b
0.59 
b
0.39 
b
0.171 (van Duuren 2011) 
a Batch culture 
b Chemostat culture 
 
2.2.2 Catabolic metabolism 
Most strikingly, P. putida lacks a functional Embden-Meyerhof-Parnas (EMP) pathway due to the 
absence of a gene for 6-phosphofructokinase (pfk) along with the expression of several transcriptional 
regulators e.g. HexR (del Castillo et al. 2008). For the catabolism of sugars the Entner-Doudoroff 
pathway is employed instead (Fuhrer et al. 2005). This catabolic route generates two carbon three blocks, 
i.e. glyceraldehyde 3-phosphate and pyruvate, from break-down of sugars such as glucose. The pentose 
phosphate pathway, however, only operates in an anabolic mode to generate biomass precursors (Ebert et 
al. 2011). Once generated, pyruvate enters the so-called pyruvate shunt which yields either oxaloacetate 
or acetyl-CoA (del Castillo et al. 2007). In addition to sugars and TCA cycle intermediates, P. putida 
KT2440 can metabolize a number of other substrates including fatty acids, polyols such as glycerol, 
amino acids, and aromatic compounds. The glyoxylate shunt, active in P. putida KT2440, is one of the 
anaplerotic reactions within the metabolic network. (Ebert et al. 2011).  
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2.2.3 Redox metabolism 
The intracellular glucose provides a huge flexibility for P. putida to channel the sugar into different 
pathways. First, glucose can be either phosphorylated to glucose-6-phosphate, followed by NADPH 
coupled oxidation to 6-phosphogluconate to enter into the central energy catabolism. Alternatively, 
glucose can be subjected to successive oxidation steps which produce gluconate and 2-ketogluconate, 
respectively, whereby these two intermediates can be either secreted or phosphorylated to 6-
phosphogluconate and 2-keto-6-phosphogluconate. The latter can be then also reduced to 6-
phosphogluconate so that a complex network of alternative pathways is formed. In P. putida KT2440 all 
three possible route towards 6-phosphogluconate work simultaneously (del Castillo et al. 2007). The 
derived 6-phosphogluconate is the key intermediate of the major catabolic route in pseudomonads, the 
Entner-Doudoroff pathway. It should be noted that the network of glucose catabolism with multiple 
reduction and oxidation steps is efficient the supply of redox power, an important feature for whole cell 
applications in industrial bio-catalysis. The challenge of an elevated NADH oxidation rate did not affect 
the metabolic performance of  P. putida KT2440 NADH oxidation rate (Ebert et al. 2011), taking the 
specific substrate uptake rate as a measure. This differs from e.g. E. coli and S. cerevisiae, underscoring 
the remarkable potential of P. putida as a suitable strain for efficient NADH-demanding production of 
chemicals. 
 
2.2.4 Bio-conversion and degradation of non-natural chemicals 
With regard to its environmental applications, huge interest focused on the degradation pathways and the 
underlying mechanisms from early on (Nakazawa and Yokota 1973). In summary, five major degradation 
pathways have been found and characterized in Pseudomonas strains, namely; the β-ketoadipate, the 
phenylacetyl-CoA, the homogentisate, the gentisate, and the homo-proto-catechuate pathway, 
respectively. Hereby, P. putida shows a naturally high capacity to tolerate and modify aliphatic, aromatic 
and heterocyclic compounds (Schmid et al. 2001).  In different isolates, plasmids could be identified 
which mediate the genes for the break-down of toluene (3-methyl-benzoate) (Nakazawa and Yokota 
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1973), naphthalene (Dunn and Gunsalus 1973), 4-chloronitrobenzene (Zhen et al. 2006), 2,4- xylenol 
(Dean et al. 1989) or phenol (Herrmann et al. 1987). In addition, also chromosomal elements contribute to 
the degradation of aromatics (Jimenez et al. 2002).  
 
2.3 Genetic engineering  
Molecular genetics has enabled the investigation of bacterial phenotypes and pathway manipulation for 
biotechnological applications in P. putida (Reva et al. 2006b). The genetic amenability of this bacterium 
has been proven to be large, making it suitable for metabolic engineering towards the creation of superior 
strains. It is an ideal host for heterologous gene expression (Meijnen et al. 2008; Ronchel et al. 1998) and 
has been certified as first Host-Vector Biosafety strain (HV1) which can be released into the environment. 
The Tn5-derived mini-transposon system has been the method of choice for genomic integration of DNA 
fragments in P. putida (De Lorenzo 1994; De Lorenzo et al. 1990). This straightforward technology 
allows several insertions into the same cell (De Lorenzo et al. 1998) and has recently led to the valuable 
creation of a genome-wide mutant library of P. putida KT2440 (Duque et al. 2007) as well as to the 
streamlining of the P. putida genome by using a combinatorial deletion method based on mini-transposon 
insertion and Flp-FRT recombination (Leprince et al. 2011). With regard to industrial application mini-
transposons are less suitable due to the antibiotic markers often used. This can be overcome by a novel 
method, that is I-Scel based chromosomal engineering (Martinez-Garcia and de Lorenzo 2011) which 
enables the precise deletion of multiple genomic segments in P. putida.  
 
2.4 In silico modeling of metabolism 
Driven by the sequencing of the genome of P. putida KT2440 (Nelson et al. 2002), and other species 
including P. putida Idaho (Tao et al. 2011), P. putida B6-2 (Tang et al. 2011) or P. putida S16 (Yu et al. 
2011), the recent years have seen a huge progress in genome scale modeling of this bacterium (Nogales et 
al. 2008; Puchalka et al. 2008; Sohn et al. 2010). Varying to some extent in complexity and study focus, 
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the created models display valuable information for systems level analysis of P. putida (Table 2), 
including investigation of the pathway repertoire, gene essentiality, resource distribution as well as model 
based strain design for the production of PHA (Puchalka et al. 2008). Model based predictions of in silico 
phenotypes were recently refined by the integration of experimental data on stoichiometric demands for 
anabolism and cellular maintenance which are crucial to increase the predictive power of computational 
design. This involved exact measurement of maintenance coefficients using a mini-scale chemostat 
system  (Ebert et al. 2011) as well as growth dependent measurement of cellular composition (van Duuren 
2011) (Table 2). These data were found useful to evaluate in silico gene essentiality as compared to gene 
expression, hereby overcoming inconsistencies from previous models. In addition, recent modeling 
approaches have aimed at resolving the dynamic behavior of pathways in P. putida and their regulation 
providing a new, interesting view into its metabolism (Koutinas et al. 2011; Koutinas et al. 2010; Silva-
Rocha et al. 2011).  
Table 2. Genome scale models for Pseudomonas putida KT2440. 
 
 
 
 
 
 
 
2.5 Systems-level profiling by omics technologies 
The development of quantitative omics technologies has provided a solid basis for systems-wide analysis 
of metabolic and regulatory features of P. putida. Most of these studies so far focused on xenobiotic 
degradation. However, recent examples have initiated the investigation of this bacterium for the 
production of value-added chemicals. This also includes a first set of multi-omics studies, combining 
systems profiling on various levels towards superior strains (Verhoef et al. 2010).  
N° of genes N° of reactions N° of metabolites Reference 
746 950 911 (Nogales et al. 2008) 
815 877 888 (Puchalka et al. 2008) 
900
 
1071
 
1044
 
(Sohn et al. 2010) 
746 952 917 (van Duuren 2011) 
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2.5.1 Transcriptomics 
Fascinating insights into the cellular program of P. putida during xenobiotic degradation could be 
obtained by transcription profiling. A pioneering study on the response of P. putida KT2440 (pWW0) to 
aromatic compounds (Dominguez-Cuevas et al. 2006) revealed that  toluene acts as a stressor rather than 
as a nutrient, activating stress tolerance genes with the minimum expenditure of energy. Similarly, other 
studies unraveled the stress response of the cell triggered by different toxic agents (Del Castillo and 
Ramos 2007; Miyakoshi et al. 2007; Reva et al. 2006a; Yeom et al. 2010) or the functionality of several 
regulators involved in this process (Fonseca et al. 2008; Hervas et al. 2008; Morales et al. 2006; Moreno 
et al. 2009; Renzi et al. 2010). More recently, transcriptomics was applied to identify targets in the strain 
P. putida S12 producing p-hydroxybenzoate on glucose and glycerol as carbon sources  (Verhoef et al. 
2010). 
 
2.5.2 Proteomics 
Almost ten years ago, first studies created a comprehensive proteome map for P. putida KT2440 and 
identified about 200 polypeptides using conventional 2D-PAGE and matrix-assisted laser desorption 
ionization time-of-flight mass spectrometry (Heim et al. 2003).  Complementary to the progress on the 
level of gene expression, the stress response of P. putida to different toxins was assessed also on the 
proteomic level (Krayl et al. 2003), so that we have a good knowledge on proteins involved in membrane 
composition, stabilization, detoxification or energy production (Benndorf et al. 2006; Santos et al. 2004; 
Segura et al. 2005; Volkers et al. 2006). In addition, studies included the characterization of aromatic 
degradation pathways and underlying mechanisms (Kim et al. 2006; Tsirogianni et al. 2006). More 
recently, also biotechnological production processes were characterized. This involved a study on the 
proteome of the strain P. putida CA-3 during growth on styrene under conditions of pure growth and also 
polyhydroxyalkanoate accumulation (Nikodinovic-Runic et al. 2009). Via shotgun proteomics it was 
possible to highlight the dual participation of proteins in stress response and PHA synthesis. P. putida 
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S12 was investigated quite intensively with regard to the effects of the enhanced production of building 
block chemicals on cellular physiology and regulation (Verhoef et al. 2010; Wierckx et al. 2009; Wierckx 
et al. 2008).  
 
2.5.3 Metabolomics 
Probably the most crucial part in quantitative metabolomics, that is the elucidation of pool sizes of the 
large set of intracellular metabolites, is related to sampling. In this regard,  different sampling methods 
were tested and validated for their applicability to different catabolic and anabolic pathways in P. putida 
(Bolten et al. 2007). More recently, a comprehensive metabolome study of P. putida S12 revealed only 
minor differences among the pool size of all synthesized metabolites while growing in different carbon 
sources e. g. fructose, glucose, gluconate or succinate (Van Der Werf et al. 2008). Large differences, 
however, could be detected among specific metabolites belonging to the intermediary degradation routes 
of the carbon sources studied.  
 
2.5.4 Fluxomics  
On the level pathway fluxes, most close to the phenotype, different 
13
C flux studies provided valuable 
insights into the carbon core metabolism of P. putida. For glucose-grown cells it was found that the 
Entner-Doudoroff pathway was the exclusive catabolic route, whereas the pentose phosphate pathway 
served mainly biosynthetic functions, involving the non-oxidative branch (Fuhrer et al. 2005). A more 
detailed view into the glucose catabolism in Pseudomonas putida revealed the simultaneous operation of 
three pathways that converge at the level of 6-phosphogluconate, which is then converted by the Entner-
Doudoroff pathway to metabolites belonging the central metabolism (del Castillo et al. 2007).With regard 
to the TCA cycle, most of the oxaloacetate was provided by the pyruvate shunt rather than by the direct 
oxidation of malate by malate dehydrogenase. At the level of substrate mixtures, P. putida exhibits a 
distinct pattern of internal carbon distribution as shown for simultaneous use of glucose and toluene (Del 
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Castillo and Ramos 2007). Interestingly, toluene directs a larger amount of carbon than glucose into the 
TCA cycle, indicating the in vivo control by carbon catabolite repression that toluene exerts over glucose. 
The central carbon and energy metabolism of solvent tolerant P. putida DOT-T1E responded to the 
drastically increased the energy demands in the presence of toxic solvents and alcohols by an enhanced 
NAD(P)H regeneration (Blank et al. 2008a; Rühl et al. 2009). This was mediated by an increased specific 
glucose uptake rate together with a reduced anabolic demand and displays a major feature of this 
bacterium for industrial applications such as whole-cell redox bio-catalysis. More recently, metabolic flux 
analysis provided valuable information during metabolic engineering of a phenol overproducer strain 
derived from P. putida S12 (Wierckx et al. 2008) (Wierckx et al. 2009). Beyond experimental 
applications, flux patterns were also applied to validate mathematical models (Puchalka et al. 2008). In 
general there was a good agreement between in vivo and in silico data, whereby certain discrepancies 
were attributed to non-optimal allocation of resources in growing cells, differing from the optimization 
function imposed in the in silico analysis.  
 
2.6 Industrial applications of P. putida strains 
Stimulated by their excellent production properties and the advent of genetic engineering, P. putida and 
related strains have been applied and optimized to a meanwhile broad portfolio of industrial products, 
involving bio-based materials, as well as de novo synthesis and biotransformation of high value chemicals 
and pharmaceuticals (Table 3).  
 
2.6.1 Bio-based materials 
Among bio-based polymers, polyhydroxyalkanoates (PHA) comprise a large class of polyesters. Their 
excellent biodegradability and biocompatibility is interesting for applications in various areas including 
tissue engineering or eco-friendly packaging (Khanna and Srivastava 2005; Liu and Chen 2007). 
Depending on the cultivation conditions, polyhydroxyalkanoates are accumulated as carbon and energy 
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storage by P. putida which has been widely exploited for their targeted biosynthesis in this organism 
(Hoffmann and Rehm 2004). Their material properties, that is elasticity, crystallinity or rigidness depend 
on the monomeric composition which can be precisely controlled by fermentation strategies 
(Albuquerque et al. 2011; Hoffmann and Rehm 2004; Sun et al. 2009) or by metabolic engineering (Liu 
and Chen 2007). A better understanding on the regulation and processes involved in polymer biosynthesis 
has enabled targeted metabolic and protein engineering approaches to improve production efficiency of 
tailor made PHAs (Rehm 2010). As example, the weakening of the competing β-oxidation pathway in the 
strain P. putida KT2442 by deletion of FadA and FadB, significantly increased overall production and 
supported the formation of medium-chain-length polymers (Liu and Chen 2007; Ouyang et al. 2007). 
Further metabolic engineering of the β-oxidation reactions has made possible to synthesis different kinds 
of homo-polymers such as poly(3-hydroxyhexanoate),  poly(3-hydroxyheptanoate) (Wang et al. 2011) , 
and poly(3-hydroxydecanoate) (Liu et al. 2011), as well as a novel PHA containing thioester groups in the 
side chain, which make them suitable for tailored chemical modifications (Escapa et al. 2011a). More 
recently, the substrate specificity of type II PHA synthase was modified by site-directed mutagenesis to 
accept short-chain-length building blocks for PHA production and further extend the product portfolio of 
this class of bio-based plastics (Yang et al. 2011). Fed-batch cultivation of P. putida GPo1 demonstrated 
the feasibility of large-scale PHA production (Elbahloul and Steinbüchel 2009). High cell density cultures 
are also well established in P. putida KT2440 (Sun et al. 2006a), enabling efficient accumulation of PHA 
during carbon-limiting exponential feeding (Sun et al. 2007a). A remarkable step towards straightforward 
biopolymer recovery has been made via a programmed self–disrupting P. putida strain that should 
significantly reduce the costs of the process (Martínez et al. 2011). This illustrates the great potential of P. 
putida species for an economically attractive production of PHA with diverse composition.     
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2.6.2 Bioconversion and de-novo synthesis of chemicals  
Beyond its more traditional application for xenobiotic degradation and PHA production, P. putida is 
gaining more and more importance as host for whole cell bio-catalysis and de novo synthesis of chemicals 
(Table 3). This takes significant benefit from its well-known capacity to tolerate and modify aliphatic, 
aromatic and heterocyclic compounds related to a versatile enzymatic set of mono-oxygenases, di-
oxygenases and hydroxylases (Schmid et al. 2001). P. putida KT2440 is able to metabolize benzoate 
which gives access to various interesting intermediates of the degradation route (Jiménez et al. 2002). As 
example, cis-cis muconate, an aromatic intermediate of benzoate degradation, is a suitable precursor for 
the production of adipic acid opening novel routes towards nylon-6,6 (Draths and Frost 1994). Recently, 
the generation of a (catR) deficient mutant of KT2440 showed high rate and yield of cis-cis muconate 
from the co-metabolization of benzoate in the presence of glucose (Van Duuren et al. 2011c). This 
overproducer strain was used in a pH-stat fed-batch process which resulted in high specific productivity 
(Van Duuren et al. 2011b) and promising life cycle characteristics for different feed stocks (Van Duuren 
et al. 2011a). Hereby, P. putida exhibits rather high tolerance as compared to many other industrial 
production organisms. This appears as an excellent starting point to overcome a major bottleneck, that is, 
substrate and product toxicity to the often unnatural chemical compounds. Indeed, solvent-tolerant strains 
of P. putida were successfully used for stereospecific epoxidation of styrene by the strain DOT-T1E 
(Blank et al. 2008b), o-cresol formation from toluene with P. putida T-57 (Faizal et al. 2005) or de novo 
synthesis of p-coumarate (Nijkamp et al. 2007), p-hydroxybenzoate (Verhoef et al. 2007) or p-
hydroxystyrene (Verhoef et al. 2009), all using P. putida S12. These successful developments also 
recruited metabolic engineering strategies. Reprogramming of the p-coumarate producing strain S12 for 
p-hydroxy-styrene production was possible by introducing the genes pal and pdc encoding L-
phenylalanine/L-tyrosine ammonia lyase and p-coumaric acid decarboxylase, respectively. Degradation 
of the p-coumarate intermediate was prevented by inactivating the fcs gene encoding feruloyl-coenzyme 
A synthetase (Verhoef et al. 2009). In addition novel reactor configurations have been developed in recent 
years, showing advantage with regard to toxicity effects. This comprised two-phase-liquid-liquid-
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cultivation systems with an aqueous and an organic phase (Schmid et al. 2001; Verhoef et al. 2009; 
Wierckx et al. 2005). Beyond this, alternative concepts involving catalytically active biofilms came into 
focus because of their inherent characteristics of self-immobilization, high resistance to reactants and 
long-term activity, which all facilitate continuous processing (Rosche et al. 2009). Using the biofilm-
forming and engineered Pseudomonas strain VLB120∆C, a stable and highly efficient continuous (S)-
styrene oxide production process was recently established (Gross et al. 2010) and optimized (Halan et al. 
2010). This profited from a high volumetric productivity  in situ substrate feed and product recovery 
(Halan et al. 2010), and improved tolerance and robustness as compared to planktonic cultures (Halan et 
al. 2011).  
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Table 3: Overview on biotechnology products derived by natural and recombinant strains of Pseudomonas putida. 
Product Parent 
strain 
Production strain Comment Reference 
PHA hetero-polymer KT2442 KT2442  Ouyang 2007 
PHA hetero-polymer with 
modified monomer composition 
KT2442 KTOY06 Altered β-oxidation 
 
Ouyang 2007 
PHA hetero-polymer with high-
content of 3-
hydroxytetradecanoate 
KT2442 KTOY06  Liu 2007 
PHA C6 and C7 homo-polymers  KT2442 KTHH03 Modified β-oxidation; feeding of 
hexanoate and heptanoate 
Wang 2011 
PHA C5 homo-polymer KTHH03 KTHH08 Deletion of mcl PHA synthase genes 
(phaC), plasmid-based expression of the 
PHA synthesis operon (phaPCJ) from 
Aeromonas hydrophila; valerate used as 
carbon source 
Wang 2011 
PHA C3 and C4 homo-polymer KTHH03 KTHH06 Replacement of endogenous phaC by 
phaC from Ralstonia eutropha; β-
butyrolactone as precursor 
Wang 2011 
Myxochromide S KT2440 P.putida::CMch37a Heterologous expression of 
myxochromide S biosynthetic gene cluster 
from Stigmatella aurantiaca 
Stephan 2006 
-- KT2440 FG2005 Integration of methyl-malonyl-CoA Gross 2006 
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pathway from Sorangium cellulosum 
Myxothiazol FG2005 FG2005::Pm-mta Integration of myxothiazol synthesis 
cluster from Stigmatella aurantiaca 
Gross 2006 
     
p-Hydroxysterene S12 S12 427Δfcs 
pJNTpalpdc 
Introduction of pal (R. glutinis) and pdc 
(L. plantarum), inactivating fcs genes 
Verhoef 2009 
D-Glucosaminic acid GNA5 GNA5 D-glucosaminic acid accumulated during 
oxidative fermentation process  
Wu 2010 
Phenol S12 S12 Introduction of tpl gene from Pantea 
agglomeran, overexpression of the aroF-1 
gene 
Wierckx 2005 
p-Coumarate S12 S12 C3 Inactivation of fcs, construction of 
phenylalanine auxothrophic mutant 
Nijkamp 2007 
3-Nitrocatechol F1 F1 Process optimization for bio-catalytic 
production 
Prakash 2010 
3-Methylcatechol F1 and 
F107 
MC1 and MC2 F107 as a 3-methylcatechol accumulating 
mutant of F1 with expression of 
todC1C2BAD under control of an 
inducible regulatory region 
Hüsken 2001 
o-Cresol T-57 TODD1 todD knockout mutant of T-57 Faizal 2005 
Aliphatic alcohols PpS81 PpS8141 Introduction of the alk regulon 
(alkBFGH/alkST) from Pseudomonas 
oleovorany 
Bosetti 1992 
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4-Valerolactone KT2440 KT2440 Introduction of tesB (E. coli G1655) to 
secrete 4-hydroxyvalerate and pon1 
(human paraoxonase I), expressed extra-
cytosolic to catalyze the utilization the 
intermediate 4-hydroxyvalerate 
Martin 2010 
p-Hydroxybenzoate S12 S12pal_xylB7 Additional copy of aroF-1 gene, 
introduction of xylAB_FGH genes (E.coli) 
and the pal gene (R. toruloides) 
Meijnen 2011 
2-Alkyl-4(1H)-quinolones and 
related derivates 
KT2440 KT2440 [pBBR-
pqsABCD] 
Insertion of pqsABCD from P. aeruginosa Niewerth 2011 
Styreneoxide DOT-
T1E 
DOT-T1E [pTEZ240] Heterologous expression of styrene 
monooxygenase StyAB from P. spec. 
VLB120  
Blank 2008 
4-Hydroxyquinaldine KT2440 KT2440 (pKP1) Inserted genes qoxLMS (Arthrobacter 
nitroguajoccolicus Rü61a) 
Ütkür 2011 
     
Biodesulfurization S12 DS23 Insertion of desulfurizing gene cluster 
(dszABCD) (P. putida A4) 
Tao 2011 
Bioconversion of limonin G7 G7 Use of whole cells permeabilized with 
EDTA and lysozyme 
Malik 2011 
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2.6.3 Pharmaceuticals and agrochemicals 
Natural products of microbial origin are widely used as pharmaceuticals and in agro-chemistry. These 
compounds are often biosynthesized by multifunctional mega-synthetases whose genetic engineering 
and heterologous expression offer considerable promise, especially if the natural hosts are genetically 
difficult to handle, slow growing, unculturable, or even unknown (Wenzel et al. 2005). In this regard, 
P. putida has shown to be capable to express and activate biosynthetic proteins of complex natural 
products from myxobacteria (Gross et al. 2005; Gross et al. 2006; Wenzel et al. 2005). This has 
enabled production of high-value pharmaceuticals in this bacterium (Table 3). Using P. putida 
KT2440 as heterologous host, myxochromide S production was successfully established (Stephan et 
al. 2006). Specific feeding strategies unraveled metabolic bottlenecks for the supply of myxochromid 
building blocks suggesting process optimization by metabolite feeding (Stephan et al. 2006) or 
metabolic engineering toward improved supply of the required compounds. In addition P. putida 
FG2005 was used as production host for heterologous myxothiazol production (Gross et al. 2006). 
More recently, transposition was established for genetic engineering of P. putida allowing efficient 
transfer of extremely large gene clusters which in general build the basis for biosynthesis of natural 
products (Fu et al. 2008). In another study, the insertion heterologous genes into P. putida KT2440 
allowed the biosynthesis of valuable carotenoids such as zeaxanthin (Beuttler et al. 2011). Hence, 
previous size problems for transformation of P. putida appear to be solved and offer novel 
possibilities to further exploit P. putida as production platform for high-value natural products. 
 
 
 
 
 
 
 
  
 28 
 Chapter II 
Table 4. Industrial processes based on Pseudomonas strains 
Product Biocatalyst Applicability Company Source 
2-quinoxalinecarboxylic 
acid 
P. putida ATCC 
33015 
Biological activity Pfizer (USA) (Wong et al. 2002) 
5-methylpirazine-2-
carboxylic acid 
P. putida ATCC 
33015 
Pharmaceutical Lonza (Switzerland) (Kiener 1992) 
Chiral amines Pseudomonas DSM 
8246 
Biological activity BASF (Germany) (Schulze and 
Wubbolts 1999) 
5-cyanopentanamide P. putida Catalysis DuPont (USA) (Stieglitz et al. 
1996) 
(S)-2-Chloropropionoc acid Pseudomonas  Herbicides Astra Zeneca (USA) (Schulze and 
Wubbolts 1999) 
D-p-hydroxyphenyl glycine  P. putida Pharmaceutical Several companies (Schulze and 
Wubbolts 1999) 
Chiral compounds P. putida ATCC 
12633 
Pharmaceutical DSM (The Netherlands) (Hermes et al. 1993) 
4-[6-hydroxypyridin-3-yl]-
4-oxobutyrate 
Pseudomonas DSM 
8653 
Pharmaceutical  Lonza (Switzerland) (Schmid et al. 2001) 
Paclitaxel Pseudomonas lipase 
AK 
Pharmaceutical Bristol-Myers Squibb (Patel et al. 1994) 
 
 
2.7 Conclusions and future perspectives 
Similar to other industrial microorganisms, the product portfolio of P. putida has strongly evolved in 
recent years (Table 3). Its good genetic accessibility and the naturally high tolerance appear as 
desirable features to overcome the toxic and harsh conditions typically linked to industrial bio-
catalysis and de-novo synthesis of often unnatural chemicals. It interesting to note, that quite a few 
commercial processes in biotechnology are based on this versatile bacterium (Table 4). P. putida and 
its enzyme repertoire are involved in the industrial synthesis of chiral compounds (Hermes et al. 1993; 
Schulze and Wubbolts 1999), paclitaxel (Patel et al. 1994), 5-methylpirazine-2-carboxylic acid 
(Kiener 1992) among others, involving large chemical and biotechnological companies such as Pfizer 
(USA), Lonza (Switzerland), DSM (The Netherlands), DuPont (USA), or  BASF (Germany) (Schulze 
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and Wubbolts 1999). The application range of P. putida in industrial biotechnology has good chances 
to further grow and expand in the future considering the interesting pipeline of novel products 
becoming available via efficient P. putida cell factories.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Integration of Pseudomonas putida as cell factory in the bio-based production pipelines 
from renewable resources. 
 
Interesting future developments might consider the integration of P. putida into existing or currently 
developed pipelines of utilizing renewable feedstocks or industrial wastes for sustainable bio-
production as visualized in Figure 2. The rich intrinsic pathway repertory enables P. putida to degrade 
and metabolize a broad range of compounds, including also complex aromatics. Together with its 
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natural high tolerance to harsh and toxic conditions this seems beneficial to couple P. putida to 
various streams of renewable feedstocks. As example, lignocellulosic biomass from catalytic 
pyrolysis containing also aromatic compounds (Bu et al. 2011) could be converted by P. putida 
capable to utilize such substrates into added value products such as as cis-cis muconate, an excellent 
precursor for the synthesis of adipic acid. Also in the sugar pipeline, P. putida seem valuable to create 
novel chemicals or materials. Hereby, the naturally high tolerance of P. putida to harsh and toxic 
conditions together with flexible genetic modifications displays an excellent starting point of further 
developing it into a production platform for other, non-natural chemicals which are not accessible so 
far. This will require experimental and computational systems level strategies to disentangle the 
complexity of the Pseudomonas putida central and peripheral metabolic pathways towards their 
targeted optimization. Synthetic biology will add a next level of design space to reshape metabolism 
for enhanced bio-production, e.g. via fine-modulated expression and control of regulation networks or 
the integration of complex heterologous pathways Rational strain engineering will be further 
completed by novel concepts or evolutionary engineering, boosting industrial implementation of 
Pseudomonas strains via novel phenotypes with even enhanced tolerance to industrial environments, a 
promising perspective for P. putida. 
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CHAPTER III. The metabolic response of P. putida KT2442 producing high levels of 
polyhydroxyalkanoate under single- and multiple-nutrient-limited growth: Highlights from 
a multi-level omics approach 
 
3.  
This chapter has been published: Ignacio Poblete-Castro, Isabel F. Escapa, Christian Jäger, Jacek 
Puchalka, Carolyn Ming Chi Lam, Dietmar Schomburg, María Auxiliadora Prieto, Vítor A. P. Martins 
dos Santos. Microbial Cell Factories (2012) 11: 34. 
3.1 Abstract 
Background 
Pseudomonas putida KT2442 is a natural producer of polyhydroxyalkanoates (PHAs), which can 
substitute petroleum-based non-renewable plastics and form the basis for the production of tailor-made 
biopolymers. However, despite the substantial body of work on PHA production by P. putida strains, it is 
not yet clear how the bacterium re-arranges its whole metabolism when it senses the limitation of nitrogen 
and the excess of fatty acids as carbon source, to result in a large accumulation of PHAs within the cell. In 
the present study we investigated the metabolic response of KT2442 using a systems biology approach to 
highlight the differences between single- and multiple-nutrient-limited growth in chemostat cultures. 
Results 
We found that 26, 62, and 81% of the cell dry weight consist of PHA under conditions of carbon, dual, 
and nitrogen limitation, respectively. Under nitrogen limitation a specific PHA production rate of 0.43 
(g·(g·h)
-1
) was obtained. The residual biomass was not constant for dual- and strict nitrogen-limiting 
growth, showing a different feature in comparison to other P. putida strains. Dual limitation resulted in 
patterns of gene expression, protein level, and metabolite concentrations that substantially differ from 
those observed under exclusive carbon or nitrogen limitation. The most pronounced differences were 
  
 43 
 Chapter III 
found in the energy metabolism, fatty acid metabolism, as well as stress proteins and enzymes belonging 
to the transport system. 
Conclusion 
This is the first study where the interrelationship between nutrient limitations and PHA synthesis has been 
investigated under well-controlled conditions using a system level approach. The knowledge generated 
will be of great assistance for the development of bioprocesses and further metabolic engineering work in 
this versatile organism to both enhance and diversify the industrial production of PHAs. 
Keywords 
P. putida KT2442, Nutrient limitation, Systems biology, Polyhydroxyalkanoates 
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3.2 Background 
Microorganisms constantly face fluctuations of nutrient concentrations in their natural environments. One 
of the common evoked responses by bacteria is the storage of carbon and energy sources, as shown by the 
considerable increase in the accumulation of various compounds, such as glycogen, polyesters, and 
polyphosphates etc. (Wilson et al. 2010). The primary feature of these compounds is that they can be 
readily degraded by the cell to satisfy metabolic demands, thus ensuring its survival during famine. 
Pseudomonas putida KT2440 is a metabolically versatile bacterium (Nelson et al. 2002) normally found 
in aerobic and semi-aerobic soil and water habitats (Timmis 2002), which has become an efficient cell 
factory for the biotechnological production of value-added compounds (Poblete-Castro et al. 2012a). It 
synthesizes medium-chain-length polyhydroxyalkanoate (PHA) that exhibit different physical properties 
than those of the first discovered polyester polyhydroxybutyrate (PHB) (Kim et al. 2007; Prieto et al. 
2007). PHAs can substitute petroleum-based non-renewable plastics and form the basis for the production 
of tailor-made biopolymers for medical applications (Rehm 2010), where fermentation strategies (Sun et 
al. 2009) and the supplied carbon sources (Hartmann et al. 2004) highly influence the final monomer 
composition of the PHA. However, despite the substantial body of work on PHA production by P. putida 
strains, it is not yet clear how the bacterium re-arranges its whole metabolism when it senses the 
limitation of an inorganic (N, S, P, or O) nutrient and the excess of fatty acids as carbon source, resulting 
in a large accumulation of PHAs within the cell. Recently, we demonstrated that this pathway acts as an 
important energy and carbon buffer under nutrient-limiting conditions that guarantee efficient growth (de 
Eugenio et al. 2010a). Inactivation of the pathway for PHA accumulation under low nitrogen growth 
conditions resulted in oxidation of the excess carbon source, rather than transforming it into biomass or 
secretable compounds, which could be further reused as carbon or energy sources (Escapa et al. 2012). 
Chemostat operation allows the single limitation of carbon or of any desirable nutrient in the culture. It is 
as well the best alternative to perform controlled and highly reproducible cultivation for studying the 
phenotype of a given organism (Hoskisson and Hobbs 2005), especially when applying hightroughput 
technology to capture the transcriptome, proteome, or metabolome of the cell for a given phenotype. 
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Using continuous cultivation, Egli and Quayle demonstrated that varying the ratio of carbon/nitrogen in 
the feed medium had a significant influence in the cellular and enzymatic composition on the yeast H. 
polymorpha (Egli and Quayle 1986). In addition, three distinct growth regimes were recognized: namely 
carbon-, carbon-nitrogen-, and strict nitrogen-limiting growth. By applying those fermentation strategies, 
P. putida GPo1 (formerly known as P. oleovorans) was investigated for its capacity to accumulate PHAs 
from different carbon sources (Durner et al. 2000; Durner et al. 2001; Hartmann et al. 2004), proving the 
high metabolic flexibility of GPo1 which was reflected in part by the broad dual-limiting area between the 
two single-nutrient limitation (for excellent review, see (Egli 1991)). One of the most interesting findings 
is that the dual-nutrient-limiting regime can result in the accumulation of PHA at levels comparable to 
those under strict nitrogen limitation (Zinn et al. 2004). As this results in less amounts of carbon used for 
comparable levels of PHA, this can substantially reduce the production costs.  
The release of the P. putida KT2440 genome sequence in 2002 (Nelson et al. 2002) has enabled 
researchers to gain deeper and broader insights into the mechanisms underlying PHA biosynthesis (de 
Eugenio et al. 2010b; Escapa et al. 2011b; Liu et al. 2011; Ouyang et al. 2007). The progress in high-
throughput technologies such as transcriptomics, proteomics, and metabolomics has expanded greatly the 
understanding of the genotype-phenotype relationships in Pseudomonas. As a result, several constrain-
based metabolic models of this versatile organism have been developed (Nogales et al. 2008; Puchalka et 
al. 2008; Sohn et al. 2010). These models are useful to improve the production of PHAs, especially since 
the metabolic responses for PHA synthesis, which takes place preferably under the limitation of several 
nutrients, are complex and so far not well-understood. The work herein described aims to unravel the 
differences between carbon-, carbon-nitrogen-, and nitrogen-limited cultures, where omic-wide 
measurements were integrated to interpret the resulting phenotype for each condition in terms of 
PHA/biomass production in P. putida KT2442. This can contribute to set a basis for further development 
of new biocatalysts and processes that can contribute to reducing the production cost, which remains the 
biggest obstacle for the economically viable industrial production of PHAs. 
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3.3 Material and Methods 
Culture conditions and bacterial strain. Pseudomonas putida KT2442 (Bagdasarian et al. 1981) was 
grown in a defined mineral medium (MM) consisting of (per liter) 12.8 g Na2HPO4.7H2O, 3 g KH2O4, 1 g 
NH4Cl, 0.5 g NaCl, supplemented with 0.12 g of MgSO4.H2O, and trace elements (mg·l
-1
): 6.0 
FeSO4.7H2O, 2.7 CaCO3, 2.0 ZnSO4.H2O, 1.16 MnSO4.H2O, 0.37 CoSO4.7H2O, 0.33 CuSO4.5H2O, 0.08 
H3BO3 and 0.1% (v/v) TEGO antifoam D 2310 (EVONIK Industries, Essen, Germany). Sodium 
decanoate (98% purity, Sigma-Aldrich) was used as a single carbon source in concentrations ranging 
from 1.90 to 8.70 g·l
-1 
(Table 1). For the preparation of the feeding solution, MM was mixed with sodium 
decanoate and TEGO antifoam. After mixing it, the solution was autoclaved for 25 min at 121°C. Once 
the bottle reached room temperature, it was placed into the clean bench where sterile trace elements 
solution and MgSO4.H2O (by filtration) were added. Continuous cultivations were carried out under 
aerobic conditions at a dilution rate (D) of 0.1 h
-1
, working volume of 0.8 liter in 1 liter top-bench 
BIOSTAT B1 bioreactor (Sartorius B Systems GmbH, Melsungen, Germany) at 30°C, constant stirring 
speed 700 r.p.m., and the pH was maintained at 7.0 by adding 2 M H2SO4. The working volume was kept 
constant by removing the fermentation broth through a peristaltic pump and recording the weight with a 
balance placed under the bioreactor. The aeration rate was set at 1 l·min
-1
 using a mass flow controller 
(PR4000, MKS Instruments, Wilmington, MA, USA), a mixture of air and pure oxygen was used to 
ensure that the dissolved oxygen was above 30% of air saturation. A paramagnetic gas analyzer 
(Servomex Xentra 4100, USA) to record online the concentrations of carbon dioxide and oxygen in the 
course of the process was coupled to the gas outlet of the bioreactor. 
Analytical procedures. Once the considered steady state was attained, - i.e. that the optical density of the 
biomass, dissolved oxygen concentration, and exhaust gas concentration remained constant for at least 
four residence times - samples from chemostat cultures were taken using a peristaltic pump and processed 
as follows: 
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Cell and ammonium concentration. Cellular dry weight was determined by centrifuging 5 ml samples of 
the culture broth for 10 min at 4°C and 10,000 rpm (centrifuge 5810 R, Eppendorf, Germany) in pre-
weighed tubes, washing the cell pellets once with distilled water and drying them at 80°C until a constant 
weight was obtained. Cell growth was recorded by measuring the optical density at 600nm (Ultraspect 
2000 UV/VIS, Hitachi, Japan). The ammonium concentration in the cell-free supernatant was measured 
using the LCK 303 kit of Hach Lange (Danaher, USA). The detection limit of this method was 
1.9 mg of N/liter.  
Fatty acid and PHA analysis. PHA compositions of the polymer produced, as well as the cellular PHA 
content and fatty acid concentration were determined by gas chromatography (GC) and mass 
spectrometry (MS) of the methanolyzed fatty acid and polyester. Methanolysis procedure was carried out 
by suspending 5–10 mg of lyophilized aliquots in 2 ml of chloroform and 2 ml of methanol containing 
15% sulfuric acid and 0.5 mg ml
-1
 3-methylbenzoic acid (internal standard) and then incubated at 100°C 
for 4 h. After cooling, 1 ml of demineralized water was added and the organic phase containing the 
resulting methyl esters of monomers was analysed by GC-MS (Lageveen et al. 1988). An Agilent 
(Waldbronn, Germany) series 7890A coupled with a 5975C MS detector (EI, 70 eV) and a split–splitless 
injector were used for analysis. An aliquot (1 ml) of organic phase was injected into the gas 
chromatograph at a split ratio of 1:50. Separation of compounds was achieved using a HP-5 MS capillary 
column (5% phenyl-95% methyl siloxane, 30 m X 0.25 mm i.d. X 0.25 mm film thickness). Helium was 
used as carrier gas at a flow rate of 0.9 ml min
-1
. The injector and transfer line temperature were set at 
275°C and 300°Crespectively. The oven temperature programme was: initial temperature 80°C for 2 min, 
then from 80°C up 150°C at a rate of 5°C min
-1
 and finally up 200°C at a rate of 10°C min
-1
. EI mass 
spectra were recorded in full scan mode (m/z 40-550).  
Exometabolite profile. 1D 
1
H nuclear magnetic resonance spectra were recorded on a Bruker AVANCE 
DMX600 NMR spectrometer at 300 K of aqueous centrifuged supernatant containing 10% D2O to give a 
final volume of 0.66 ml. The water signal was suppressed using standard Bruker software. For 
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comparison purposes, spectra of solutions of initial medium containing antifoam and sodium decanoate 
were recorded. In order to acquire an appropriate signal-to-noise ratio, spectra were recorded under 
standard conditions (sweep width: 20 ppm, acquisition time: 1.36 s, pulse delay: 1 s, number of scans: 
1400, Bruker program noesypr1d). 
Transcriptomics. Aliquots of 10 ml of culture broth were placed in RNAprotect buffer (Qiagen), cell 
pellets were further frozen at -80°C. Isolation of total RNA was performed using RNeasy kits (Qiagen), 
according to the instructions provided by the manufacturer. Progenika Biopharma (Vizcaya, Spain) P. 
putida Oligonucleotides Arrays were used for all transcriptional analyses. Fluorescently labelled cDNA 
for microarray hybridizations was obtained by using the SuperScript Indirect cDNA Labeling System 
(Invitrogen), as recommended by the supplier. In brief, 20 µg of total RNA was transformed to cDNA 
with Superscript III reverse transcriptase using random hexamers as primers, and including aminoallyl-
modified nucleotides in the reaction mixture. After cDNA purification, the Cy3 or Cy5 fluorescent dyes 
(Amersham Biosciences) were coupled to the amino-modified first-strand cDNA. Labeling efficiency was 
assessed using a NanoDrop ND1000 spectrophotometer (NanoDropTechnologies). Equal amounts of 
Cy3- or Cy5-labelled cDNAs, one of them corresponding to the control and the other one to the condition 
to be analyzed, were mixed and dried in a Speed-Vac. The scanning was done with a GenePix 400B 
Scanner (Molecular Devices Corporation, Sunnyvale, California, USA.) at a 10 µm resolution. The 
images were quantified with GenePix Pro 5.1. Images from Cy3 and Cy5 channels were equilibrated and 
captured with a GenePix 4000B (Axon) and spots were quantified using GenPix Pro 5.1 software (Axon). 
The microarrays were analyzed using various packages from the Bioconductor suite (Gentleman et al. 
2004). The results of image analysis were read in using the 'limma' package. The quality of the chips was 
analyzed with the 'arrayQualityMetrics' package (Kauffmann et al. 2009). The intensity values were 
background-corrected using the “'normexp” method of the limma package (Ritchie et al. 2007) and 
normalized with the variance stabilization method (Huber et al. 2002). The significantly differentially 
expressed genes were identified by fitting the linear model (using the functions 'lmFit' and 'eBayes' from 
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the 'limma' package) (Smyth 2004). Genes for which the adjusted p-value (by Benjamini-Hochberg 
method) was lower than 0.05 and the fold change exceeded 2 in either direction were assumed to be 
significantly expressed. 
Proteomics. For protein extraction, cells were centrifuged at 8000 g for 15 minutes (centrifuge 5810 R, 
Eppendorf, Germany), the pellet was washed twice with PBS solution (pH 7.4). The resulting pellet was 
resuspended in lysis buffer consisting of 7 M urea, 2 M thiourea, 4% w/v CHAPS, 20 mM Tris base and 
30 mM 1.4 dithiothreitol (DTT), together with protease inhibitor cocktail tablets. The lysis was 
complemented by sonication (Labsonic U, B. Braun, Germany. The resulting solution was 
ultracentrifuged (Sorval ultracentrifuge OTD-Combi, Thermo Electron, Germany) at 12000 g, 4°C for 30 
min. The supernatant, corresponding to the soluble protein fraction, was aliquoted and further precipitated 
by using the 2-D Clean-Up Kit (GE Healthcare, USA). Analytical determinations were carried out with 
100 mg of protein mixture determined by Bradford (Bio-Rad protein assay, Bio-Rad, USA), diluted up to 
300 ml with rehydration solution (7 M urea; 5% w/v Serdolit; 2 M thio-urea; 4% w/v CHAPS; 20 mM 
Trizma base) in the presence of ampholytes and under reducing conditions, on ReadyStrip IPG strips, 17 
cm, pH 3–10 (Bio-Rad, USA). Passive rehydration was carried out for 2 h at 20°C on the focusing tray. 
Samples were covered with silicon oil to avoid dehydration. Active rehydration was performed at 50 V 
for 12 h. Isoelectric focusing was done at a final voltage of 10 000 V on ProteanIEF cell (Bio-Rad, USA) 
until reaching 75 kVh. Focused samples were stored at -70°C until the second dimension step. Focused 
ReadyStrip IPG strips were equilibrated first in equilibration buffer containing 6 M urea, 0.375 M Trizma 
base (pH 8.6), 30% v/v glycerin, 2% w/v SDS and 2% w/v DTT and later in the same buffer replacing 
DTT with 2.5% w/v iodoacetamide. After equilibration, second-dimension separation was performed on 
12–15% gradient SDS-polyacrylamide 20 X 20 cm gels with the focused sample embedded in 0.5% IEF 
agarose in a Protean Plus Dodeca Cell (Bio-Rad, USA) at 100 V overnight. The gels were fixed in 10% 
trichloroacetic acid solution for a minimum of 3 h, stained with 0.1% w/v Coomassie Brilliant Blue G-
250 solution overnight and finally de-stained with distilled water. Images of the 2-DE gels were captured 
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with a molecular imager GS-800 calibrated densitometer (Bio-Rad, USA) and processed using Phoretix 
2D image analysis software version 2004 (NonLinear Dynamics, UK) for protein DE analysis. 
Differential expression was defined as the ratio of spot protein expression in a comparative image to the 
expression of a corresponding spot in a reference image. Up- and down-regulation of protein expression 
were considered when the p value was less than 0.05, and twofold (or higher), and 0.5-fold (or lower) DE 
values, correspondingly. Protein spots were excised manually from the gels. Spots were de-stained and 
digested overnight using sequence grade modified trypsin (Promega, USA). The peptides were eluted and 
desalted with ZipTip (Millipore, USA). For MALDI-TOF analysis, the samples were loaded along with a-
cyano-4-hydroxycinnamic acid matrix. The target was then analyzed using an Ultraflex II ToF (Bruker 
Daltonics, USA). The resulting spectra were used for Peptide Mass Fingerprint (PMF) and analyzed using 
FlexAnalysis 2.0 and Biotools 2.2 software (Bruker Daltonics). Proteins were identified using an in-
house-licensed Mascot search engine (version 2.1.0, Matrix Science, U.K.). The P. putida KT2440 
database was searched using the MALDI TOF-MS data with carbamidomethyl cysteine as a fixed 
modification and oxidized methionine as a variable modification. Trypsin was specified as the proteolytic 
enzyme and up to two missed cleavages were allowed. 
Metabolomics. For metabolite extraction, cells were centrifuged at 4629 g, 4 °C for 3 minutes (centrifuge 
5810 R, Eppendorf, Germany). The supernatant was discarded and the cell pellet was resuspended in 10 
ml pre-cooled 0.9% NaCl (w/v). After further centrifugation the supernatant was discarded to complete 
the washing step. Furthermore, the resulting cell pellet was resupended in 1.5 ml cold methanol 
containing 60 µl ribitol (0.2 g·l
-1
) as internal standard. To achieve cell lysis the tubes were incubated in an 
ultrasonic bath (15 min, 70 °C). After the samples were cooled down for 2 min by placing them on ice, 
1.5 ml of deionized H2O was added and vortexed for 30 s. The addition of 1 ml chloroform was followed 
by mixing and centrifugation (9000 g, 4 °C, 5 min); 1 ml of the polar phase was subjected to a 
centrifugal-vacuum concentrator to allow evaporation. For derivatization, dried pellets were redissolved 
in 20 µl pyridine, containing 20 mg ml
-1
 methoxyamine hydrochloride, at 30 °C for 90 min under shaking. 
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After adding 32 µl N-methyl-N-trimethylsilyltrifluoroacetamide, samples were incubated at 37 °C for 
30 min, followed by incubation at room temperature for 90 min under continuous shaking. Finally, the 
samples were centrifuged at 14 000 g for 5 min and the supernatant was used for GC-MS analysis. All 
samples were analysed within 24 h after derivatization. A retention index marker (n-alkanes ranging from 
C10...C36 in cyclohexane) was used to convert retention times to retention indices. 
GC-MS analysis was performed on a FinniganTrace mass spectrometer (ThermoFinnigan, San Jose, 
USA). In summary, 1 µl of the derivatized samples was injected in randomized sequence into a 
programmed temperature vaporizer in split mode (1:25) at 70 °C. After an initial time of 0.2 min the 
injector was ramped at 14 °C s
-1
 to a final temperature of 280 °C and held for 5 min. The gas 
chromatograph was equipped with a J&W DB-5MS column (30 m x 0.25 mm ID, 0.25 µm film 
thickness). The GC was operated at constant flow of 1 ml min
-1
 helium. The temperature program started 
at 70 °C, held for 1 min, followed by a temperature ramping of 10 °C min
-1
 to a final temperature of 
325 °C, which was held constant for 6 min. The transfer line temperature was set to 275 °C. Ion source 
temperature was adjusted to 200 °C. Full-scan mass spectra of m/z 40...460 were collected at an 
acquisition rate of 2.5 scans sec
-1
. Solvent delay time was 4.5 min. For data acquisition Xcalibur 1.2 
(Thermo Scientific) was used. 
All chromatograms were processed using MetaboliteDetector (Hiller et al. 2009) for targeted analysis. 
The software supports automatically deconvolution of all mass spectra from a chromatogram and 
calculates the retention indices. The obtained mass spectra were matched against the reference with a 
minimum match factor of 0.75. Compounds were annotated by retention index and mass spectra 
comparison to our in-house library. Selected fragment ions unique for each individual metabolite were 
used for quantification. Finally, each compound was normalized by peak area from the internal standard 
(ribitol) and given cell dry weight. 
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Transcmission electron microscopy 
Bacteria were fixed with 2% glutaraldehyde and 3% formaldehyde in cacodylate buffer (0.1 M 
cacodylate, 0.01 M CaCl2, 0.01 M MgCl2, 0.09 M sucrose, pH 6.9) for 1 hour
 
on ice, washed with 
cacodylate buffer, and osmificated with
 
1% aqueous osmium for 1 hour at room temperature. Samples 
were
 
then dehydrated with a graded series of acetone (10%, 30%, 50%,
 
70%, 90%, and 100%) for 30 
minutes at each step. Dehydration
 
in the 70% acetone step was done with 2% uranyl acetate overnight.
 
Samples were infiltrated with an epoxy resin according to the
 
Spurr formula (Spurr, 1969). Ultrathin 
sections were cut with a diamond-knife, counterstained with uranyl acetate and lead citrate,
 
and examined 
in a TEM910 transmission electron microscope (Carl
 
Zeiss, Oberkochen) at an acceleration voltage of 80 
kV. Images were taken
 
at calibrated magnifications using a line replica. Images were recorded digitally 
with a Slow-Scan CCD-Camera (ProScan, 1024x1024, Scheuring, Germany) with ITEM-Software 
(Olympus Soft Imaging Solutions, Münster, Germany).  
 
Calculations 
In the chemostat, the physiological parameters, as well as the PHA productivity where calculated 
according to the following equations: 
    [g·g-1]   (1) 
 
    [g·g-1]   (2) 
 
[g·(g·h)-1]  (3) 
 
[g·(g·h)-1]  (4) 
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The nutrient yield coefficient for carbon and nitrogen were used to calculate the boundaries according to 
the procedure described by Egly and Quayle (1986): 
 
[mol·mol-1]  (5) 
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3.4 Results and Discussion 
3.4.1 Physiological response of Pseudomonas putida under nutrient-limited conditions 
In order to evaluate both the capacity of P. putida to produce medium-chain-length 
polyhydroxyalkanoates (mcl-PHAs) and the global cellular responses at the transcriptome, proteome, and 
metabolome levels, continuous cultivations were conducted under different nutrient-limited conditions. At 
least three independent experiments for each nutrient limitation were performed under aerobic chemostat 
conditions. To achieve metabolic steady-state at a dilution rate (D) of 0.1 h
-1
, five to eight times the 
residence volume were necessary to attain constant macroscopic physiological parameters across the time. 
From continuous and flask-culture cultivations the maximum specific growth rate (µmax) on decanoate 
was found to be 0.53 h
-1
 (data not shown). When D approaches µmax, the amount of PHA decreases within 
the cell (Huijberts and Eggink 1996). Therefore, we imposed a low D (0.1 h
-1
) to obtain as much PHA as 
possible. Decanoate was employed as the unique carbon and energy source, whereas ammonium [NH4
+
] 
as used as the nitrogen source. We changed the (C0/N0) ratios in the feed medium by keeping the nitrogen 
concentration invariable and increasing the carbon quantity. We were able to establish three specific 
environments within the chemostat: carbon- (C), carbon-nitrogen- (dual), and strictly nitrogen- (N) 
limited cultures, which were confirmed by the analytical measurement of the fermentation broth (Table 
1). 
1
H spectra were recorded from samples taken under all limiting fermentation conditions. In all cases 
there was no significant accumulation of acetate or any other soluble small molecular weight metabolite.  
To obtain insights into the distribution of the metabolized carbon within the cell, we have performed a 
carbon mass balance analysis for each condition tested (Fig. 1).  
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Figure 1. Fate of consumed carbon based on the carbon balance within the chemostat subjected to 
carbon, carbon-nitrogen, and nitrogen limitation.  
 
This was calculated based on number of moles of carbon consumed and generated within the chemostat. 
The C-mol content in the biomass (PHA-free) was assumed to be constant which corresponds to a 
molecular weight of 27 g (C-mol biomass)
-1
 (van Duuren 2011). The environment which is assigned less 
CO2 (in terms of percentage) among those tested conditions is the dual limitation. A similar percentage of 
carbon ended up in PHAs in carbon-nitrogen- and nitrogen-deprived cells. In decanoate and decanoate-
ammonium-limited cultures, mass-balances indicated that the entire carbon available in the reaction 
volume was converted to biomass, CO2, and PHA (Fig. 1). As shown in (Fig. 2A), the biomass yield on 
decanoate decreased when the ammonium concentration limited growth, expressing its major effect under 
strict nitrogen limitation. The physiological response of KT2442 to the nutrient-deprived environments 
differed in the build-up of biomass for both C-N- and N-limited cultures as compared with the C-limited 
culture. This might be due to the increased pool of metabolites suitable for PHA accumulation in the β-
oxidation pathway, which consequently decreases the buffer of precursor for biomass formation, affecting 
the energy efficiency not only for strict N-deprived cultures (Follonier et al. 2011), but also for C-N-
deprived cells.  
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Figure 2. Physiological parameters of chemostat subjected to nutrient limitations. A) Grams of 
biomass (PHA-free) per gram of decanoate; B) Grams of PHA per gram of decanoate; C) Grams of 
decanoate per gram of biomass (PHA-free) per hour; D) Grams of PHA per gram of biomass 
(PHA-free) per hour. 
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The PHA yield on decanoate was very similar for both dual and strict nitrogen limitation (Fig. 2B). 
Because of this, the additional carbon source is nearly superfluous, indicating potential for savings on the 
raw materials. Besides, the imposed carbon/nitrogen ratio to achieve the dual limitation environment 
(Table 1) was significantly higher than the calculated boundary of this condition, which is known to 
achieve a higher PHA yield (Durner et al. 2001). Remarkably, P. putida KT2442 showed a different 
behavior compared to P. putida GPo1 with regard to the residual biomass, since for KT2442 this was not 
constant under CN-and N-limiting growth conditions (Table 1). For GPo1, once the growth condition 
reached the dual limitation area, the residual biomass remained constant while the PHA content increased 
proportionally with respect  to the C0/N0 ratio in feed medium (Durner et al. 2000). In our study the 
maximum specific PHA production rate of KT2442 was obtained when the single nitrogen limitation was 
imposed to the chemostat (Fig. 2 D), reaching a value of 0.43 (g·(g h)-1). This productivity is 3.5-fold 
higher than the one showed by GPo1 with the same dilution rate while growing on octanoate (Durner et 
al. 2000), and 2-fold higher than the processes using 10-undecenoate as carbon source with also P. putida 
GPo1 (Hartmann et al. 2004).  
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Table 1. PHA production and relative monomer composition by P. putida KT2442 in continuous culture at D = 0.1 h
-1 
Limitation  (C0/N0)*  Y X/C Y X/N  (C0/N0)
b     Residual carbona  Residual nitrogena     CDWa  PHA contenta Monomer composition  
             Borders          (mol %)    
   (mol mol-1)  (g g-1) (g g-1) (mol mol-1) (g)  (g)     (g l-1)      (% CDW)  C6 C8
 C10 
 
Carbon   5.83  1.11 9.80    10.40  N.D.       0.112 ± 0.01 1.46 ± 0.04     25.78 ± 0.97 3.3 53.4 43.3 
 
Carbon-Nitrogen 16.56  1.16 16.67   N.D.  N.D. 4.35 ± 0.13     61.94 ± 4.95 4.8 42.8 52.4 
 
Nitrogen  26.97  1.01  17.74    20.50         1.53 ± 0.04  N.D. 4.63 ± 0.14     80.58 ± 0.24 4.3 40.2 55.5 
 
a
 Standard deviation (±) from at least three independent experiments. 
*C0/N0: Initial feeding ratio of carbon-nitrogen. 
N.D.: Not detectable 
b
 According to the procedure described by Egly and Quayle (1986) 
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3.4.2 PHA accumulation versus nutrient availability 
To assess the capability of P. putida to synthesize mcl-PHAs, we used gas chromatography to quantify 
intracellular polyester content and characterize the monomer composition from each individual chemostat 
culture. The heteropolymer was synthesized under each condition, with the accumulation range of the 
storage compound in the cell increasing when the (C0/N0) ratio in the feed medium is higher (see Table 1). 
P. putida KT2442 was capable of synthesizing PHA up to 26% of its total cell dry weight (CDW) in 
carbon-limited cultures. A similar PHA concentration (20% of CDW) was found when KT2442 was 
grown in oleic acid with a C-mol/N-mol ratio of 10 in continuous cultures (Huijberts and Eggink 1996). 
Such polymer accumulation is one of the special characteristics shown by P. putida strains under carbon-
limiting conditions. Nevertheless, not all of them reach high levels of PHA accumulation. In the case of 
P. putida GPo1 the polyester synthesis yielded 2% of the CDW during carbon-limited growth on 
heptanoate and octanoate, but with nonanoate PHA accounted for 19 wt% of the biomass (Durner et al. 
2001). Under dual limitation 62% of the CDW of KT2442 was composed of PHAs, whereas under strict 
nitrogen-limitation this was 81%. 
We were able to identify three saturated monomers in the polyester (Huijberts et al. 1992; Ouyang et al. 
2007) composed of 3.3 mole% of 3-hydroxyhexanoate (C6), 53.4 mole% of 3-hydroxyoctanoate (C8), 
and 43.3 mole% of 3-hydrodecanoate (C10) when carbon was the limited compound. The monomer 
composition present in this study is extremely similar when P. putida KT2440 was grown in batch 
cultures supplemented with decanoate (Huijberts et al. 1992). When decanoate is supplied as the only 
carbon source, the catabolic process occurs through the -oxidation pathway. This correlates with the 
chain length structure detected in the heteropolymer showing C10, C8, and C6 hydroxyl-fatty acids as 
monomers, as consequence of two carbons loss during each round of the metabolic cycle. Comparing all 
nutrient-limited regimes, no remarkable difference could be observed in the monomer distribution. 
However, when ammonia was the limiting inorganic nutrient, a slight increase (of approximately 10%) in 
C10 was observed. When both carbon and nitrogen were bellow the detection limit in the chemostat, the 
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monomer composition of the polymer was almost the same as the one observed in nitrogen deprived 
cultures (Table 1). Further discussion is made below (see fatty acid and PHA metabolism). 
 
3.4.3 Global multi-omics analysis of P. putida response under various nutrient limitations 
Transcriptomics 
Employing genome-wide microarray technology, we quantified the variation in gene expression levels of 
all three limiting conditions. As we set up our experiments under steady-state, the measurements reflected 
a snap-shot of the metabolic state under the desirable growth limitation by nitrogen or carbon-nitrogen. 
Three independent biological replicates were analyzed statistically after hybridization. The conditions of 
strict nitrogen limitation and carbon-nitrogen limitation were compared independently to carbon 
limitation, i.e. N vs. C and CN vs. C, respectively. The resulting intensities were treated using a different 
package from the Bioconductor suite (see material and methods). The classification of the resulting 
variations in gene expression were based on Cluster of Orthologous Groups (COG) 
(http://www.ncbi.nlm.nih.gov/COG/grace/cogenome.cgi?g=287) and illustrated in Fig. S1  
(supplementary material). In total, 215 genes were differentially expressed (P < 0.05), from which 36% of 
their gene products were assigned as having unknown function (Table S1). The analysis of N vs. C and 
CN vs. C revealed 42 and 31 upregulated genes, while those that had a fold change less than 0.5-fold 
were 17 and 125, respectively (Table S1, supplemental material). As such, the N vs. C and CN vs. C 
comparisons shared 20 Open Reading Frames (in grey background Table. 2), with 11 showing more than 
2-fold differential expression (Table 2).  
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Figure S1. Genes differentially expressed in response to the limitation of nitrogen and carbon-nitrogen 
limitation. The generated functional categories groups were based on COG data. 
 
Proteomics  
Proteome profiling of Pseudomonas putida was performed using two-dimensional electrophoresis gels for 
each limiting condition to gain insight into the PHA accumulation machinery. As performed in the 
transcriptome analysis the gels from N- and CN-limited conditions were overlapped against the gel of C-
limitation (master gel). The proteomic profile for the CN vs. C exhibited only 17 spots with differential 
expression (DE). A completely different scenario was detected by overlapping the nitrogen limiting 
growth gel with the master gel, giving 74 spots with differential expression. After searching the sequence 
similarity for protein identification (see materials and methods), out of these 74 spots, 45 met the 
requirements for protein identification. The proteins were classified using COGs and JCVI-CMR 
(http://cmr.jcvi.org/cgi-bin/CMR/CmrHomePage.cgi) and presented in table 3. The transcriptome 
response based on DNA microarray was compared to the proteome data. For C/N vs. C limitation only 5 
proteins matched with their corresponding gene expression, and for N vs. C limitation 6 fell into this 
category (Table 3, in grey background). Although, 2-D PAGE proteome analysis is one of the most 
employed techniques in the field, it did not capture the entire proteome of the tested conditions (no 
identification of PhaC or PhaF), thus having a significant impact on the comparison.  
  
 62 
 Chapter III 
 
Table 2. Selected genes differentially expressed within nitrogen (N) or carbon-nitrogen (C-N) 
limited cultures relative to carbon limited chemostat cultures. 
Cellular role category Locus tag Description Fold change 
   N C-N 
Energy metabolism     
 PP2638 Cellulose synthase operon C putative 3.9 4.3 
 PP0813 Cytochrome o ubiquinol oxidase subunit I 5.0 1.2 
 PP0814 Cytochrome o ubiquinol oxidase subunit III 4.4 -1.1 
 PP4050 Glycogen synthase 3.1 1.3 
 PP0555 Acetoin dehydrogenase alpha subunit -6.7 -8.3 
 PP0556 Acetoin catabolism protein -3.7 -4.6 
 PP0554 Acetoin dehydrogenase beta subunit -4.6 -4.2 
 PP0553 Acetoin dehydrogenase dihydrolipoamide -5.3 -4.0 
 PP0557 Acetoin catabolism regulatory protein -3.4 -3.6 
 PP2149 Glyceraldehyde 3-phospate dehydrogenase 1.5 -3.7 
 PP4715 Triosephosphate isomerase 1.9 -3.3 
 PP4737 D-lactate dehydrogenase putative -2.6* -3.1 
 PP0545 Aldehyde dehydrogenase family protein -1.9 -3.1 
 PP1083 Bacterioferritin-associated ferredoxin putative      1.4 2.9 
 PP3071 Acetoacetyl-CoA synthetase putative 1.1 -2.6 
 PP4736 L- lactate dehydrogenase -1.1 -2.5 
 PP4192 Succinate dehydrogenase hydrophobic 3.9* -2.4 
 PP4193 Succinate dehydrogenase cytochrome 2.7* -2.2 
 
Amino acid transport and biosynthesis 
   
 PP4842 Branched-chain amino acid ABC transport           15.9 5.8 
 PP4841 Branched-chain amino acid ABC transport 7.3 4.5 
 PP5075 Glutamate synthase small subunit 3.4 1.2 
 PP3021 Transporter LysE family -1.4 2.2 
 
Transport and binding proteins 
    
 PP4147 Peptide ABC transporter -1.1 -2.7 
 PP1076 Glycerol uptake facilitator protein 1.4 -2.9 
 PP3954 Periplasmic binding protein putative -1.9 -3.2 
Nitrogen metabolism     
 PP5234 Nitrogen regulatory protein P-II 25.1 12.2 
 PP5233 Ammonium transporter 13.7 2.6 
 PP1705 Nitrate reductase 4.1* 5.2 
 PP1703 Assimilatory nitrate reductase putative 2.3* 3.6 
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 PP2094 Nitrate-binding protein 4.5* 2.6 
 PP2092 Nitrate transporter 2.3* 3.7 
 PP2846 Urease accessory protein UreE 3.1* 2.8 
 PP2847 Urease accessory protein UreJ 2.6* 2.5 
 PP2843 Urease gamma subunit UreA 2.3 2.2 
Polyhydroxyalkanoate    
 PP5008 PHA granule-associated 1 protein (phasin) 6.1 2.5 
 PP5007 PHA granule-associated 2 protein (phasin) 3.1* 2.3 
 PP5003 PHA polymerase 1 3.4* 1.0 
 PP5005 PHA polymerase2 1.2 1.1 
Fatty acid and phospholipid metabolism    
 PP2050 Conserved hypothetical protein 28.4 1.2 
 PP2051 Acetyl-CoA acetyltransferase 27.9 -1.1 
 PP2049 Alcohol dehydrogenase iron-containing 28.3 1.1 
 PP2047 3-hydroxyacyl-CoA dehydrogenase family             20.9 1.1 
 PP2048 Acyl-CoA dehydrogenase putative 19.8 1.5 
 PP4550 Long-chain-fatty-acid-CoA ligase 4.2 1.5 
 
Stress response 
PP2437  Acyl-CoA dehydrogenase putative -1.4 -3.2 
 PP3781 Oxygen-independent Coproporphyrinogen III        7.5 -1.1 
 PP1185 Outer membrane protein H1 6.6 2.0* 
 PP1360 Chaperonin, 10 kDa 3.4 -1.1 
Other functions      
 PP2141 Hypothetical protein -4.0 -3.1 
 PP1659 Hypothetical protein -4.8 -2.4 
 PP0765 Hypothetical protein -7.1 -2.8 
 PP2685 Hypothetical protein 11.1 4.0 
 PP2686 Transglutaminase-like superfamily 6.6 4.6 
 PP2687 Conserved hypothetical protein 7.1 2.6 
 PP2689 Endoribonuclease  putative 1.7 2.5 
* 0.1 > P-value > 0.05 
Gray background indicates matching gene expression of N vs. C and CN vs. 
 
Relationships and discrepancies between transcripts and proteins  
The correlation between increased transcripts and their corresponding protein abundance is very poor as 
shown in Table 3 for CN vs. C and N vs. C comparisons. Earlier studies have previously shown this trend 
between mRNA and protein levels (Kolkman et al. 2006; Lu et al. 2007; Verhoef et al. 2010). It has 
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mainly been attributed to post-transcriptional events (Kolkman et al. 2006) e.g. translation efficiency or 
protein degradation, and/or false-positive results either on the mRNA or protein levels (Resch et al. 2006). 
The generated gels from the proteome analysis in this study were made in triplicate for each tested 
condition, giving a confident proteome profile. Therefore, the high discrepancy between the transcript and 
protein expression levels, for both comparisons, might be evoked by a post-transcriptional regulation. 
This is supported by the number of differentially expressed genes  especially while comparing CN vs. 
C limitation  and the matched protein/mRNA abundance. Nevertheless, to fully confirm this hypothesis 
further studies should be addressed with more accurate techniques by which thousands of proteins can be 
quantified and compared (Lee et al. 2011). In this study, a surprisingly high number of downregulated 
genes in CN-limitation relative to C-limitation was found (Fig. S1). This highly differs from the proteome 
profile (Table 3). In addition, it is interesting to see how P. putida KT2442 displays many changes at the 
transcription level, but at the translation level the final response is quite conservative upon CN limitation. 
One could propose that under CN-limitation the coupling between anabolism and catabolism is tighter 
than N-limitation, as it can be seen by the residual biomass formation under the mentioned conditions 
(Fig. 2). Therefore, it seems that dual limitation is more similar to C-limiting than N-limiting cultures, 
since the proteome profile which is a closer link than transcriptome to the final phenotype of the cell  
did not have a significant change for the dual limitation relative to strict carbon limitation (Table 3).  
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Table 3. Change in protein expression in response to nitrogen and carbon-nitrogen limitation in 
comparison with carbon-limitation. 
 Locus tag Gene 
symbol 
Protein  Transcript 
   D.E  aPeptides 
No. 
 Fold 
change 
P-
value 
Differential protein expression of CN vs. C      
Energy metabolism         
ATP synthase F1, α-sub PP5415 atpA only in CN  12  ND ND 
Glycogen debranching PP4055 glgX 4.5  20  1.9 0.05 
Acetolactate synthase PP3365  3.5  15  -1.0 n.s 
Isocitrate dehydrogenase PP4011 icd -5.0  28  -1.4 n.s 
Acetoin dehydrogenase α-sub PP0555 acoA -4.0  7  -8.3 0 
Acetoin dehydrogenase β-sub PP0554 acoB -5.6  23  -4.2 0 
Acetoin dehydrogenase PP0553 acoC -3.7  10  -4.0 0 
Nitrogen metabolism         
Nitrogen regulatory protein P-II PP5234 glnK only in CN  6  10.4 0 
Protein synthesis         
Elongation factor Tu PP0452 tuf-2 only in CN  16  -1.6 n.s 
Amino acid transport and 
biosynthesis 
        
Branched-chain amino acid ABC trans PP4841 livK 26.4  22  4.5 0 
Glutamine synthetase PP5046 glnA 2.2  28  1.0 n.s 
Signal transduction         
Response regulator PP5048 ntrC 6.7  43  1.7 n.s 
Transport and binding protein         
Outer membrane porin PP1206 oprD 2.7  11  -1.1 n.s 
Outer membrane porin PP2089 oprF 2.6  21  1.2 n.s 
Purine ribonucleotide biosynthesis         
adenylosuccinate synthetase PP4889 purA -4.4  16  -1.1 n.s 
Hypothetical protein PP2384  -2.8  6  1.5 n.s 
Protein fate PP0980 pepA -2.3  30  1.0 n.s 
Differential protein expression of N vs. C       
Energy metabolism         
Succinyl-CoA synthetase PP4185 sucD only in N  8  1.2 n.s 
ATP synthase F1, alpha sub PP5415 atpA only in N  13  ND ND 
Glycogen debranching PP4055 glgX 12.3  31  2.4 n.s 
Electron transfer flavoprotein PP4203  4.5  36  0.90 n.s 
Succinate dehydrogenase PP4191 sdhA 3.9  23  2.8 n.s 
NADH dehydrogenase I PP4123 nuoF 2.9  15  2.4 n.s 
Glycosyl hydrolase PP4053  2.6  21  3.0 n.s 
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Phosphoenolpyruvate synthase PP2082 ppsA 2.4  24  1.5 n.s 
Acetoin dehydrogenase β-sub PP0554 acoB only in C  23  -4.0 0 
Acetoin dehydrogenase PP0553 acoC only in C  10  -5.3 0 
Malate synthase PP0356 glcB -9.1  9  -1.2 n.s 
Aldehyde dehydrogenase PP0545 glcB -5.9  19  -1.9 n.s 
thioredoxin reductase PP0786 trxB -5.6  11  1.3 n.s 
Isocitrate lyase PP4116 aceA -4.2  19  1.3 n.s 
Isocitrate dehydrogenase PP4011 icd -2.1  14  1.1 n.s 
Fatty acid metabolism         
3-hydroxyacyl-CoA dehydrogenase PP2047  only in N  18  20.9 0 
Acetyl-CoA acetyltransferase PP2051 atoB only in N  20  27.9 0 
acetyl-CoA carboxylase PP0558 accC-1 8.3  27  1.3 n.s 
Fatty oxidation complex α-sub PP2136 fadB 3.1  13  2.3 n.s 
3-oxoacyl-CoA thiolase PP2137 fadA 3.0  23  2.4 n.s 
Fatty-acid CoA ligase PP0763  -2.9  15  -1.1 n.s 
Transport and binding protein         
Outer membrane porin PP2089 oprF 5.4  17  1.4 n.s 
ABC transporter PP1726  -25.0  15  1.2 n.s 
Amino acid transport and 
biosynthesis 
        
Branched-chain amino acid ABC PP4864  only in N  9  -1.1 n.s 
Amino acid biosynthesis PP5046 glnA 16.0  17  1.5 n.s 
Hydantoin racemase PP4310  8.8  15  1.2 n.s 
General amino acid ABC transporter PP1300 aapP 4.0  16  1.1 n.s 
amino acid ABC transporter PP1071  only in C  23  -2.0 n.s 
amino acid ABC transporter PP0282  -33.3  15  -1.2 n.s 
Branched-chain amino acid ABC  PP4867  -16.7  11  1.8 n.s 
Dipeptide ABC transporter PP0885  -5.0  22  1.2 n.s 
Amino acid biosynthesis PP0671 glyA-2 -3.6  20  -1.3 n.s 
Cell envelope         
Outer membrane protein H1 PP1185 oprH only in N  8  6.6 0.01 
Cellular processes         
Small multidrug resistance PP4930  4.9  216  1.1 n.s 
superoxide dismutase PP0915 sodB -20.0  4  -1.3 n.s 
DNA interactions         
Transcriptional regulator, LysR PP5375  -12.5  5  -1.5 n.s 
C4-type zinc finger protein PP4693  -11.1  5  1.4 n.s 
Protein fate         
ATP-dependent Clp protease PP2300  only in N  7  1.2 n.s 
Protein synthesis         
Elongation factor-G PP0451 fusA-1 20.0  26  1 n.s 
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Hypotetical protein PP2050  9.4  10  28.4 0 
Purine ribonucleotide biosynthesis PP0722 prsA 6.6  24  2.0 n.s 
Cell division PP1342 ftsZ -7.1  5  1.0 n.s 
Nucleoside interconversions PP0849 ndK -3.3  6  1.2 n.s 
Biosynthesis of co-factors  PP0842 iscS-1 -2.9  18  1.3 n.s 
Chemotaxis and motility PP4366 flil -2.3  7  1.3 n.s 
         
Gray background indicates matching between protein and transcript changes. 
a
Amount of peptides utilized for protein identification. 
ND. Not determined 
n.s. P-value not significant (> 0.05) 
 
Metabolomics 
Applying metabolome analysis, the peak areas of the Entner-Doudoroff-pathway and TCA cycle 
intermediates, and amino acids were determined and the mass corresponding masses quantified as 
described in Materials and Methods. The reproducibility of the analytical protocols (technical 
reproducibility) was determined for every sample set by establishing the relative standard deviation 
(RSD) among three samples harvested from the same fermentor. An average RSD of 22% was obtained 
for the technical reproducibility analyzed by GC-MS. In addition, an average RSD was calculated for 
specific metabolites in cells grown under the same condition in two independent cultivations (RSDC-
limitation 32%, RSDCN-limitation 28%, RSDN-limitation 49%). A Pearson correlation factor of 0.97 between 
measured metabolites in C- and CN-limitation was determined, which indicates slight differences in 
metabolite levels in the central carbon metabolism. Between C- and N-limitation, a Pearson correlation 
factor of 0.84 was obtained, but the biological variances were clearly higher in N-limitation within 
independent cultivations. Because of the high variability of specific metabolites among biological 
replicates, most probably due to the sampling procedure since we did not have a fast sampling device for 
quenching samples, their concentration levels could not be determined. Therefore, these metabolites were 
excluded from the discussion. Globally, 233 intracellular compounds were found in the chromatogram 
(containing systemic peaks derivates). According to their retention times and mass spectra, 80 metabolites 
could be identified by comparison to our in-house libraries.  
  
 68 
 Chapter III 
 
Table 4.     Metabolites of known level changes in comparison to carbon-limiting condition.  
 CN-limitation N-limitation 
Entner-Doudoroff-pathway   
Glucose up up 
2-Keto-3-deoxy-6Pgluconate up n.d 
3-Phosphoglycerate up n.d 
TCA cycle   
Citrate up up 
2-Ketoglutarate down down 
Succinate up down 
Fumarate up down 
Malate up down 
Amino acids   
Aspartate down down 
Cysteine up n.d 
Glutamate down down 
Glutamine up up 
Glycine up up 
Isoleucine up n.d. 
Ornithine n.d down 
Serine n.d up 
Threonine n.d up 
Tyrosine up down 
Valine up up 
n.d, not defined 
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3.4.4 Integrated analysis of the various “omics” results under different nutrient limitations 
The profile of metabolites in a cell at any given moment is closely related to the perturbation of gene 
expression and the modulation of protein function (Saito and Matsuda 2010). All together, the data from 
these three levels of cellular response offer a more comprehensive global view of the changes taking place 
under limitation of carbon and/or nitrogen sources. 
 
Nutrient limitation leads to modulation of several transport systems  
Pseudomonas putida KT2440 possesses approximately 370 cytoplasmic membrane transport systems, a 
feature that confers a greater transport capability to this versatile bacterium (Martins Dos Santos et al. 
2004). When comparing N- versus C-limitation, both the ABC transporter that belongs to the ATP-
binding cassette superfamily (encoded by PP_4864) and the general amino acid system AapP (encoded by 
PP_1300) were found, by proteomics, to have increased enzyme levels. In contrast, the genes encoding 
for proteins responsible for importing specific amino acids, e.g. glutamate, aspartate, and other 
compounds across the membrane, as well as periplasmic ABC transporters (encoded by PP_1071, 
PP_0282, PP_0112, PP_0885) (Table 3) were clearly downregulated. The dual limitation triggered high 
induction of only one ABC transporter, LivK (26.4-fold), which is one of the five proteins that form the 
branched-chain amino acid ABC transporter system and whose transcript level was found also to be 
induced (Table 2). Another amino acid transporter differentially expressed was LysE (encoded by 
PP_3021), as well as the urea assimilation system (UreE, UreJ, and UreA). The activation of urease may 
increase competitive fitness of bacteria under nitrogen-limiting conditions, since urease catalyzes the 
hydrolysis of urea to yield ammonia and carbamate (Mobley et al. 1995). For instance, many pathogens 
are able to colonize several niches in the human body due to the capacity of synthesizing nitrogen from 
urea, which helps them to overcome nitrogen limitation and thereby increase their potential to thrive in 
the host (Burne and Chen 2000). 
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The activation of the major porin protein OprF (encoded by PP_2089) in Pseudomonas, was indicated by 
the variation of the protein production by 2.6-fold and 5.4-fold in CN vs. C and N vs. C, respectively. 
OprF is involved in conferring several degrees of permeability to the cell (Bellido et al. 1992) and has 
been described as one the intrinsic factors in P. aeruginosa that strongly increases its resistance to 
antibiotics (Hancock et al. 1979; Peng et al. 2005). Another member of the porin family OprD (encoded 
by PP_1206) was exclusively induced by the dual limitation. The specific porin OprD has been shown to 
be implicated in the uptake of basic amino acids (Ochs et al. 1999; Trias and Nikaido 1990), facilitating 
their diffusion across the membrane. Such behavior indicates that the outer membrane composition 
follows a sensitive response to different signals, e.g. nutrient and/or metabolite concentrations, which is 
reflected in the modulation of specific transporters as needed. Furthermore, based on the high 
incorporation level of OprH exclusively under  N vs. C limitation, it seems that OprH, an outer membrane 
protein mainly responsible for membrane stabilization (Bell et al. 1991; Volkers et al. 2006), has an 
important role in KT2442 to cope with such elevated concentrations of decanoate used to reach the strict 
nitrogen limitation.  
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Figure 3. The scheme shows the changes on the metabolic response at gene, protein, and metabolite level, while growing the cells under 
carbon-nitrogen in comparison to carbon limitation using decanoate as carbon source.
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Fatty acid metabolism and PHA synthesis 
Fluorescent pseudomonads are able to metabolize a broad range of fatty acids. The cells first convert the 
fatty acid to the corresponding acyl-CoA thioester, which is further oxidized by the β-oxidation cycle 
(Steinbüchel and Lutke-Eversloh 2003). In this regard, three sets of FadAB genes have been described in 
KT2440 (Liu and Chen 2007): FadB and FadA (PP_2136 and PP_2137), FadBx and FadAx (PP_2214 
and PP_2215), and PP_2047 and PP_2048, which encode 3-hydroxyacyl-CoA dehydrogenase (FadB-like) 
and acyl-CoA dehydrogenase (FadE-like), respectively (Escapa et al. 2011b; Liu et al. 2011). Mutations 
of those genes showed that FadB and FadA played important roles in fatty acid degradation. However, the 
deletion of these genes could not completely block the -oxidation pathway and mutant strains produced 
PHA with longer chain monomers, likely due to a slower or defective -oxidation pathway (Escapa et al. 
2011b; Liu et al. 2011; Olivera et al. 2001). Several intermediates from the cycle, such as 2-trans-enoyl 
CoA, (S)-3-hydroxyacyl-CoA, and 3-ketoacyl-CoA, may serve as precursors for PHA synthesis. The 
latter intermediate is also cleaved by a -ketothiolase to yield acetyl-CoA and acyl-CoA, which have two 
less carbons compared with the one that initially entered the cycle. It is still unclear which intermediate 
contributes the most to produce the PHA polymerase substrate (R)-3-OH-acyl-CoA.  
Relative to carbon limitation, dual limitation showed no upregulation of enzymes or genes belonging to 
the -oxidation pathway (Fig. 3). It was not the case for the PHA gene cluster, where the phasins PhaI and 
PhaF were found upregulated (Table 2B).  The application of non-standard accumulating conditions e.g. 
all nutrients in excess or carbon limitation, has been reported to lead to the biosynthesis of polyesters 
(Huisman et al. 1992; Sun et al. 2007b). Nevertheless, a clear explanation of this phenomenon remains 
unknown. Based on our findings, we argue that P. putida KT2442 has a metabolic system in which the 
constant channeling of precursors for PHA accumulation occurs even under carbon limitation since the 
activity of the -oxidation pathway (fatty acid metabolism) and the PHA synthases (PhaC) did not change 
significantly between dual vs. carbon limitation (Table 2, 2B, and 3). Dual limitation resulted in 60% of 
the CDW as PHA. In this case the phasins may segregate and distribute more PHA (Galan et al. 2011) 
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than under carbon limitation, thus explaining their induction. In contrast, one set of proteins that showed a 
high expression level under N vs. C were related to the -oxidation cycle (Table 3). Indeed, this is the 
main route to metabolize aliphatic fatty acids, where the synthesis of two key metabolites, (S)-3-hydroxy-
acyl-CoA and acetyl-CoA, occurs simultaneously (Steinbüchel and Lutke-Eversloh 2003).  
The most over-expressed proteins in the fatty acid group, 3-hydroxyacyl-CoA dehydrogenase (encoded 
by PP_2047) and acetoacetyl-CoA thiolase (encoded by PP_2051), matched the remarkable induction of 
the gene cluster (PP_2047-PP_2051) at the mRNA level (Table 3). Recent evidence indicates that the 
protein product of the PP_2047 and PP_2048 open reading frames play very important roles in defining 
the PHA composition when fatty acids are the carbon source (Liu et al., 2011). In this respect, the 
observed enrichment in C10 found in the chemostat subjected to strict nitrogen limitation could be 
assigned to this dehydrogenase (PP_2047), since a dramatic shift was obtained in the monomer 
composition when the gene encoding this enzyme was knocked-out in KT2442 (Liu et al., 2011). 
Nevertheless, under dual limitation a similar monomer composition was found where no overexpression 
of PP_2047 could be observed at the proteome level. Based on these results, the defined monomer 
composition is a much more complex mechanism, where nutrients availability seems to be another 
important factor in controlling the fate of carbon in PHA synthesis. The protein FadA, which is the 
product of gene PP_2137 (Table 3) that belongs to the first set of genes coding for the -oxidation 
pathway in P. putida converting 3-ketoacyl-CoA into acetyl-CoA and acyl-CoA, is responsible for the last 
step in the -oxidation pathway and its expression showed a 3.0-fold increase. Furthermore, FadB was 
identified in two different spots where the average of its protein abundance was about 3-fold. AccC-1 
(encoded by PP_0558), an important protein involved in PHA synthesis (Huijberts et al., 1992), presented 
an 8.3-fold induction at N vs. C. It is noteworthy that this enzyme leads the initial step from acetyl-CoA 
to fatty acid de novo synthesis via malonyl-CoA and it is normally activated while growing on non-PHA-
related substrates such as sugar and gluconate (Rehm et al. 1998).  Taking all together, we could capture 
the difference at single molecular levels within the -oxidation pathway which is known to generate 
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intermediates for both biomass and PHA synthesis while fatty acids are supplied as carbon sources 
(Huijberts and Eggink 1996).  Huijbert and co-workers hypothesized that, at certain level of C/N ratio, the 
catabolic cycle for fatty acids switches its precursor preference, where instead of replenishing its 
intermediates for further oxidation, they are converted to PHA monomers. The finding in this study, 
where the residual biomass is not constant for C/N- and N-limited cultures  which was not observed in 
previous reports using P. putida GPo1  can be explain by the fact that several enzymes (FadB, FadA) 
and the gene cluster PP_2047-PP_2051 were differentially expressed when comparing N- vs. C-limiting 
growth. To further investigate which genes contributed most to this difference, we performed a 
transcriptome analysis comparing N vs. CN limitation using a very strict cut-off (Fold change > 3.5 and a 
P value < 0.03). Only 9 genes fell into this group (Table S3). The gene cluster PP_2047-PP_2051 exhibits 
more than 10-fold change in expression, and especially 3-hydroxyacyl-CoA dehydrogenase (encoded by 
PP_2047) was induced by 25-folds (Table S3). Based on this result, we can postulate that these ORFs are 
responsible for the diminishing on biomass formation, where the generated precursors within the 
oxidation cycle are redirected to PHA synthesis. On top of this, AtoB (encoded by PP_2051) is an 
enzyme that converts acetyl-CoA into acetoacetyl-CoA, a competing pathway for the TCA cycle. By a 
chain elongation process the acetyl-CoA is further condensed to 3-hydroxyacyl-CoA which is finally 
involved in PHA synthesis (Huijberts et al. 1994a), thus explaining the variation on biomass formation 
while comparing N vs. CN-limited growth in P. putida KT2442. With regard to the degradation system of 
the PHA granule in P. putida strains, recent studies have elucidated its influence on the metabolic balance 
of the cell. A negative PhaZ mutant strain from P. putida KT2442 had shown no increase in PHA yield 
but a reduction in the biomass concentration relative to the wild-type in batch cultures (de Eugenio et al. 
2010a). In the same study, it was demonstrated that PHA metabolism is an ongoing cycle where synthesis 
and degradation of the polyester is a simultaneous process. The same result was found using P. putida U, 
where the activities of PhaC and PhaZ are concomitantly active (Ren et al. 2010). It is worth to mention 
that in batch processes the kinetic limitation of a single nutrient takes place. As the present study was 
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performed using chemostat cultures, the cells are always exponentially growing, and therefore the 
physiological state of the cells differs from that shown in batch culture. The expression level of the phaZ 
depolymerase gene was not affected by the dual limitation in comparison to carbon limitation (Table 2B). 
This was not the case when nitrogen was the single limiting nutrient, showing an increase in phaZ 
expression (Table 2B). In agreement with one of our previous reports, the transcription levels of phaC and 
phaZ are highly correlated (de Eugenio et al. 2010b), thus indicating that such regulatory system is 
independent of the cultivation mode. This result supports the postulate that at high production rate of 
PHAs, the expression of the PhaZ is needed for the efficient production of the polyester (Garcia et al. 
1999; Ren et al. 2009). 
 
Energy metabolism 
TCA Cycle 
Once the fatty acid is oxidized in subsequent steps within the -oxidization cycle, acetyl-CoA is produced 
in the TCA cycle for energy generation and to sustain biomass and maintenance of the cell. Little is 
known about the regulation of this pathway when fatty acids are used as a carbon source and several 
nutrient limitations are imposed on the system. This is even more complex since intermediates and co-
factors of the Krebs cycle inhibit various enzymatic reactions within the cycle itself. For instance, NADH 
inhibits the isocitrate dehydrogenase, 2-ketoglutarate dehydrogenase, and isocitrate synthase. A crucial 
question is how the cells orchestres its metabolism to generate the energy for sustaining growth while 
simultaneously large quantities of PHA is being synthesized. The F0F1 synthase subunit alpha AtpA 
(encoded by PP_5415) (oxidative phosphorylation) was overproduced in dual and strict nitrogen 
limitation as compared to the carbon limitation. According to this finding, oxygen may also have an effect 
on the PHA production capacity in P. putida KT2442, but this statement still needs to be tested. The 
increased expression of the F0F1-type ATP synthase might be necessary for the cell in order to produce 
ATP molecules via the loss of proton-motive force, since high PHA yields decrease intracellular levels of 
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ATP (Ruiz et al. 2001). This effect might trigger different expression patterns from enzymes in the TCA 
cycle which is an important source of ATP generation along with the electron transport chain. As for the 
activity of the Krebs cycle, several genes were repressed under the dual limitation condition (Table 2). At 
the protein level only one enzyme, isocitrate dehydrogenase ICD (encoded by PP_4011), showed a fold 
change less than 2 (Table 3). The deficiency in the TCA cycle was confirmed by the metabolome 
analysis, where the increase in the pool size of succinate is a direct consequence of the repression of the 
sdhC and sdhD genes (Fig. 3, Table 2). The quantitative increase of fumarate and malate was also 
triggered by the dual limitation. As catabolism and anabolism are tightly coupled under carbon limitation, 
the cell may coordinate the energy requirement in such a way that no overflow of carbon is present.  
When both carbon and nitrogen are the limiting nutrients simultaneously, the gluconeogenesis pathway 
responded by repressing the genes tpiA and gap-2, which coordinate carbon re-funneling in the Krebs 
cycle and the conversion rates of dihydroxyacetone phosphate and glyceraldehyde3-phosphate (Fig. 3). 
The findings suggest that the carbon catabolic repression observed in the TCA cycle can be attributed to 
the high expression of the nitrogen regulatory protein NtrC (encoded by PP_5048) (Table 3), which is 
believed to control such an effect under nitrogen limitation (Hervas et al. 2008).  
High-energy compounds 
The strict nitrogen-limited cultures differ in their response to energy requirement relative to the CN-
limited cultures, principally due to the elevated level of enzymes participating in the Krebs cycle. 
Succinyl-CoA synthase SucD (encoded by PP_4185), which participates in the synthesis of the high-
energy compounds ATP and GTP, was identified in cells only under strict nitrogen limitation. Examining 
the metabolome, we found a decreased pool size of metabolites down- and up-stream of succinate 
dehydrogenase, namely succinate and fumarate, respectively (Fig. 4).  
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Figure 4. The scheme shows the changes on the metabolic response at gene, protein, and metabolite level, while growing the cells under 
strict nitrogen in comparison to carbon limitation using decanoate as carbon source. 
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All together it appears that the TCA cycle plays an important role in providing the necessary energy to the 
cell when PHAs are accumulated in increased proportion. Employing 2-D gels, we also identified a 
particular modulation of another important enzyme in the cycle, isocitrate dehydrogenase ICD (encoded 
by PP_4011), which can be repressed by various mechanisms together with the low expression of ICD, 
two enzymes of the glyoxylate shunt, isocitrate lyase (encoded by PP_4116) and malate synthase 
(encoded by PP_0356), were significantly downregulated at strict nitrogen limitation.  As such, this 
phenomenon can be directly related to the repression of the glyoxylate shunt, resulting in the 
downregulation of malate, which is the main precursor for oxaloacetate synthesis and is known as an 
essential compound for increasing the flux of acetyl-CoA into the TCA cycle (Klinke et al. 2000). In this 
sense, the inactivation of isocitrate lyase and isocitrate dehydrogenase in KT2442 led to the enhancement 
of PHAs when gluconate was used as the carbon source (Klinke et al. 2000). The inactivation of the 
glyoxylate shunt including the downregulation of malate synthase (GlcB) regulates the concentration of 
malate. Moreover, downregulation of isocitrate dehydrogenase (ICD) had a direct influence on the pool 
size of 2-ketoglutarate and consequently on glutamate formation. The cell triggered the activation of 
glutamine synthase (GlnA) to form glutamine to counteract the decreased pool of precursor for the 
synthesis of amino acids. In this respect, the metabolome profile showed an increase in the concentration 
of glutamine under CN vs. C limitation. No change in glutamine concentration was observed at N vs. C 
limitation, although GlnA was also found upregulated. Another metabolite that is directly regulated by the 
expression of isocitrate dehydrogenase is citrate. Studies on bacteria and yeast subjected to nitrogen 
limitation (Hua et al. 2004; Morgunov et al. 2004), have shown repression of isocitrate dehydrogenase. 
Morgunov and co-workers found an increased concentration of citrate in yeast probably caused by the 
high ratio of NADH/NAD
+
, which inhibits isocitrate dehydrogenase. Notably, after comparing N vs. C 
and CN vs. C, the pool size of citrate increased under both conditions (Table 4). Although the expression 
of isocitrate dehydrogenase was found to be significantly reduced under dual limitation, the inactivation 
was not accompanied by a downregulation of enzymes belonging to the glyoxylate pathway, suggesting a 
distinct regulatory system in this particular environment.  
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Electron transport chain 
Another important finding while comparing N vs. C limitation was the high induction of genes encoding 
the cytochrome o ubiquinol oxidase Cyo (encoded by PP_0813-0814) (Table 2). Cyo is a terminal 
oxidase of the electron transport chain which is believed to sense the energetic state of the cell, thus 
controlling the catabolic pathways and the expression of different genes (Rojo 2010). In addition, terminal 
oxidases are highly regulated by oxygen concentration (Kawakami et al. 2010; Morales et al. 2006). Due 
to the high oxygen concentration supplied to the bioreactor in order to keep the oxygen tension above 
20%, it is most likely that such an environment affects the composition of the electron transport chain. 
One possible explanation for the reorganization of the terminal oxidase under strict nitrogen limitation, is 
to optimize the energy generation in the cell (Morales et al. 2006) since a remarkable energy 
accumulation in the polyester form is present. In addition, Cyo levels have been shown as being 
responsible for decreasing the expression level of many promoters in P. putida including the PalkB 
promoter (for alkane assimilation). Furthermore, rather than a carbon catabolic repression, this effect has 
been postulated as a general physiological control mechanism (Dinamarca et al. 2003). Whether or not 
Cyo modulates the expression of genes under strict nitrogen limitation is still a question to be answered. 
There is a clear correlation between the TCA cycle and the electron transport chain, as shown by the high 
expression of the protein succinate dehydrogenase (4-fold change) which stimulates the cytochrome o 
ubiquinol oxidase by supplying electrons directly to it.  
The overflow metabolism is one of the repeated trends of chemostats subjected to strict nitrogen 
limitation (Durner et al. 2000). Since the exo-metabolite profile did not contain any secondary metabolites 
under this condition, P. putida KT2442 seems to arrange its metabolism in such a manner that it blocks 
energy-spilling by strongly repressing enzymes involved in the pyruvate and acetate pathways (acoA, 
acoB, acoC, PP_0545) (Table 3), thus preventing the shortage of partially oxidized metabolites (Russell 
and Cook 1995). This may be desirable because of the huge channeling of the consumed carbon (reflected 
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in energy storage) towards polyester synthesis. Despite the dowregulation of those enzymes in the 
pyruvate and acetate pathways where acetyl-CoA is needed, there was a high expression of isoacetyl-CoA 
carboxylase and biosynthetic thiolase, which are the first enzymes responsible for channeling acetyl-CoA 
to de novo fatty acid and ketona bodies biosynthesis, respectively. Interestingly, it seems most likely that 
P. putida KT2442 channels the remaining acetyl-CoA into storage compounds by activating those 
pathways to save energy for later consumption (Fig. 4). 
 
(iv) Nitrogen and amino acid metabolism  
As seen in tables 2 and 3, the nitrogen regulatory protein P-II GnlK (encoded by PP_5234) showed a 
large change in both mRNA abundance and protein level, when Pseudomonas putida was subjected to 
dual limitation. This was not the case when we examined the proteome profile from strict nitrogen-
deprived cells, since the spot for this enzyme did not show differential expression compared to the 
carbon-limited cultures. The expression of GnlK is led by the nitrogen availability via the nitrogen 
transcriptional regulator NtrC in P. putida KT2442 (Hervas et al. 2009). We also found that KT2442 
displays the upregulation of NtrC when both carbon and nitrogen were completely depleted (Table 3).  
NtrC also modulates the expression of the glnA gene (Hua et al., 2004), which is positioned upstream in 
the glnA-ntrAB operon in Escherichia coli. Hervas and co-workers showed NtrC-dependency for the 
(glnA) gene in KT2442, postulating that it could be part of an operon together with (ntrB) and (ntrC) 
genes, like in enterobacteria. Notably, GlnA exhibited the highest levels of induction among the proteins 
associated to amino acid biosynthesis (Table 3) in the case of strict nitrogen limitation.  The condition 
also caused significant repression of several enzymes that were identified as serine 
hydroxymethyltransferase GlyA, putative hydantoin racemase (encoded by PP_4310), and branched-
chain amino acid aminotransferase IlvE. In the valine, leucine, and isoleucine metabolic pathway IlvE has 
a double function to either act together with leucine dehydrogenase in the synthesis/degradation of leucine 
or in the degradation of valine and isoleucine to glutamate by transferring nitrogenous groups. Another 
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enzyme responsible for the turnover of certain amino acids in the same family is GlyA, which carries out 
the conversion of glycine by transferring one-carbon group, giving serine as a product. Furthermore, it 
catalyzes the reaction of glycine with acetaldehyde to form threonine. Particularly, the downregulation of 
the periplasmic glutaminase-asparaginase protein occurred solely under strict nitrogen limitation. This 
protein is responsible for the uptake of the acidic amino acids, e.g. aspartate and glutamate (Sonawane et 
al. 2003b).  Carbon catabolite repression of the periplasmic glutamate/aspartate transporter took place 
when KT2440 was exposed to glucose or mono- and dicarboxylic acids (Sonawane et al. 2003a). 
However, the metabolome profile showed a decrease in the pool size of fumarate and succinate (Table 4). 
Therefore, there may be another system which drives the transport selectivity described here.  
 
(v)  Stress response proteins  
Besides their primary feature as a reservoir of energy and carbon, PHAs have displayed a key role in 
conferring robustness to the bacteria under unfavorable conditions, such as temperature, UV irradiation, 
chemicals, and osmotic pressure (Zhao et al. 2007). In contrast, based on the high polyester accumulation 
within the cell (Table 1), PHAs have also been postulated to act as a stressor, especially concerning 
protein synthesis and the activation of various protective proteins(Han et al. 2001). It is worth noting that 
all studies which stated such a stress produced by the polyester inclusion to the cell, have been performed 
in metabolically engineered E. coli (Han et al. 2001; Kang et al. 2008; Tessmer et al. 2007). The use of 
electron microscopy allows dimensioning how the cytoplasmic space has been occupied by the polymeric 
inclusion under production conditions (Fig. 5). 
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Figure 5. Electron-microscopic pictures of P. putida KT2442 when decanoate was in excess in 
continuous fermentation. 
 
In the current study a stress response of the cell while growing under CN- and N-limitation can be seen. 
The high expression level of elongation factor enzymes is the first indicator of such an effect. The protein 
abundance of TuF-2 (encoded by PP_0452, Table 3), one of the Tu- elongation factor enzymes, was 
extremely high under CN limitation. Besides its primarily role of binding and transporting the proper 
codon-specified aminoacyl-tRNA to the aminoacyl site of the ribosome, TuF-2 also has chaperon-like 
functions that enhance protein folding and stress protection(Caldas et al. 1998). Strict nitrogen-limited 
cultures exhibit overexpression of the elongation factor FusA-1 (encoded by PP_0451, Table 3), which is 
a GTPase (classified as a G-elongation factor) that is involved in the translocation of bacterial ribosomes 
along messenger RNA during protein biosynthesis (Rodnina et al. 1997). On the other hand, the protease 
enzyme PP_2300, which is involved in hydrolysis of proteins to small peptides, was strongly induced in 
the presence of excess carbon (Table 3). So far, the decreased expression level of Tu-elongation factor has 
been related to the reduced capability of a metabolically engineered Escherichia coli to synthesize 
proteins (Han et al., 2001). However, E. coli does not naturally accumulate PHAs, therefore it is not 
surprising that KT2442 showed a different proteome pattern for these elongation factor enzymes. Indeed, 
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the normal protein synthesis machinery is affected by the shortage of nitrogen; thereby the cell may react 
in such a way that guarantees the biosynthesis of the main building blocks (amino acids) of these 
macromolecules. In addition, the induction of the gene encoding the chaperonin 10 GroES (Table 2) was 
another metabolic adaptation against the stress produced by the nitrogen limitation. Han and colleagues 
also observed a high level expression of several heat shock proteins, arguing that the polyester inclusion 
disturbs the normal intracellular architecture due to its direct contact with the chromosome, resulting in 
activation of the heat shock response. Nevertheless, GroES also mediates protein folding. We suggest that 
this may be the principal reason for its incorporation since the genes coding the phasin enzymes were 
found to be induced (Table 1). The phasins prevent the disturbance of intracellular architecture by 
forming a protein layer covering the hydrophobic surface of the PHAs, thus creating a protective barrier 
between the core of the granule and the cytoplasm (Prieto et al. 2007). Very recently, we have 
demonstrated that the phasin PhaF is involved in granule cell localization and granule segregation during 
cell division by interaction with the chromosome (Galan et al. 2011). Based on our results, we cannot 
elucidate whether or not phasins enzymes, PhaF or PhaI, have an influence on stress protein formation. 
To address this question, mutants strain deficient of genes encoding for PhaF and PhaI should be 
generated and assessed, by comparing them against the wild-type strain at the proteomic level under well-
defined conditions (chemostat). 
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3.4.5 Process optimization for increasing PHA synthesis in chemostat culture based on a “top-
down” approach 
In order to increase the PHA accumulation within the carbon-nitrogen limiting condition, we looked 
deeply into the most significant changes at the protein and transcriptional levels, which are linked to 
energy metabolism. As PHA is an energy storage compound its accumulation dependents highly on the 
energetic state of the cell (Huisman et al. 1989). In the sections 3.4.4 (energy metabolism) was shown that 
genes belonging to the Electron Transport Chain and TCA cycle were differentially expressed under the 
tested conditions. Both pathways are modulated by several factors, with special importance being the 
oxygen availability (Kawakami et al. 2010). Therefore, the fermentor was supplied only with pure air 
instead of a gas mixture (70% air, 30% O2, keeping the same aeration rate, see material and methods) and, 
thus assessing the influence of this parameter on the PHA synthesis. Table 5 demonstrates the final PHA 
accumulation under the set conditions under strict carbon, dual and strict nitrogen limitation. No 
difference in PHA accumulation could be observed under carbon limitation. Also, total biomass yield on 
decanoate did not change at any tested condition (Table 5). Nevertheless, under strict nitrogen limitation 
the PHA yield drops from 80 to 56% of the cell dry weight. Supplying pure air increased the PHA yield 
by 21% under dual limitation, resulting in a total accumulation of 71% of CDW as PHA.  
 
 
 
 
 
 
 
Figure 6. Comparison in the PHA productivity under several nutrient limitations in chemostat cultures. 
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To our knowledge, this is the highest PHA yield (in terms of percentage) ever reached under dual 
limitation. In addition, it was possible to increase the PHA yield at the dual limiting condition (Fig. 6), 
which has proved to be the most efficient way to produce PHA in continuous process. These results 
clearly prove the importance of oxygen within the process of PHA synthesis. A possible explanation for 
such changes, when oxygen concentration dropped, is that PHA not only acts as an energy storage 
compound, but also as an electron-sink (Kosseva and Kennedy 1996).  It was first proposed in the early 
70s (Senior et al. 1972), where A. beijerinckii accumulated higher PHA under oxygen limitation in 
chemostat cultures either under nitrogen-limited or nitrogen-sufficient environments. Further studies with 
the same strain showed that NADH oxidase activity is reduced upon oxygen limitation, but the 
NADH/NAD ratios increase accompanied by the rise in PHA accumulation (Jackson and Dawes 1976). It 
was finally demonstrated that PHA can partially replace respiration, thus acting in a concert manner with 
it as an electron-sink (Carter and Dawes 1979).  
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Table 5. PHA production and relative monomer composition by P. putida KT2442 in continuous culture at D 0.1 h
-1
 and aeration rate 1(L/min) 
[pure air]. 
Limitation   PO2  Residual carbon  Residual nitrogen CDW           PHA content      Monomer composition  
                       (mol %)    
 
    (%)    (g)   (g)  (g l
-1
)      (% CDW) C6 C8 C10 
 
Carbon   66.3   N.D      0.131 ± 0.02  1.41 ± 0.08 24.32 ± 0.60 3.0 52.1 44.8 
 
Carbon-Nitrogen 25.7   N.D   N.D  4.21 ± 0.25 76.40 ± 1.14 4.7 40.8 54.3 
 
Nitrogen    0         1.44 ± 0.25   N.D  4.73 ± 0.18 56.43 ± 0.24 4.6 43.2 52.0 
 
a
 Standard deviation (±) from two independent experiments. 
N.D: Not detectable 
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It is noteworthy that all experiments described above were preformed with glucose as the carbon source. 
In this study, as decanoate was the unique carbon and energy source, the oxidation process occurred 
through the β-oxidation route, which replenishes precursors for both PHA and biomass synthesis. Because 
of the nature of the catabolic pathway, under strict nitrogen-oxygen limitation (Table 5), the PHA 
accumulation dropped as compared with oxygen-sufficient. Another scenario is governing the dual 
limitation, because there was enough oxygen, in both conditions, to oxidize the carbon source and make 
the pathway work efficiently, thus generating the needed precursor for the PHA synthesis. Therefore, the 
difference could lie at the level of acetyl-CoA, where two pathways, the TCA cycle and the de novo fatty 
acid synthesis, compete for it. A metabolically engineered strain from P. putida lacking the PhaG gene, 
which encodes for (R)-3-hydroxydecanoyl-ACP:CoA transacylase —being the main precursor for PHA 
synthesis from de novo synthesis— resulted in a reduction by 30% in the PHA yield compared with the 
parental strain KT2442 when decanoate was used as the unique carbon source (Liu et al. 2011). Thus, 
reflecting the key role of this route for the formation of PHA when the fatty acid is the carbon source. The 
reduction in the oxygen concentration in the culture may affect the respiration system, and as in A. 
beijerinckii, PHA may act to some extend as an electron-sink in P. putida KT2442.  
 
3.5 Conclusions 
By combining measurements of transcriptomics, proteomics, and metabolomics, under well-controlled 
nutrient limitations, we have shown that the underlying cellular wiring is remarkably different when two 
nutrients are limiting at the same time, as compared to those under single limitation. We have captured 
the response of P. putida KT2442 to the shift in resource distribution and how these changes 
activate/repress several metabolic pathways along with transporter systems. We have found that the 
modulation of the expression of outer membrane proteins  in particular porins  under nitrogen and 
dual limitation correlates with the specific uptake rate of decanoate within the chemostat. We have shown 
that these two conditions also promote the overexpression of many transporters for scavenging nitrogen 
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sources. The PHA content under nitrogen limitation was found to be the highest, followed by dual 
limitation and carbon limitation. The residual biomass was not constant for dual- and strict nitrogen-
limiting growth, showing a different feature in comparison to other P. putida strains. Furthermore, the 
high accumulation of PHA under carbon limitation is a result of the constant channeling of precursors for 
PHA biosynthesis since no significant difference could be observed within the -oxidation pathway at any 
omic level, when compared to dual limitation. Regarding energy generation, genes and proteins belonging 
to the electron transport chain system were found significantly upregulated when there was a considerable 
amount of PHA stored in the cell. To overcome the stress caused by the shortening of precursors for 
amino acid synthesis (nitrogen) and, consequently protein production, elongation factors along with 
chaperons guarantee the biosynthesis of the main building blocks (amino acids) of these macromolecules.  
The systems approach applied in this study has enabled us to gain substantial insights into the metabolic 
adaptation of Pseudomonas putida KT2442 to nutrient limitation. Owing to its comprehensiveness and 
integration, the knowledge generated will be of great assistance on the development of further metabolic 
engineering work in this versatile organism to both enhance and diversify the production of PHAs. Our 
findings, especially concerning the dual limitation that uses both the carbon and nitrogen sources in the 
most economical manner, have brought an alternative to fulfill one of the remaining gaps in further 
improving industrial production of PHAs. 
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CHAPTER IV. In silico-driven metabolic engineering of Pseudomonas putida for enhanced 
production of poly-hydroxyalkanoates 
 
This chapter has been published: Ignacio Poblete-Castro, Danielle Binger, Andre Rodrigues, Judith 
Becker, Vitor A. P. Martins dos Santos and Christoph Wittmann. Metabolic Engineering (2012). 
 
4.1 Abstract 
Here, we present systems metabolic engineering driven by in-silico modeling to tailor Pseudomonas 
putida for synthesis of medium chain length PHAs on glucose. Using physiological properties of the 
parent wild type as constraints, elementary flux mode analysis of a large-scale model of the metabolism 
of P. putida was used to predict genetic targets for strain engineering. Among a set of priority ranked 
targets, glucose dehydrogenase (encoded by gcd) was predicted as most promising deletion target. The 
mutant P. putida Δgcd, generated on basis of the computational design, exhibited 100% increased PHA 
accumulation as compared to the parent wild type, maintained a high specific growth rate and exhibited 
an almost unaffected gene expression profile, which excluded detrimental side effects of the modification. 
A second mutant strain, P. putida Δpgl, that lacked 6-phosphogluconolactonase, exhibited a substantially 
decreased PHA synthesis, as was also predicted by the model. The production potential of P. putida Δgcd 
was assessed in batch bioreactors. The novel strain showed an increase of the PHA yield (+ 80%), the 
PHA titer (+ 100%) and cellular PHA content (+ 50%) and revealed almost unaffected growth and 
diminished by-product formation. It was thus found superior in all relevant criteria towards industrial 
production. Beyond the contribution to more efficient PHA production processes at reduced costs that 
might replace petrochemical plastics in the future, the study illustrates the power of computational 
prediction to tailor microbial strains for enhanced biosynthesis of added-value compounds. 
  
 105 
 Chapter IV 
Key Words: elementary flux modes; pathway engineering; phosphogluconolactonase; glucose 
dehydrogenase; polyhydroxyalkanoates; in-silico design, Pseudomonas putida KT2440, systems 
metabolic engineering; bio-polymer; transcriptome 
 
4.2 Introduction  
Bio-based plastic materials are among the most important products to overcome the shortage of fossil 
resources and the environmental burden linked to conventional plastics produced from petroleum. 
Particularly, poly-hydroxyalkanoates (PHAs) have proven valuable to replace common oil-based 
polymers because of their similar mechanical and physical properties (Madison and Huisman, 1999).  
Through the past decades, short-chain-length PHAs such as poly(3-hydroxybutyrate) and related co-
polymers have been commercialized in the biopolymer market because of a well-established production 
process (Ryu et al., 1997; Wang and Lee, 1997), supported by knowledge on the underlying biosynthetic 
pathway at the molecular level (Rehm, 2003). However, these short-chain-length polymers reveal rather 
poor physical properties which restricts them to the production of soft plastic such as packaging films 
(Chen, 2009). This has recently shifted the interest to medium-chain-length PHAs with superior 
properties that promise a broader spectrum of applications (Kim et al., 2007) in the chemical industry 
(Chen and Wu, 2005), but also as material for medical purposes  (Zinn et al., 2001), protein purification 
(Rehm, 2007), and drug delivery (Grage et al., 2009). Pseudomonas putida KT2440 and related strains 
produce such medium-chain-length PHAs (Huijberts et al., 1992). Most of the investigations with this 
bacterium have focused on the use of fatty acids as carbon source, since these promote high accumulation 
of the biopolymer up to 80% of the cell dry weight (Poblete-Castro et al. 2012). The production of 
medium-chain-length PHAs on fatty acids has meanwhile been complemented by the identification of 
PHA regulatory factors (de Eugenio et al., 2010a; de Eugenio et al., 2010b), the generation of new co-
polymers (Liu et al., 2011) and process development (Kellerhals et al., 2000; Sun et al., 2007). As the raw 
material accounts for the most part of the production costs for PHAs (Yamane, 1993), one step ahead 
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towards a cost-effective process is the use of substrates, such as glucose, which are cheaper than fatty 
acids. Nevertheless, a previous report has shown that glucose-grown P. putida accumulates much less of 
the desired biopolymer as compared to other substrates, including fatty acids (Huijberts et al., 1992), 
which places sugar-based production as economically not viable against the conventional oil-based route.  
In this regard, systems metabolic engineering now opens novel avenues to enhance the synthesis of value-
added products. As the genomic repertoire of P. putida comprises the entire set of enzymes to synthesize 
PHAs, there seems no direct need to insert heterologous genes in first instance. In fact, a re-engineering of 
its metabolic pathway network towards improved PHA production appears more straightforward. Hereby, 
the sequenced genomes of different P. putida strains (Nelson et al., 2002; Tang et al., 2011; Tao et al., 
2011) and the genome-scale networks created (Nogales et al., 2008; Puchalka et al., 2008; Sohn et al., 
2010) now enable a next level of strain design, i.e. design-based systems metabolic engineering, which 
recruits systems-wide network modeling to predict genetic targets. The beauty of this approach was 
successfully demonstrated by model-based design of a bacterial strain that then accumulated 120 g L
-1
 
lysine with only 12 defined genomic traits (Becker et al., 2011). Design-based strain engineering is 
supported by powerful software tools such as Minimization of Metabolic Adjustments (MOMA) (Segre et 
al., 2002), and Optknock (Burgard et al., 2003), and more recently FluxDesign (Melzer et al., 2009). The 
latter is based on elementary flux modes and thus enables the simultaneous prediction of amplification, 
attenuation and deletion targets for any biological system of interest (Melzer et al., 2009). Here, we 
rationally re-designed P. putida KT2440 towards enhanced production of medium-chain-length PHAs 
using glucose as carbon source. Translating the computational design guided by FluxDesign into the 
laboratory, the metabolically engineered strain that carried only one predicted key mutation, revealed a 
100 % increase in the final PHA titer, a 50 % increase of the cellular PHA content and a 80 % in the PHA 
yield, relative to its parent strain, P. putida KT2440. This displays an important step towards industrial 
production of medium-chain-length PHAs using P. putida as a cell factory. 
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4.3 Materials and methods 
 
Strains and plasmids.  
The parent strain P. putida KT2440 (DSM 6125) was obtained from the German Collection of 
Microorganisms and Cell Cultures (DSMZ, Braunschweig, Germany). All PCR fragments generated for 
the construction of plasmids were sub-cloned into the plasmid pCR®2.1 (Invitrogen, CA, USA), 
transformed into E. coli 
(Martinez-Garcia and de Lorenzo, 2011) was used for the construction of pEMG_ PP1023 and 
P. putida 
gene PP1023, i.e. pgl that encodes for 6-phosphogluconolactonase, were amplified using Taq DNA 
polymerase (Qiagen, Venlo, The Netherlands) with primers UP1023XbaIF and UP1023ClaIR, as well as 
DOWN1023ClaIF and DOWN1023XmaIR (Table 1) and genomic DNA from strain P. putida KT2440. 
Both PCR fragments were inserted into the XmaI-XbaI restriction sites of pEMG, which generated 
pEMG_
the gene PP1444, i.e. gcd that encodes glucose dehydrogenase, were amplified using the primers 
UP1444KpnIF and UP1444R, as well as DOWN1444F and DOWN1444EcoRIR (Table 1). Both PCR 
fragments were fused by PCR (Shevchuk et al., 2004). The resulting fragment was integrated into pEMG 
via the EcoRI-KpnI restriction sites to generate pEMG_
transformed into E. coli CC118λpir (Herrero et al., 1990) to generate donor cells for the later tri-parental 
mating with P. putida KT2440 (Bagdasarian et al., 1981; Regenhardt et al., 2002) and the helper strain E. 
coli HB101 as described by (de Lorenzo and Timmis, 1994).  
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Genetic engineering of P. putida 
To generate single and double deletion mutants of Pseudomonas putida KT2440, genome editing was 
applied (Martinez-Garcia and de Lorenzo, 2011). For this purpose, the pEMG derivatives were first co-
integrated by a single crossover into the chromosome of P. putida KT2440 using tri-parental mating with 
E. coli HB101 as helper strain, as well as the donor strains E. coli CC118λpir pEMG_ PP1023 and E. 
coli CC118λpir 
was confirmed by PCR (data not shown). The successful genomic deletions were confirmed by PCR. 
 
Table 1. Primers used in this study 
Primer Sequence (5’-3’) 
UP1023XbaIF TCTAGACGGCCAGTACATTGCCGGCT 
UP1023ClaIR ATCGATGGTCCGCCAGTTCATGAGCCTT 
DOWN1023ClaIF ATCGATGGCCTGTCGATGACCCGTTCGCT 
DOWN1023XmaIR CCCGGGGGCGGTAGCCCAGGGCATAGC 
UP1444KpnIF GGTACCGGTTTCAAGCTCAGCGGCAG 
UP1444R CGACCGAAACGCGACACAAGGGTTAGAAACTGCTCTGGATCTTCAG
G 
DOWN1444F GATCCAGAGCAGTTTCTAACCCTTGTGTCGCGTTTCGGTCGCGCAGC 
DOWN1444EcoRIR GAATTCGACCTCGTCGGTCGGCTCGG 
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Medium 
P. putida strains were grown in a defined mineral medium (M9) consisting of (per liter) 12.8 g 
Na2HPO4
.
7H2O, 3 g KH2O4, 1 g NH4Cl, and 0.5 g NaCl. This basic solution was autoclaved and 
subsequently supplemented with 0.12 g of MgSO4
.
H2O, trace elements (mg L
-1
): 6.0 FeSO4
.
7H2O, 2.7 
CaCO3, 2.0 ZnSO4
.
H2O, 1.16 MnSO4
.
H2O, 0.37 CoSO4
.
7H2O, 0.33 CuSO4
.
5H2O, 0.08 H3BO3, and 18.5 g 
L
-1
 glucose (all filter-sterilized). 
Cultivations  
Flask experiments 
P. putida strains, kept as frozen stock in 25 % glycerol at -80°C, were streaked on Luria Bertani agar 
plates and incubated for one day at 30 °C. Single colonies were then picked from the plate and inoculated 
it into a 50 mL shake flask containing 10 ml of the above described medium and incubated overnight 
under aerobic conditions at 30 °C and 180 rpm (Innova, Enfield, USA) set. By taking a calculated volume 
of the obtained cell suspension from the pre-culture (to begin the PHA-accumulating process with an 
initial OD of 0.05), 1000 mL baffled shake flasks containing 200 mL of culture medium were inoculated 
and placed in a rotary shaker under aerobic conditions at 30 °C. Each culture was carried out by triplicate.  
Batch fermentations 
Batch fermentations were carried out in a 2L top-bench BIOSTAT B1 bioreactor (Sartorius B Systems 
GmbH, Melsungen, Germany) with a working volume of 1.5 L, at 30°C. The aeration rate was set to 0.5 
L L
-1
 min
-1
 using a mass flow controller (PR4000, MKS Instruments, Wilmington, MA, USA). The 
dissolved oxygen level was kept above 20% of air saturation by control of the agitation speed up to a 
maximum of 900 rpm. The pH was maintained at 7.0 by automatic addition of 0.5 M H2SO4 and 1 M of 
KOH.  
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Analytics of substrates and products  
Cell growth was recorded as optical density (OD) at 600nm (Ultraspec 2000, Hitachi, Japan). The cell dry 
weight was determined gravimetrically after collection of 10 mL culture broth for 10 min at 4°C and 
3,800 x g (Eppendorf 5810 R, Hamburg, Germany) in pre-weighed tubes, including a washing step with 
distilled water, and drying of the obtained pellet at 100 °C until constant weight. The ammonium 
concentration in cell-free supernatant was measured by a photometric test (LCK 303 kit, Hach Lange, 
Danaher, USA). The glucose concentration in cultivation supernatant and medium was analyzed after 
appropriate dilution by enzymatic analysis (2300 STAT Plus, Yellow Spring Instrument, Ohio, USA). 
Gluconate and 2-keto-gluconate were quantified by HPLC (Hitachi Elite LaChrom, Krefeld, Germany) 
equipped with an Aminex HPX 87 H column (Biorad, Hercules, CA, USA) as the stationary phase and 
12.5 mM H2SO4 as the mobile phase at 0.5 mL min
-1
 and 45 °C, and UV detection at 220 nm.   
 
PHA characterization and quantification 
PHA was first characterized by NMR to confirm its basic structure. For this purpose, 30 mL of culture 
were harvested (3,800 xg, 15 min, 4°C, (Eppendorf 5810 R, Hamburg, Germany). Then, the pellet was 
washed with deionized water, frozen at -20°C, and lyophilized in a freeze-dryer Alpha 1-4 LCS (Christ, 
Osterode, Germany). The obtained lyophilizate was suspended in 10 mL chloroform and kept for 3 h at 
80 °C to extract the PHA. The chloroform solution was filtered to remove cell debris and then 
concentrated by rotary evaporation. Subsequently, the PHA was isolated and purified by precipitation 
through drop wise addition into cold methanol. The methanol-chloroform mixture was decanted and the 
pure polymer was stored under nitrogen at -20 °C. For 
1
H-NMR analysis, 5-10 mg of polymer was 
dissolved in 0.7 mL deuterated chloroform (CDCl3), whereas 15-20 mg of polymer was used for 
recording the 
13
C spectra. 
1
H and 
13
C NMR spectra were recorded at 300K on a Bruker DPX-300 NMR 
Spectrometer (Bricker, Billerica, MA, USA) locked to the deuterium resonance of the solvent (CDCl3). 
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Chemical shifts are given in ppm relative to the signal of the solvent (
1
H: 7.26, 
13
C: 77.3) and a coupling 
constant in Hz. Standard Bruker pulse programs were used throughout.  
 
PHA compositions of the polymer produced, as well as the cellular PHA content concentration were 
determined by gas chromatography (GC) and mass spectrometry (MS) of the methanolyzed polyester. 
Methanolysis was carried out by suspending 5–10 mg of lyophilized aliquots (see above) in 2 mL of 
chloroform and 2 mL of methanol containing 15 % sulfuric acid and 0.5 mg mL
-1
 3-methylbenzoic acid as 
internal standard, respectively, followed by incubation at 100 °C for 4 h. After cooling, 1 mL of 
demineralized water was added and the organic phase containing the resulting methyl esters of monomers 
was analyzed by GC-MS. Analysis was performed in Varian GC-MS system 450GC/240MS ion trap 
mass spectrometer (Varian Inc., Agilent Technologies) and operated by the software MS Workstation 
6.9.3 (Varian Inc., Agilent Technologies). An aliquot (1 mL) of the organic phase was injected into the 
gas chromatograph at a split ratio of 1:10. Separation of the analytes of interest (i.e. the methyl esters of 
3-hydroxyexanoate, 3-hydroxyoctanoate, 3-hydroxydecanoate, 3-hydroxydodecanoate, 3-hydroxy-5-cis-
dodecanoate, 3-hydroxytetradecanoate) was achieved by a FactorFour VF-5ms capillary column (30 m X 
0.25 mm i.d. X 0.25 mm film thickness). Helium was used as carrier gas at a flow rate of 0.9 mL min
-1
. 
The injector and transfer line temperature were 275°C and 300°C respectively. The oven temperature 
program was: initial temperature 40°C for 2 min, then from 40°C up 150°C at a rate of 5°C min
-1
 and 
finally up to 280°C at a rate of 10°C min
-1
. Positive ions were obtained using electron ionization at 70 eV 
and the mass spectra were generated by scanning ions of m/z 50 to m/z 650. The PHA content (wt%) was 
defined as the percentage of the CDW represented by the polyhydroxyalkanoate. 
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Transcriptome analysis  
Aliquots of 10 mL of culture broth were transferred into RNA protect buffer (Qiagen, Hilden, Germany), 
and 5 mL of cold methanol (-80°C) was added to the tube and further centrifuge after which the 
supernatant was discarded. Cell pellets were stored at -80°C for further RNA extraction. Isolation of total 
RNA was performed using the RNeasy kit (Qiagen, Venlo, The Netherlands), according to the 
instructions provided by the manufacturer. An amount of 2 μg total RNA was then labeled, either with 
Cy3 or with Cy5 using the ULS-system (Kreatech, Amsterdam, The Netherlands) according to the 
manufacturers manual. Equal amounts of Cy3 or Cy5-labelled RNA, one corresponding to the control and 
the other one to the condition to be analyzed, were then mixed by pipetting. A 600-ng weight of labeled 
RNA was fragmented and hybridized to the microarray. Agilent 8x15K two-color microarrays (Agilent 
Technologies, USA), designed for Pseudomonas putida KT2440, were used for all transcriptional 
analyses. The microarrays were scanned using a GenePix Pro 4001 scanner and the GenePix 4.0 software 
(Axon Instruments, Foster City, USA). The microarrays were analyzed using various packages (see 
below) from the Bioconductor suite. The results from the image analysis were read in by the 'limma' 
package. The quality of the chips was analyzed with the 'arrayQualityMetrics' package (Kauffmann et al., 
2009). The intensity values were background-corrected using the “'normexp” method of the limma 
package (Ritchie et al., 2007) and normalized with the variance stabilization method (Huber et al., 2002). 
The significantly differentially expressed genes were identified by fitting the linear model (using the 
functions 'lmFit' and 'eBayes' from the 'limma' package) (Smyth, 2004). Genes for which the adjusted p-
value (by Benjamini-Hochberg method) was lower than 0.05 and the fold change exceeded 2.00 in either 
direction were considered to be differentially expressed. 
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Elementary flux mode analysis 
For elementary flux mode analysis, the genome-scale network of P. putida KT2440 (Sohn et al., 2010) 
was condensed into a large-scale network comprising the central catabolic reactions, energy metabolism, 
the entire set of anabolic pathways to  biomass, as well as the biosynthetic routes to the desired product 
PHA, and by-products such as gluconate or 2-ketogluconate. The list of reactions is provided in the 
supplement. Considering the monomeric composition of the PHA homo-polymer obtained by P. putida 
from glucose, carbon ten acyl CoA monomers were regarded as building blocks (Nogales et al., 2008). 
The network comprised different compartments for gluconate and 2-ketogluconate formation (periplasm) 
and all other reactions (cytosol) (Daddaoua et al., 2010). Elementary flux modes were calculated as 
described previously (Melzer et al., 2009). Evaluation of the obtained modes was carried out in Excel 
(MS Office, Windows, 2007) and provided relative pathway fluxes and yields for each of the modes as 
well as the theoretical maximum yield for PHA among all modes. In addition, the data set was used to 
predict deletion, attenuation and amplification targets for rational strain engineering based on metabolic 
pathway correlations, i. e. flux correlation coefficients between the target flux (PHA production) and the 
other fluxes in the network (Driouch et al., 2012; Melzer et al., 2009). 
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4.4 Results 
4.4.1 Growth and PHA production performance of the Pseudomonas putida wild type on glucose 
as carbon source 
The performance of the wild type P. putida KT2440 was assessed in minimal medium with 18.5 g L
-1
 
glucose as carbon source and a limiting amount of 350 mg L
-1
 ammonium as nitrogen source (Figure 1). 
This aimed at the characterization of its physiological properties to integrate these as realistic constraints 
into the subsequent model-driven strain design. The cells rapidly consumed glucose and exhibited 
exponential growth as long as ammonium was present in the medium. Subsequently, growth continued, 
but slowed down. As observed previously for P. putida (del Castillo et al., 2007; Vicente and Canovas, 
1973), gluconate was detected as major by-product. Gluconate accumulated in large amounts in the broth 
and reached a maximum level of about 12 g/L after 35 h of cultivation, when the glucose was completely 
consumed. The cells then switched to consume gluconate, which led to a further increase of the cell 
concentration. The final OD value corresponded to about 4 g L
-1
 of cell dry weight. The cells of P. putida 
KT2440 contained about 26 % of the desired polymer at the final harvest (Figure 2). During the process, 
the formation of 2-ketogluconate was almost negligible. A minor amount appeared only transiently during 
the first hours. The yield for biomass of 0.25 g (g glucose)
-1
 was relatively low, resulting in an overall 
PHA yield of 0.07 g (g glucose)
-1
.  
 
4.4.2 In silico network modeling of PHA production in the Pseudomonas putida wild type 
As next step, in silico design was carried out using the software tool FluxDesign to derive predictions for 
promising genetic targets (Melzer et al., 2009; Driouch et al., 2012). For this purpose, elementary flux 
mode analysis was carried out for the metabolic network of PHA-producing P. putida, which considered 
glucose and ammonium as nutrients. The calculation yielded 1,029 unique elementary modes that defined 
the possible solution space for the investigated strain with all theoretically possible metabolic flux 
distributions. Interestingly, the yields for PHA, biomass and gluconate substantially differed between the 
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modes. This was obviously reflected by a strongly different pathway use, being a first indication that 
fluxes are inherently linked to production properties. The most common product, found in 82 % of the 
modes, was biomass, whereas gluconate was observed for 29 % of the modes. PHA production was found 
in 24 % of the modes. The maximum product yield, found among all the modes, was 0.4 mol mol
-1 
on 
basis of the assumed C10 building block. This value defined the theoretical optimum of PHA production 
from glucose in P. putida. Taking the molecular weight of the monomer (MW = 170 g mol
-1
) into 
account, the resulting optimum yield was 0.37 g (g glucose)
-1
 on a mass basis. Obviously, it was 
significantly higher as compared to the real value found for the wild type (0.07 g g
-1
), leaving substantial 
space for strain improvement.  
 
 
 
 
 
 
 
 
 
Figure 1. Growth of P. putida KT2440 on glucose under PHA-producing conditions.  
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4.4.3 In silico flux design for superior PHA production  
The model-driven strain design on basis of these elementary modes was now focused to reflect the actual 
physiology of the parent strain considered the actually occurring substrates and products of the wild-type 
based process. To this end, a careful selection of a subset of modes from the total data set was performed. 
On basis of the obtained cultivation data (Figure 1), we decided to only including modes with 
simultaneous production of PHA and gluconate, whereas biomass formation was left optional due to the 
intentionally introduced growth limitation by ammonium. The further pathway analysis therefore focused 
on a selected set of 54 modes, representing the metabolic state that was most close to the observed 
production characteristics of the wild type. These modes were now screened for promising genetic targets 
via flux correlation coefficients between the target reaction towards PHA and all other individual 
reactions through the network. As illustrated in Figure 2, numerous reactions in the entire network had 
substantial impact on PHA production. Several reactions exhibited negative flux correlation coefficients 
and obviously competed with the production, whereas other showed positive correlation and were found 
supportive. By the  concept and algorithm of FluxDesign, this information could be translated and 
visualized as priority ranked list of deletion, attenuation and amplification target (Melzer et al., 2009; 
Driouch et al., 2012). Most strikingly, glucose dehydrogenase in the periplasm was predicted as deletion 
target with the highest priority with regard to PHA production (Figure 2). Glucose 6-phosphate isomerase 
was predicted as important deletion target. A negative influence was also predicted for the TCA cycle, 
obviously withdrawing the polymer precursor acetyl-CoA. Selected reactions were found beneficial for 
PHA synthesis. This was most pronounced for glucose 6-phosphate dehydrogenase, identifying the G6P 
node as key switch point for rational strain engineering. In addition, pyruvate dehydrogenase appeared as 
promising amplification target, probably in line with its supply of acetyl-CoA, as also true for all 
reactions downstream of glyceraldehyde 3-phosphate that lead to this precursor.  
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Figure 2. In silico driven metabolic engineering for the prediction of targets towards optimized 
production of PHA in Pseudomonas putida. Pathway correlations were determined from calculated 
elementary modes and are indicated in green (positive correlation) and red (negative correlation). 
Reactions with most pronounced correlations represent deletion (red) or amplification (green) 
targets. 
 
Overall, the model identified glucose dehydrogenase and glucose 6-phosphate dehydrogenase as two key 
targets for PHA production. The flux of glucose dehydrogenase, linked to gluconate secretion, was 
negatively coupled to PHA production efficiency, probably due to the competition for carbon (Figure 4 
A). An elevated polymer synthesis can be only realized at low or diminished flux through this reaction. 
The opposite is true for the glucose 6-phosphate dehydrogenase flux. In all the modes, the flux through 
this reaction obviously supports superior PHA production (Figure 4 B). Based on Flux Design, selected 
mutants were generated. The deletion strain P. putida KT2440 Δgcd that lacked glucose dehydrogenase 
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aimed at superior PHA production as predicted by the model. In addition, the mutant P. putida KT2440 
Δpgl, deficient in the PHA supporting pathway via glucose 6-phosphate dehydrogenase, served as 
interesting and relevant proof-of-concept for the model-based approach. Both mutants did not contain any 
foreign DNA, which is desirable regarding industrial application due to the non-use of antibiotic markers 
(Poblete-Castro et al., 2012a). 
 
4.4.4 Construction and evaluation of PHA-producing capacity of different metabolically 
enginnered P. putida strains 
 
The novel strains were first evaluated in batch-flask experiments under PHA-producing conditions. Most 
beautifully, the design-based strain P. putida KT2440 Δgcd revealed a 60 % increase in the final PHA 
concentration as compared to the parent strain (Figure 2). In line, also the PHA yield of 0.10 g (glucose)
-1
 
was substantially higher upon the elimination of gcd, thus having an excellent match with the in silico 
prediction. It was also interesting to see that the deletion of pgl strongly reduced the PHA formation by 
almost 50 %, which also nicely matched with the in silico design (Figures 3 and 4 B). Cell dry weight as 
well as PHA synthesis dropped by almost by 50% as compared to the wild type strain (Figure 3). 
Recently, genome-scale modeling of P. putida KT2440 (iJP815) (Puchalka et al., 2008), along with the 
OptKnock approach (Burgard et al., 2003), predicted that a double mutation (pgl and gcd genes) in P. 
putida KT2440 would increase PHA production. In contrast Flux Design suggested that only gcd should 
be deleted, whereas pgl was identified as important reaction to be amplified. This was also tested in the 
present work by construction of the double deletion strain P. putida KT2440 Δgcd-pgl (see material and 
methods) and its evaluation for PHA-synthesis. The Δgcd-pgl strain synthesized slightly more PHA than 
the wild type, but was less efficient than the single mutant P. putida KT2440 Δgcd (Figure 3).  
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Figure 3. Cell dry weight and PHA content (% wt) of the wild type P. putida KT2440 and the 
deletion mutants P. putida KT2440 ∆gcd, ∆pgl, ∆gcd-pgl. 
 
Figure 4. Metabolic pathway correlation of PHA production and (A) gluconate production or (B) 
glucose 6-phosphate dehydrogenase flux. Negative correlation for gluconate secretion indicates 
gluconate synthesis as promising deletion target for improved production. Contrarily, positive 
correlation for the glucose 6-phosphate dehydrogenase flux suggests amplification of the encoding 
gene. Data are given as relative molar fluxes normalized to the substrate influx.  
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4.4.5 Transcriptome profiling of the designed producing strains P. putida Δgcd and Δgcd-pgl 
To study the response of the complex glucose metabolism from a more global perspective, gene 
expression of the superior single mutant P. putida Δgcd and the double mutant P. putida Δgcd-pgl was 
compared to the parent wild type. Four biological replicates each were used for the analysis. Remarkably, 
both over-producing strains exhibited a rather unaffected expression of genes in the central metabolic 
pathways (Table 3). The network of P. putida thus seemed capable to fully redirect the fluxes towards the 
desirable compounds via the enzymatic set available, reflecting a high versatility. Concerning the PHA 
biosynthetic pathway, the ORFs PP5008 and PP5007, encoding for the phasin enzymes PhaI and PhaF, 
respectively, were up-regulated, whereas the other genes were unaffected. Overall, only 34 genes were 
differentially expressed (Table 2). More than 50% of the genes were hypothetical proteins (COG 
classification), whereas genes with known function belonged to energy metabolism, cell envelope, 
regulatory function, PHA metabolism, and transport and binding proteins (Table 2 and 3). The lrgA and 
lrgB genes were down regulated most (Table 2). Although their function is not fully understood, it is 
proposed that they act against cell death and lysis (Yamaguchi et al., 2011). The oxidative 
phosphorylation system, which provides the ATP, exhibited two genes with a lower transcript level 
(PP4650 and PP4651) relative to KT2440 (Table 2). Interestingly, Δgcd also showed an up-regulation 3-
hydroxybutyrate dehydrogenase (encoded by PP3073), which yields 3-hydroxybutyrate. One of the most 
important regulators for glucose metabolism, PtxS (encoded by PP3380), was found to be down-
regulated.  
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Table 2. Genes differentially expressed in the metabolically engineered strains as compared to the 
wild type Pseudomonas putida KT2440. 
Cellular role category Locus tag Description Fold change 
   Δgcd Δgcd-
pgl 
Energy metabolism     
 PP4650 Cytochrome d ubiquinol oxidase subunit 
II 
-5.0 -1.4* 
 PP4651 Ubiquinol oxidase subunit II -3.8 -1.7* 
 PP4655 Protocatechuate 3,4-dioxygenase -4.1 -13.7* 
 PP1444 Glucose dehydrogenase -2.3 -2.9 
 PP3161 Benzoate dioxygenase, alpha subunit -2.2 -2.1 
 PP5270 D-amino acid dehydrogenase -2.0 -1.6 
 PP1023 6-phosphogluconolactonase -1.4 -3.8 
 PP4666 3-hydroxybutyrate dehydrogenase  3.3 1.0 
 PP4667 Methylmalonate dehydrogenase  3.6 1.1 
Regulatory function    
 PP2695 LysR family transcriptional regulator -4.7 -13.3 
 PP3380 PtxS family transcriptional regulator -2.2 -1.9* 
Cell envelope    
 PP4626 LrgA family protein -7.4 -2.9 
 PP4625 LrgB family protein -4.5 -3.4 
 PP1185 Outer membrane protein H1 -1.9* -2.2 
Transport and binding proteins    
 PP0057 major facilitator family transporter  2.3 1.6 
 PP1400 major facilitator superfamily (MFS)  2.4 1.3 
     
 
* p-value > 0.05 
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Table 3. Expression profile of genes belonging to  PHA biosynthesis and central metabolic pathways 
in the metabolically engineered strains as compared to wild type Pseudomonas putida KT2440. 
Gene name Locus tag Description Fold change 
   Δgcd Δgcd-
pgl 
PHA synthesis    
phaI PP5008 PHA granule-associated 2.4 1.7 
phaF PP5007 PHA granule-associated  2.5 1.6 
phaC1 PP5003 PHA polymerase  1.4 1.4 
phaC2 PP5005 PHA polymerase  1.1 1.0 
phaZ PP5004 PHA depolymerase  1.1 1.0 
phaD PP5006 Transcriptional regulator  1.3 1.2 
phaG PP1408 Acyl-transferase  1.5 *2.0 
bdhA PP3073 3-hydroxybutyrate dehydrogenase 2.0 1.2 
Glycolysis/gluconeogenesis    
glk PP1011 Glucokinase -1.4 1.0 
pgi PP1808 Glucose-6-phosphate isomerase  1.1 1.0 
fbp PP5040 Fructose-1,6-bisphosphatase  1.1 1.1 
fda PP4960 Fructose-1,6-bisphosphate aldolase  1.0 1.0 
tpiA PP4715 Triosephosphate isomerase -1.0 -1.0 
gap1 PP1009 GAP dehydrogenase, type I -1.1 -0.9 
gap2 PP2149 GAP dehydrogenase, type II  1.0 -1.1 
pgk PP4963 Phosphoglycerate kinase -1.0 -1.1 
pgm PP5056 Phosphoglyceromutase  1.0 1.1 
eno PP1612 Phosphopyruvate hydratase -1.1  1.0 
pyk PP1362 Pyruvate kinase -1.2 -1.5 
Pentose phosphate pathways    
zwf1 PP1022 G6P dehydrogenase -1.3 -0.7 
zwf2 PP4042  -1.0 -1.0 
zwf3 PP5351   1.0  1.1 
gnd PP4043 6-phosphogluconate dehydrogenase -1.0 -1.0 
gnuK PP3416 Carbohydrate kinase -1.1 -1.0 
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kguK PP3378 Dehydroglucokinase -1.5 -1.5 
kguD PP3376 2-Ketogluconate 6-phosphate 
reductase 
-1.2 -1.2 
rpiA PP5150 Ribose-5-phosphate isomerase A  1.0  1.0 
rpe PP0415 Ribulose-phosphate 3-epimerase  1.0 -1.1 
tktA PP4965 Transketolase  1.0 -1.0 
tal PP2168 Transaldolase B -1.2 -1.2 
Entner-Doudoroff pathway    
edd PP1010 6-Phosphogluconate dehydratase  1.4 1.0 
eda PP1024 KDPG aldolase -1.7 -1.3 
Pyruvate metabolism    
acoA PP0555 Pyruvate dehydrogenase 1.0 1.0 
 PP0545 Aldehyde dehydrogenase 1.2 1.1 
acsA PP4487 Acetyl-CoA synthetase -1.0 -1.0 
accC-2 PP5347 Pyruvate carboxylase -1.3 1.0 
ppsA PP2082 Phosphoenolpyruvate synthase -1.1 -1.1 
ppc PP1505 Phosphoenolpyruvate carboxylase -1.0 1.1 
TCA cycle    
gltA PP4194 Citrate synthase -1.0 1.1 
acnA PP2112 Aconitate hydratase  1.1 1.1 
acnB PP2339 Aconitate hydratase -1.2 -1.1 
icd PP4011 Isocitrate dehydrogenase  1.0  1.1 
sucA PP4189 2-Oxoglutarate dehydrogenase -1.1 -1.2 
sucD PP4185 Succinyl-CoA synthetase sub alpha  1.1 1.1 
sucC PP4186 Succinyl-CoA synthetase sub beta      1.0 1.1 
sdh PP4191 Succinate dehydrogenase -1.3 -1.5 
fumC PP0944 Fumarate hydratase -1.0 1.0 
mdh PP0654 Malate dehydrogenase  1.0  1.1 
Glyoxylate shunt    
aceA PP4116 Isocitrate lyase 1.3 1.1 
glcB PP356 Malate synthase  1.0 1.1 
     
* p-value > 0.05 
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4.4.6 Evaluation of the designed PHA hyper-producer P. putida Δgcd in batch bioreactors 
It was now important to validate the potential for medium chain length PHA production of the designed 
strains in a sophisticated process environment in bioreactors that allowed controlling the process settings 
more precisely than it was possible in the initial shake flask studies (Figure 3). The culture profile of the 
parent strain P. putida KT2440 on glucose as the sole carbon and energy source is given in Figure 5 A. 
During the initial period of about 12-15 h, glucose and ammonium were depleted, which as accompanied 
by accumulation of gluconate. During this phase, the strain had a specific growth rate of 0.53 h
-1 
(Table 4 
A). The PHA level began to increase, after ammonium was exhausted, and continuously increased up to a 
final value of 0.88 g L
-1
. At the final stage of the process, the cells consisted of about 25 % of the polymer 
(Table 4 B). Gluconate and 2-ketogluconate were detected as by-products in the fermentation broth. The 
designer mutant, P. putida KT2440 Δgcd, revealed a much higher synthesis of the desired polymer 
(Figure 5 B). The final PHA titer was 1.76 g L
-1
 and thus 100 % higher as compared to the parent strain. 
At the same time, also the cellular PHA content was substantially increased to more than 35 %, resulting 
in an almost doubled polymer yield (Tables 4 A and B). The deletion of glucose dehydrogenase did not 
substantially affect the value of μmax, since the cells still grew rather fast (Table 4 A, Figure 5 B). 
Synthesis of both organic acids was completely abolished, which obviously supported the redirection of 
carbon to anabolism and PHA biosynthesis. The monomer composition of the produced PHAs did not 
differ significantly between the strains (Table 5). The major monomer was 3-hydroxy-decanoate (C10), 
accounting for a fraction of more than 70%. In addition, also larger monomers up to C14 were 
incorporated.  
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Figure 5. Growth and PHA production of the parent wild type P. putida KT2440 (A), and the deletion 
mutants P. putida KT2440 ∆gcd (B), ∆pgl (C), ∆gcd-pgl (D). Cells were grown in lab scale bioreactors 
containing minimal medium with 18.5 g L
-1
 glucose as carbon source. All data reflect the mean from two 
parallel cultivations. 
 
 
Table 4 A. Physiological parameters of the wild type P. putida KT2440 and different metabolically 
engineered strains in batch cultures on glucose. All data reflect the mean and standard deviation from two 
parallel bioreactor cultivations (see Figure 5). 
            
  KT2440 Δgcd Δpgl Δgcd-pgl       
μ max           (h
-1
)  0.53 ± 0.02 0.45 ± 0.01  0.28 ± 0.01 0.31 ± 0.00       
YX/S
§ 
          (g/g)  0.19 ± 0.04 0.25 ± 0.02 0.17 ± 0.02 0.21 ± 0.01       
YXr/S
¤ 
         (g/g)  0.14 ± 0.04 0.15 ± 0.02 0.15 ± 0.02 0.15 ± 0.00       
YPHA/S         (g/g)  0.05 ± 0.00 0.09 ± 0.00 0.02 ± 0.04 0.06 ± 0.01       
            
§Total cell dry weight yield on glucose. 
¤Residual biomass yield on glucose. 
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Table 4 B. Final concentration of biomass (CDW), PHA, and secreted organic acids of the wild type P. 
putida KT2440 and different metabolically engineered strains in batch cultures on glucose. In addition, 
the PHA content of the cells is given. All data reflect the mean and standard deviation from two parallel 
bioreactor cultivations (see Figure 5) and the end of the process after 50 h. 
 
       
  KT2440 Δgcd Δpgl Δgcd-pgl  
CDW       (g/L)  3.6 ± 0.7 4.6 ± 0.3 2.4 ± 0.3 3.9 ± 0.3  
PHA      (wt%)    25.4 ± 0.9 38.0 ± 2.5 12.9 ± 3.3 29.5 ± 3.0  
PHA         (g/L)  0.9 ± 0.0 1.8 ± 0.0 0.3 ± 0.0 1.2 ± 0.2  
Gluconate (g/L)  4.4 ± 0.3 n.d. 4.7 ± 0.2 n.d.  
2-Ketogluconate(g/L)  n.d. n.d. 2.8 ± 1.0 n.d.  
 
n.d.: not detected, less than 0.05 g L
-1 
 
4.4.7 Characteristics of P. putida strains deficient in 6-phosphoglucolactonase   
The PPP enzyme 6-phosphoglucolactonase was deleted to test the model-based prediction that it is crucial 
for enhanced PHA production. The growth and production behavior of the corresponding deletion strain 
P. putida KT2440 Δgcd fully confirmed this prediction (Figure 5 C). The growth of the mutant was 
significantly retarded (Table 4 A). Moreover, PHA production was reduced almost 100 % as compared to 
the wild type. In contrast, the deletion enhanced the final concentrations of the by-products gluconate and 
2-ketogluconate in the process, which accumulated to high amounts, but obviously could not be re-
utilized by the strain during the later process stages. The negative effects of the deletion of 6-
phosphoglucolactonase were also obvious in the double mutant P. putida KT2440 Δgcd-pgl (Figure 5 D). 
In terms of PHA production is was slightly better than the parent wild type, but by far did not reach the 
performance of the FluxDesign strain.  
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Table 5. Monomer composition of medium chain length PHA produced by metabolically engineered P. 
putida strains in bioreactors. The data were determined by GC/MS and are given as relative molar 
fraction (%) of C6: 3-hydroxyexanoate, C8: 3-hydroxyoctanoate, C10:3-hydroxydecanoate, C12: 3-
hydroxydodecanoate, C12:1: 3-hydroxy-5-cis-dodecanoate, and C14: 3-hydroxytetradecanoate. 
             
Strain  C6 C8 C10 C12 C12:1 C14      
KT2440  n.d. 11.8 ± 0.2 73.0 ± 0.1  4.7 ± 0.2 9.4 ± 0.7 0.8 ± 0.3      
Δgcd  n.d. 14.0 ± 0.4 71.1 ± 0.8 4.6 ± 0.9 8.5 ± 0.4 1.1 ± 0.2      
Δpgl  n.d 8.6 ± 0.2 74.2 ± 1.0 4.8 ± 0.4 8.1± 0.7 6.5 ± 0.0      
Δgcd-pgl  n.d 12.2 ± 0.3 72.4 ± 0.6 5.3 ± 0.2 9.3 ± 0.1 0.8 ± 0.1      
             
 
n.d. : not detected, less than 0.2%. 
 
4.5 Discussion 
Pseudomonas putida and related species are known as natural producers of medium chain length PHAs, a 
promising sustainable substitute of oil-based plastics. Over more than three decades, P. putida has been 
investigated as a model strain for PHA production. Excellent studies have elucidated pathway 
organization (Huijberts et al., 1992; Rehm et al., 1998) and regulation of the PHA machinery (de Eugenio 
et al., 2010b) and of PHA granule formation (Galan et al., 2011; Prieto et al., 2007). These were 
complemented by the development of polymers with improved properties (Hartmann et al., 2004; Liu et 
al., 2011) and the increase of the total accumulation of these polyesters (Poblete-Castro et al., 2012b; Sun 
et al., 2009). With regard to the last point, fatty acids have been the most used carbon source, since they 
promote rapid and high accumulation of the biopolymer. Metabolic engineering of genes belonging to the 
β-oxidation pathway has led to an increased accumulation of PHAs in comparison to the wild-type strain 
(Ouyang et al., 2007). Nevertheless, the still low PHA volumetric productivity by the metabolically 
engineered strains along with the high cost associated to the use of fatty acids limits the competiveness of 
such strains against established petroleum-based plastic production processes. In this regard, the use of 
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low cost sugars such as glucose  - the carbon source of choice in industrial biotechnology (Straathof et al., 
2002) - would open a new avenue to compete against petrochemical plastics. 
In this work, we generated a metabolically engineered P. putida strain, which showed superior PHA 
accumulation. To achieve desirable features of the PHA-producer strain, we used a metabolic model and 
the FluxDesign framework to identify target genes to enhance the synthesis of medium chain length 
PHAs in P. putida KT2440 on glucose. With full consideration of network stoichiometry, glucose 
dehydrogenase (encoded by PP1444, gcd) was predicted as target with highest priority to be deleted for 
increased PHA synthesis (Figure 3), although the predicted mutation point seemed far away from the 
biosynthetic PHA pathway. The mutant P. putida KT2440 Δgcd indeed showed superior production 
performance. Already in shake flask tests, the PHA content of the cells increased by 60 % as compared to 
the parent strain (Figure 2), whereby no more by-products were secreted. The industrial production 
performance was then assessed by well-controlled bioreactor fermentations. This further increased the 
PHA titer of the designed strain, P. putida KT2440 Δgcd (Table 5 and Figure 5 A). Here, the single 
deletion of gcd allowed a remarkable increase of the PHA concentration of 100% as compared to KT2440 
(Figure 5, Table 5). It is important to note that the deletion strain could almost maintain growth rate of the 
wild type strain (Table 4), a crucial feature, since this value will finally affect the total PHA volumetric 
productivity.  
More than one decade ago, previous metabolic engineering of P. putida KT2442 was based on 
inactivating the enzyme isocitrate lyase (ICL) which consumes the main PHA precursor acetyl-CoA 
(Klinke et al., 2000). That obtained mutant strain (KT217) grew to a maximum specific growth rate of 
0.25 h
-1
 and showed a PHA content of 0.34 g L
-1
 (Klinke et al., 2000). Those values are far below that of 
the novel over-producer strain P. putida KT2440 Δgcd, which grows almost twice as fast and 
accumulates about 5-fold more PHA than KT217. It is interesting to note that the elimination of the 
glyoxylate shunt was also predicted by the model-based design, however, at a much reduced priority 
(Figure 2), which might explain the relatively weak improvement observed previously. The predictive 
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power of the model could be also verified by the second tested mutant strain (Δpgl). The simulations in 
Figure 2 show that glucose 6-phosphate dehydrogenase (pgl), supplying 6-phosphogluconate (Daddaoua 
et al., 2010; del Castillo et al., 2007), should be amplified to redirect metabolic fluxes to PHA formation. 
Deleting this gene resulted in poor PHA production (Table 5 and Fig 4, 5C), but rather stimulated the 
secretion of gluconate and 2-ketogluconate at high concentration (Figure 5C), reducing carbon 
availability for biomass and PHA synthesis. 
The generated double mutant (Δgcd-pgl) synthesized slightly more PHA than KT2440, but suffered from 
weak growth. This indicates the basic potential of using genome-scale metabolic reconstruction models to 
enhance PHA production in P. putida (Puchalka et al., 2008), although this approach failed to predict the 
single gene deletion as most promising and even suggested to disrupt the obviously rather important 6-
phospho-glucolactonase. One of the main reasons for the suboptimal outcome seems that the previous 
genome-scale model approximated PHA production by supply of its precursor acetyl-CoA. This neglected 
NADPH required for assembling the acetyl-CoA units into the building blocks of the polymer the long 
chain acyl units. Indeed, the two entry reactions into the PPP, predicted as amplification targets, supply 
NADPH, which is probably the major reason for their high importance. The full consideration of 
stoichiometry for the finally obtained product, as done here, seems therefore crucial in model-based 
design.  
With regard to transcriptional regulation, LysR and PtxS showed reduced expression levels (Table 2). 
Recent studies revealed that PtxS controls the expression of the enzyme for oxidation of gluconate to 2-
ketogluconate, its transport (del Castillo et al., 2008), and the compartmentalization of glucose 
metabolism in P. putida KT2440 (Daddaoua et al., 2010). Most likely due to the lack of carbon through 
the periplasm oxidation pathway in both mutants that lacked glucose dehydrogenase, this regulator was 
no longer active. LysR belongs to the largest family of transcriptional regulators in bacteria (Tropel and 
van der Meer, 2004). Nevertheless, we could not associate it to any specific pathway, although, operons 
from the benzoate pathway are under control of LysR-type regulators such as CatR and BenR (Cowles et 
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al., 2000; Rothmel et al., 1990). Concerning energy metabolism, the expression of genes belonging to the 
cytochrome ubiquinol oxidase in P. putida KT2442 were found to be up-regulated under high PHA-
accumulating condition (Poblete-Castro et al., 2012b). This effect was because - as PHA is an energy-
storage compound - the cell reorganizes the terminal oxidase accordingly, in order to generate enough 
ATP molecules for biomass and maintenance requirements. In this study, the repression of the 
cytochrome bd complex (PP4650-4651) (Table 2), could be assigned to normal operation of the 
cytochrome bo which is more effective in proton-pumping oxidase than bd, and thus better conserves the 
energy that is produced at the respiratory electron transport (D'mello et al., 1996). The phasin enzymes 
where the highest among expression levels of genes belonging to PHA metabolism (Table 2), as also 
previously reported (Poblete-Castro et al., 2012b) This confirms that these enzymes play a very important 
role in PHA formation not only when fatty acids are supplied as carbon source, but also in the presence of 
glucose. Interestingly, 3-hydroxybutyrate dehydrogenase (encoded by PP3073) was up-regulated in the 
single mutant strain. It has been shown by several reports that P. putida KT2442 cannot incorporate the 
monomer 3-hydroxybutyrate in the final monomer composition e.g. 3-hydroxydecanoate-co-3-
hydroxyoctanoate, due to the specificity of PhaC synthase for monomers containing at least six carbon 
atoms in their chemical structure (Kessler and Witholt, 2001; Steinbüchel and Lutke-Eversloh, 2003). 
Thereby is seems a good target for increasing the available carbon for PHA synthesis.  
 
4.6 Conclusion 
The present work describes the successful application of in silico driven systems metabolic engineering to 
biopolymer over-production. The tailored approach allowed an almost doubled production performance 
by only one single gene deletion, apparently located in the metabolic network far away from the 
biosynthetic PHA chain, which had been the major focus of research in the past. The computational 
predictions from the systems-wide design strategy thus seem a nice complementation to be integrated 
with previous metabolic engineering of the terminal biosynthetic chain (Liu et al., 2011) to further 
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generating improved biocatalysts for enhanced synthesis of medium chain length PHAs. The excellent 
performance of the designed strain visualizes the truly predictive power of design-based systems 
metabolic engineering that integrates the full stoichiometry of the pathway repertoire for strain 
engineering. It will interesting to evaluate the potential of the generated hyper-producer strains in high 
cell density fed-batch processes to exploit their production capacity and further close the gap between 
synthetic and bio-based plastic production. So far only a few examples have really managed to 
successfully translate model-based predictions to direct strain engineering on a global scale, examples 
being succinate (Lee et al., 2006), 1,4 butandiol (Yim et al., 2011), sequipertenes (Asadollahi et al., 
2009), bio-ethanol (Bro et al., 2006), and amino acids (Becker et al., 2011). However, we can expect that 
this powerful concept of design-based systems metabolic will be recruited far more in the future for the 
synthesis of valuable products.  
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CHAPTER V. Production of mcl(PHA) in high-cell-density cultures of metabolically 
engineered P. putida strains. 
 
5.1 Abstract 
Medium-chain-length polyhydroxyalkanoates mcl(PHAs) have become popular due to their similar 
properties to petroleum-based plastics, thus opening an alternative-sustainable option to obtain this highly 
demanded commodity. Nevertheless, the high costs associated with the production process of mcl(PHAs) 
using fatty acid as the carbon source make them not suitable yet for production at industrial scale. One 
possibility to address such drawback is the use of sugars as carbon sources. As shown in Chapter 4, we 
have created a metabolically engineered P. putida strain which can accumulate 60% more mcl(PHA) 
relative to its parental strain KT2440 in the presence of glucose using batch as the cultivation mode. 
Beyond this, the generated mutant strains were now challenged with the process of choice for industrial 
biotechnology  the fed-batch process. For the ∆gcd mutant and the wild-type strain, the imposed 
specific growth rate µ [0.25 h
-1
] worked well, reaching 35 [g/L] of biomass in 15 hours. It was not the 
case for the double-deletion mutant, which the set µ evoked glucose accumulation during the exponential 
feeding phase, having a big impact on biomass and PHA synthesis. For the PHA accumulation process, 
two induction techniques were tested under nitrogen limitation  the substrate-pulse feeding was more 
efficient than the linear feeding to promote the accumulation of the desirable product within high cell 
density cultures. The total PHA accumulation was 0.44 and 0.19 [g/L·h] for P. putida KT2440 and ∆gcd, 
respectively. Although the mutant strain did not show improved accumulation of PHA in comparison to 
the wild-type strain, several drawbacks during the fed-batch process were observed for the engineered 
strain, concluding that the chose feeding-strategy but not its bio-production capacity was the main cause 
of such PHA accumulation within the process. 
 
 
  
 137 
 Chapter V 
5.2 Materials and methods 
Strains and growth medium 
P. putida KT2440, ∆gcd , and ∆gcd-pgl mutant strains were used in this study. P. putida strains, kept as 
frozen stocks in 25% glycerol at -80°C, were straigthed in Luria Bertani agar dish plates to obtain single 
colonies after one day incubation at 30°C. Inocula were prepared by picking up one colony from the plate 
and inoculating it into a 50 mL shake flask containing 10 mL of the defined minimal medium (M9) 
consisting of (per liter) 12.8 g Na2HPO4.7H2O, 3 g KH2O4, 4.7 g (NH4)2SO4, 0.5 g NaCl. This medium 
was autoclaved and subsequently supplemented with 0.12 g of MgSO4.H2O, trace elements (mg·L
-1
): 6.0 
FeSO4.7H2O, 2.7 CaCO3, 2.0 ZnSO4.H2O, 1.16 MnSO4.H2O, 0.37 CoSO4.7H2O, 0.33 CuSO4.5H2O, 0.08 
H3BO3, and 3 g/L of glucose (all filter-sterilized) as the unique carbon source. The cells were grown 
under aerobic conditions at 30 °C in an Innova incubator shaker set at 180 rpm. By taking a calculated 
volume of the overnight-growth cell suspension from the pre-inoculum, 1000 mL baffled Erlenmeyer 
flasks containing 200 mL of culture medium were inoculated and placed in a rotary shaker under aerobic 
conditions. This second preculture was used as seed for the Fed-batch process. The starting medium (M9) 
in the Fed-batch process was supplemented with 3 g/L glucose,  0.12 g/L MgSO4.H2O, and 8 mL of trace 
element solution. Nitrogen source was supplied by using 14% (w/v) NH4OH to control the pH for the 
batch and exponential feeding phase. For the PHA accumulation phase NH4OH was replaced by NaOH 
10%. Each liter of feeding medium contained 600 g glucose and 12 g MgSO4.H2O. 
 Fed-batch cultivations  
Fermentations were carried out in a 10 L B10 stirred tank bioreactor (Biologische Verfahrenstechnik, 
Basel, Switzerland). The starting working volume was 4 L in all experiments. The temperature was 
controlled at 30°C, and the pH was set at 7.0 by controlled addition of H2SO4 (4%) or [NH4OH or NaOH 
(see above)]. The dissolved oxygen partial pression (pO2) was set at 20% by spargeding a mixture of air 
and pure oxygen at > 0.33 vvm and by adjusting the agitation speed up to 1000 rpm. A gas analyzer 
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(BlueSense, BCpreFerm, Germany) to record online the concentrations of carbon dioxide and oxygen in 
the course of the process was coupled to the gas outlet of the bioreactor.  
Analytical procedures 
Cell dry weight, ammonium, optical density, and PHA concentration were performed as described 
previously in the materials and methods section 4.3 in Chapter 4. 
Calculations 
In the C-limitied exponential phase of fed-batch cultures using glucose as the solely carbon source the 
volumetric feeding rate was calculated using the following equation: 
 
(1) 
 
where  
F(t) volumetric feeding rate      [L/h] 
S0 concentration of the substrate in the feeding solution  [g/L] 
µset predetermined specific growth rate    [1/h] 
Yx/s yield coefficient of biomass from glucose   [g/g] 
m specific maitenence coefficient    [g/g·h]  
V0 initial volume of the bioreactor    [L] 
X0 initial biomass concentration     [g/L] 
t  time        [h] 
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5.3 Results 
5.3.1 High-cell-density culture of P. putida KT2440 
To develop a robust carbon-limited fed-batch fermentation process, an exponential feeding strategy was 
applied which allows setting a constant and a specific growth rate at will (Korz et al. 1995) by using 
glucose as the growth limiting nutrient. Maintenance and yield coefficients obtained from chemostat 
cultures (van Duuren 2011) were used to fill Eq. (1). The fermentor was inoculated with cells to reach an 
OD600 of 0.2. After 6 hours the initial glucose concentration [3 g/L] was totally consumed. In that stage 
(I), P. putida KT2440 was growing at a maximum specific growth rate of 0.56 h
-1
. In the second stage 
(II), the exponential feeding started with a μset of 0.25 [h
-1
]. After 10 hours of feeding, the process reached 
a biomass concentration of 51 g/L, where no glucose or another secondary metabolite was accumulated in 
the culture (Fig. 1). It reflects the successful application of the exponential feeding strategy at a constant μ 
of 0.25 [h
-1
] to achieve a good biomass concentration in a short period of time. Similar concentrations 
have been achieved using the same feeding strategy on P. putida (Sun et al. 2006b).  
 
5.3.2 Nitrogen limitation along with a linear feeding strategy induces PHA synthesis 
As PHA accumulation is normally stimulated by the limitation of an inorganic nutrient while the carbon 
source is in excess (Hartmann et al. 2004). The stage III was conducted by stopping the exponential 
feeding and replacing NH4OH by NaOH. This promoted rapid nitrogen consumption, making it 
undetectable after 6 hours. Glucose was supplied to the fermentor until 45 [g/L] of the sugar was 
accumulated in the process, followed by a linear feeding rate of 70 [g/h]. At 32 h glucose was still present 
in the medium, resulting in a slight rise in PHA concentration. Therefore, it was decided to stop the linear 
feeding and let the cells consume the remained sugar in the bioreactor. Surprisingly, this promoted rapid 
accumulation of the polyester. In order to test the influence of different feeding aproaches on the PHA 
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accumulation, a double feeding strategy (glucose- of 120 [g/h] and ammonium-feeding rate of 9.6 [g/h]), 
was set at 35 h. After 9 hours, this strategy did not bring any improvement on PHA synthesis. As done in 
part of stage III, glucose was not added anymore to the fermentor, as well as the ammonium to let the 
cells deplete the remained sugar. At that point glucose had a concentration of 52 [g/L]. In the next 6 hours 
most part of the glucose was converted to PHA, which finally reached a concentration of 21.3 [g/L] at 50 
hours. It represents 38% of the CDW as PHA with a final PHA productivity of 0.44 [g/L·h]. 
 
 
            I        II            III         IV            V 
 
 
 
 
 
 
 
 
 
Figure 1. Fermentation profile of P. putida KT2440 during fed-batch process; batch (stage I), 
exponential feeding (II), Linear feeding (III), Double linear feeding (IV), no glucose or ammonium 
addition (V). 
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5.3.3 High-cell-density cultures of mutant strains 
In order to compare the PHA productivity among the mutant strains and the wild type in fed-batch 
processes, first the ∆gcd mutant strain was subjected to a similar feeding profile as described above. 
Within the batch phase the mutant strain grew to a maximum specific growth rate of 0.44 [h
-1
]. At 7 hours 
after inoculation, the exponential feeding was set at μ 0.25 [h-1]. Glucose accumulation began after 15 
hours of feeding, where at that time the biomass concentration was 34 [g/L]. As the μset was closer to μmax 
for this mutant as compared to the wild type, it was not possible to keep the carbon-limited fed-batch to 
the desirable period of time. Once glucose reached 10 g/L within the culture broth, the feeding strategy 
was stopped, letting the cells to consume the accumulated carbon source. At 25 hours the linear feeding 
strategy began with a rate of 70 [g/h] of glucose. Unexpectedly, the mutant ∆gcd consumed all the 
supplied glucose during the following 10 hours, as well as showing a small PHA accumulation. At 35 
hours the single linear feeding was shifted to a double one. After 10 hours, the glucose concentration 
reached a value of 30 [g/L]. As performed with the wild type, the feeding pumps were switched off to let 
the cell to uptake the accumulated sugar. Instead of synthesizing PHA, the mutant used mainly the 
glucose for biomass production reaching a total biomass of 60 [g/L] at 50 hours (Fig. 2A). Only 16% of 
the CDW was synthesized as PHA, resulting in a final PHA productivity of 0.19 [g/L·h]. 
The ∆gcd-pgl mutant strain showed a maximum specific growth rate of 0.33 [h-1] within the batch phase. 
It was challenged to grow at a set μ of 0.25 [h-1], as we performed with the other strains. The culture could 
not stand such imposed specific growth rate, showing through the exponential feeding glucose 
accumulation and low biomass production (data not shown). Therefore we started the exponential feeding 
with a μ of 0.1 [h-1]. After 26 h of feeding, the culture reached a biomass concentration of 33 [g/L]. At 
that point the concentration of glucose was under the detection limit. To promote PHA accumulation 
within the process, a pulse of glucose was given to the bioreactor to reach a sugar concentration of 40 
[g/L], following by a linear feeding of 70 [g/h] of the carbohydrate (Fig. 2B). This strategy did not 
promote PHA synthesis within the cell, resulting in glucose accumulation up to 49 [g/L]. Once the linear 
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feeding was stopped, the cells began to catabolize the available sugar to a rate of 2.5 [g/h]. The overall 
PHA productivity at 50 h was 0.063 [g/L·h]. 
          A 
 
 
 
 
 
 
B 
 
 
 
 
 
 
 
 
Figure 2. Fermentation profile of Δgcd (A) and Δgcd-pgl (B) mutant strains during fed-batch 
process. 
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Table 1. Summary of PHA production by P. putida strains in fed-batch process. 
Strain µ  
(h 
-1
) 
CDW  
(g/L) 
PHA [ ]  
(g/L) 
PHA content 
(%) 
Productivity 
(g/L·h) 
P. putida KT2440 0.25 56 22 38 0.44 
Δgcd 0.25 60 9.6 16 0.19 
Δgcd-pgl 0.10 33 3.15 10.5 0.06 
 
 
5.4 Discussion 
Commercialized PHAs  (Mirel
®
, Metabolix, USA) are currently produced using fed-batch processes 
(Chen 2009), thus fed-batch is still the most employed technique to obtain both high cell and PHA 
concentration (Chen 2009; Sun et al. 2007c).  In this study, it was demonstrated that P. putida KT2440 is 
a suitable microbial factory for the production of mcl(PHA). P. putida strains grew very well on glucose 
reaching more than 80 (g/L) at 20 hours in feed-batch processes (Sun et al. 2006a). Nevertheless, the key 
step to stimulate PHA synthesis is to shift from carbon-limitation to carbon-excess along with the 
limitation of an inorganic nutrient e.g. nitrogen (Lee et al. 1999). The commonly used two-step 
cultivation has yielded high PHA accumulation as impressively shown by Alacaligenes latus (5.13 
[g/L·h]) (Wang and Lee 1997),  P. putida (1.91 [g/L·h]) (Lee et al. 2000), and  Ralstonia. eutropha (3.14 
[g/L·h]) (Ryu et al. 1997), among others. The accumulation phase — inorganic nutrient limitation — can 
be done in many different ways: e.g. linear feeding where a constant feed-rate of the substrate is applied 
to the bioreactor (Wang and Lee 1997); via pulses by adding a known concentration of the substrate and 
then leaving the culture to metabolize it till the presence of the carbon source is very low within the 
culture, the procedure is further cyclically repeated to the end of the process (Ryu et al. 1997). By 
applying the first described strategy (above), Sun and coworkers produced 0.91 [g/L·h] in P. putida 
KT2440 using nonanoic acid as carbon source under nitrogen limitation (Sun et al. 2007b). We applied 
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the same procedure in KT2440 in the presence of glucose (Fig 1). It took 6 hours after the set feeding rate 
70 [g/L] affected the culture as such that it could not metabolize more glucose, and progressively the 
sugar accumulated within the process.  The PHA content did not substantially change (Fig. 1), 
demonstrating that the linear feeding strategy is not a good approach when glucose is used as carbon 
source. We next proceeded to increase the feeding rate to 120 [g/L] along with ammonium. This strategy 
was shown to be very promising for organisms that can accumulate PHAs even when all nutrients are in 
excess (Lee et al. 2000; Sun et al. 2007b). As P. putida has been shown to be one of them (Poblete-Castro 
et al. 2012b), we thought that it could highly promote the PHA synthesis. Nevertheless that was not the 
case since a only little rise in the PHA concentration was observed, thus confirming that linear feeding is 
not as efficient as when fatty acid is used as carbon source (Sun et al. 2007b). The glucose accumulated to 
a concentration of 53 [g/L] (Fig. 1), which normally inhibits growth and PHA synthesis (Kim et al. 1997). 
When we determined such glucose concentration within the culture broth, we stopped the feeding of 
glucose and ammonium. Surprisingly, once more P. putida showed its robustness by starting 
metabolizing the remaining glucose to a consumption rate of 2.5 [g/ L h], which led to a sharp increase of 
the PHA concentration at the end of the process (Fig. 1). 
By comparing KT2440 against Δgcd mutant strain, the latter did not accumulate more PHAs under the 
same fed-batch feeding approach (Fig. 1 and 2A). Although, the reached biomass concentration was 
pretty much the same value for both strains at 17 hours, the first drawback for the mutant started when the 
set feeding rate was not enough to promote glucose accumulation in the culture (Fig. 2A), thus delaying 
the induction of PHAs synthesis, which finally affects the overall productivity. It is interesting to see that 
when both strains had glucose in excess and sensed that glucose was provided, no PHA-accumulation was 
promoted, but as soon as glucose feeding stop rapidly, PHA accumulation was triggered by such 
environmental condition (Fig. 1 and 2A). As expected, the double-deletion mutant is a less efficient 
producer strain in comparison to the wild-type and the single-deletion mutant, since the reduced specific 
growth rate negatively influenced the overall PHA accumulation (Fig. 2B). 
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Several reports have shown to achieve high PHA concentration using P. putida (Kim et al. 1997; Lee et 
al. 2000; Sun et al. 2007b). The use of fatty acids has been the dominating practice in such processes. In 
this study we developed a fed-batch process where the cheap substrate glucose was used as carbon source. 
A total PHA productivity of 0.44 and 0.19 [g/L·h] was obtained with P. putida KT2440 and its mutant 
strain (∆gcd), respectively. Although we were far from 0.7 [g/L·h], which is a needed value for making a 
process economically viable (Huijberts and Eggink 1996), we have gained deep knowledge concerning 
feeding strategies when glucose is the substrate. This work will serve as the base to lead further 
investigation in the metabolically engineered P. putida strain, which has very promising features for 
sustainable production of polyhydroxyalkanoates. 
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CHAPTER VI. Summary and outlook 
 
White Biotechnology is devoted to the industrial production of chemicals using living cells or their 
components (enzymes) to perform biotransformations towards a desired product. The application of such 
approaches at industrial scale aims at developing more cost-effective and environmental-friendly 
processes than conventional chemical conversions. As microorganisms have evolved through millions of 
years, their intrinsic metabolic repertoire has been continuously reshaped by the natural environment. 
Their capability to synthesize thousands of value-added compounds has served to solve a broad range of 
challenges in production processes in the modern society. Metabolic engineering marked a major turning 
point in white biotechnology when the application of recombinant DNA methods was proved to be 
extremely efficient to restructure metabolic networks and improve the yield of metabolite and protein 
products. This has brought many innovations to various industrial areas, especially concerning to the use 
of alternative substrates and energy sources. In this concern, a priority point on the agenda of industrial 
application of biotechnologies has been the replacement of oil-based plastics production. For more than 
30 years, polyhydroxybutyrate (PHB) and its co-polymer polyhydroxybutyrate-co-valerate (PHBV) have 
been extensively produced to satisfy the demand of the biopolymer market. Nevertheless, these types of 
biopolymers have a slim range of applications because of their limited range of mechanical and physical 
properties. Medium-chain-length (mcl) polyhydroxyalkanoates (PHAs) have opened a new avenue to 
fulfill the gap between petroleum-based plastic and PHB (as shown in Chapter I). Pseudomonas species 
belonging to rRNA homology group I can naturally accumulate such polyesters as inclusion bodies in the 
cytoplasmic space of the cell, which can amass up to 60% of its dry weight as PHA in the presence of 
fatty acids as carbon sources. Nevertheless, production of mcl-PHA is currently restricted due to the high 
costs associated to the production process, as they are 5-10 times more expensive to obtain than 
conventional polymers. Therefore, whole-cell biocatalyst and process development for PHA synthesis 
requires in-depth understanding of the metabolic response of the cell at several omics levels to unravel the 
biological functions and regulations in a more systematic fashion.  The application of a systems 
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biotechnology approach  combination of quantitative measurements (omics data) and in silico modeling 
of the cellular metabolism towards the improvement of a target compounds in a rational manner  
appears to be powerful a tool to step ahead in the production of biopolymers along with the use of 
inexpensive substrates.  
In Chapter II, P. putida and related species are shown to be suitable as whole-cell biocatalyzers for the 
production of several value-added compounds. Their enzymatic repertoire to carry out specific chemical 
conversions e.g., oxygenases and the naturally high tolerance along with their versatile metabolism appear 
as desirable features to develop a strong platform for obtaining de novo chemicals at industrial scale, 
among them sustainable biopolymers. In this concern, the study described in Chapter III attempted to 
highlight the differences between nutrient limitations and their impact on PHA synthesis under well-
controlled conditions using a system-level approach. This allowed successful development of three 
different processes where carbon-, carbon-nitrogen-, and strict nitrogen-limitation led to 26, 62, and 81% 
of the cell dry weight as PHA, respectively. In order to consume all available carbon and nitrogen by the 
cells growing at a specific growth rate of 0.1 [h
-1
] under steady-state condition, the culture should be 
supplied with a carbon/nitrogen (C/N) ratio lower than 20.5 [mol/mol]. A high specific PHA production 
rate of 0.43 [g/g·h] was obtained under nitrogen limitation, which is the highest ever achieved in 
chemostate cultures in comparison to other P. putida strains. Transcriptome, proteome, and metabolome 
analyses were employed to investigate the metabolic responses under such limiting conditions. Dual 
limitation showed different expression patterns in comparison to those observed under strict carbon- or 
nitrogen-limiting conditions. Energy metabolism, fatty acids metabolism, stress response, and proteins 
belonging to the transport system were the components of the cell which were highly affected by the 
imposed nutrient limitation. Driven by the top-down approach, it was possible to increase the PHA 
accumulation under dual limitation from 62 to 77% of the cell dry weight, which finally resulted in a 
specific accumulation rate of 0.34 [g/g·h]. Our study concluded that oxygen availability highly affects the 
PHA synthesis within continuous cultivation mode in P. putida KT2442 and the integration of 
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hightroughtput data is a powerful tool for process reengineering towards increasing biopolymer 
production. 
 Chapter IV describes the enhancement of PHA synthesis in P. putida KT2440 applying a model-driven 
metabolic engineering approach along with the use of the cheap carbon source glucose. From the in silico 
modeling using FluxDesign, glucose dehydrogenase (encoded by gcd) was predicted as a target with the 
highest priority to be deleted. The created Δgcd mutant strain exhibited 60% increase in PHA 
accumulation as compared to the parental wild-type strain. The mutant maintained a high specific growth 
rate and exhibited an almost unaffected gene expression profile. To further develop an industrial-scale 
PHA production process, the generated mutant strain and its parental strain KT2440 were subjected to the 
industrial process of choice  the fed-batch cultivation (Chapter V). The wild-type reached a total PHA 
productivity of 0.44 [g/L·h] in the presence of glucose. It is concluded that linear feeding is not the best 
feeding strategy for PHA synthesis in P. putida within high cell cultivations. Instead, a pulse-feeding 
approach  to reach cyclically a concentration up to 40 g/L of glucose  is found to be more 
appropriate. The mutant strain (Δgcd-pgl) did not accumulate more PHA than its parental wild-type strain 
due to the high uptake rate of glucose under the same linear-feeding conditions, thus delaying glucose 
accumulation in the fermentor which finally impacts the total PHA productivity. Further investigations of 
the metabolically engineered strain in the fed-batch process with higher feeding rates along with a pulse-
feeding strategy are necessary in order to fully exploit the metabolic capacity of the mutant strain for the 
production PHAs. 
In conclusion, the results described in this thesis have shown the strength of in silico modeling and 
integration of omics measurements to lead metabolic engineering works towards optimal performance of 
the cell and reengineering processes for the synthesis of polyhydroxyalkanoates. In addition, we have 
proved that inclusion of co-factors, e.g. NADPH, within the in silico metabolic network of P. putida is of 
great importance in allowing PHA synthesis; but maximizing only the availability of main precursors 
such as acetyl-CoA does not guarantee an increase in PHA yield without detrimental physiological 
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effects. Furthermore, NADPH appears to be key for mcl-PHAs synthesis in P. putida in the presence of 
glucose since the deletion of glucose-6P dehydrogenase (encoded by PP_1023)  which generates high 
levels of NADPH  lead to a decrease in PHA accumulation relative to KT2440. On the other hand, it is 
also known that NADPH is a needed co-factor in the synthesis of de novo fatty acids which generate 
intermediate PHA precursors (Fig. 6.1).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.1. The sheme shows pathways for PHA synthesis and the requirement of NADPH for 
reduction of intermediates for its production. Different strategies (knockout/overexpression of 
genes, in red) for possible enahnicing of PHA synthesis. 
 
In this concern, based on the transcriptome analysis of the PHA-overproducer strain (∆gcd) a further 
promising deletion target would be the protein 3-hydroxybutyrate dehydrogenase (encoded by PP_3073) 
which shows a high mRNA expression level. This enzyme requires NADPH as a cofactor to yield (R)-3-
  
 151 
 Chapter VI 
hydroxybutanoate from acetoacetate. (R)-3-hydroxybutanoate cannot be incorporated into the monomer 
composition of the resulted PHA due to the specificity of the PHA synthase PhaC (encoded by PP_5003) 
towards the carbon chain length of PHA precursors (C6 hydroxy alkanoates or higher), and as shown by 
our metabolome analysis (R)-3-hydroxybutanoate is accumulated in the cell. Therefore, this engineering 
strategy might lead to an increase of available NADPH molecules which can be exploited for other 
metabolic functions such as PHA synthesis (Fig. 6.1).  
This work has demonstrated the advantages of applying a systems biotechnology approach for the 
production of PHAs. The rational design of processes and superior strains is the base for making white-
biotechnology an economically sustainable-viable alternative towards the synthesis of various industrially 
valuable compounds. Altough consirerable progesses have been made in increasing our understanding of 
the PHA synthesis taking into account of whole metabolic system of P. putida strains, continued effort to 
strengthen both fine-tuned strategies of systems metabolic engineering and process optimization are 
required to fully replace convetional oil-based plastic production processes.  
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CHAPTER VII. Supplementary material 
 
Supplementary Table S1. Transcriptomic data of genes differentially expressed with a fold change above 
2 and below -2 and a P value below 0.05. Comparison 1: CN- vs. C-limited cultures. Comparison 2: N- 
vs. C- limited cultures. 
Comparison 1 
Locus 
name Gene Name Log change Fold change p-value 
PP_0555 
acetoin dehydrogenase  alpha subunit 
gb|AE015451.1|:c645014-644037 -3.12 -8.68 0.00 
PP_4006 
arginine-tRNA-protein transferase-related protein 
gb|AE015451.1|:4516135-4516842 -2.84 -7.14 0.00 
PP_0600 
ribosomal protein S20 gb|AE015451.1|:c707346-
707068 -2.75 -6.73 0.00 
PP_0556 
acetoin catabolism protein gb|AE015451.1|:c646092-
645037 -2.18 -4.55 0.00 
PP_0554 
acetoin dehydrogenase  beta subunit 
gb|AE015451.1|:c644003-642981 -2.04 -4.12 0.00 
PP_0553 
acetoin dehydrogenase  dihydrolipoamide acetyltransfe 
gb|AE015451.1|:c642984-641878 -2.01 -4.03 0.00 
PP_1037 
phosphoribosylformylglycinamidine synthase 
gb|AE015451.1|:1184794-1188693 -2.00 -3.99 0.01 
PP_2297 
integrative genetic element Ppu40  integrase 
gb|AE015451.1|:2624995-2625819 -1.99 -3.97 0.00 
PP_2435 
cysteine desulfurase gb|AE015451.1|:c2782362-
2781145 -1.96 -3.89 0.00 
PP_3504 
conserved hypothetical protein 
gb|AE015451.1|:3974810-3975076 -1.96 -3.88 0.01 
PP_2149 
glyceraldehyde 3-phosphate dehydrogenase 
gb|AE015451.1|:2455283-2456746 -1.89 -3.70 0.00 
PP_4872 
conserved hypothetical protein 
gb|AE015451.1|:c5540982-5538628 -1.85 -3.59 0.00 
PP_0557 
acetoin catabolism regulatory protein 
gb|AE015451.1|:646376-648229 -1.81 -3.50 0.00 
PP_2423 
conserved hypothetical protein 
gb|AE015451.1|:c2771139-2770240 -1.75 -3.37 0.02 
PP_4715 
triosephosphate isomerase gb|AE015451.1|:c5362357-
5361602 -1.72 -3.29 0.01 
PP_4793 
conserved hypothetical protein 
gb|AE015451.1|:c5456039-5455725 -1.72 -3.28 0.00 
PP_0389 
ribosomal protein S21 gb|AE015451.1|:c475503-
475288 -1.71 -3.28 0.00 
PP_5214 
transcription termination factor Rho 
gb|AE015451.1|:c5948464-5947205 -1.71 -3.27 0.02 
PP_4174 
3-hydroxydecanoyl-(acyl-carrier-protein) dehydratase 
gb|AE015451.1|:4716908-4717423 -1.70 -3.26 0.01 
PP_3954 
periplasmic binding protein  putative 
gb|AE015451.1|:4460534-4461484 -1.70 -3.24 0.04 
PP_2437 
acyl-CoA dehydrogenase  putative 
gb|AE015451.1|:2783545-2784789 -1.68 -3.20 0.00 
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PP_1016 
sugar ABC transporter  permease protein 
gb|AE015451.1|:1159286-1160194 -1.67 -3.17 0.04 
PP_0545 
aldehyde dehydrogenase family protein 
gb|AE015451.1|:c633438-631918 -1.66 -3.17 0.01 
PP_4737 
D-lactate dehydrogenase  putative 
gb|AE015451.1|:5386489-5389299 -1.66 -3.15 0.01 
PP_2141 
conserved hypothetical protein 
gb|AE015451.1|:2444126-2444359 -1.65 -3.14 0.00 
PP_5224 
conserved hypothetical protein 
gb|AE015451.1|:c5960294-5960070 -1.60 -3.03 0.01 
PP_0469 ribosomal protein L6 gb|AE015451.1|:557869-558402 -1.59 -3.02 0.00 
PP_5127 
conserved hypothetical protein 
gb|AE015451.1|:5847820-5849016 -1.58 -2.99 0.03 
PP_3560 
transcriptional regulator  LysR family 
gb|AE015451.1|:4039141-4040004 -1.55 -2.93 0.01 
PP_1076 
glycerol uptake facilitator protein 
gb|AE015451.1|:c1236186-1235335 -1.54 -2.91 0.03 
PP_1083 
bacterioferritin-associated ferredoxin  putative 
gb|AE015451.1|:c1242882-1242664 -1.54 -2.91 0.01 
PP_1430 
alginate biosynthesis negative regulator  serine prot 
gb|AE015451.1|:1629584-1631062 -1.53 -2.89 0.03 
PP_0551 
MORN domain protein gb|AE015451.1|:c640742-
638814 -1.52 -2.87 0.04 
PP_0765 
conserved hypothetical protein 
gb|AE015451.1|:880484-882370 -1.46 -2.74 0.01 
PP_0932 
glutamyl-tRNA(Gln) amidotransferase  C subunit 
gb|AE015451.1|:c1075177-1074869 -1.45 -2.74 0.01 
PP_1099 
cold-shock domain family protein 
gb|AE015451.1|:c1257128-1256919 -1.45 -2.74 0.01 
PP_2086 crfX protein gb|AE015451.1|:2378443-2378715 -1.42 -2.68 0.02 
PP_0974 hypothetical protein gb|AE015451.1|:1113202-1113531 -1.42 -2.68 0.01 
PP_2088 
RNA polymerase sigma factor SigX 
gb|AE015451.1|:2379632-2380222 -1.42 -2.68 0.01 
PP_4517 
conserved hypothetical protein 
gb|AE015451.1|:5131645-5132232 -1.41 -2.65 0.02 
PP_3071 
acetoacetyl-CoA synthetase  putative 
gb|AE015451.1|:c3455887-3453935 -1.41 -2.65 0.01 
PP_1766 
initiation factor 2 subunit family 
gb|AE015451.1|:1969627-1970703 -1.40 -2.65 0.01 
PP_2258 sensory box protein gb|AE015451.1|:2574821-2576509 -1.40 -2.64 0.04 
PP_4147 
peptide ABC transporter  periplamic peptide-binding p 
gb|AE015451.1|:4685186-4687021 -1.40 -2.64 0.01 
PP_2853 
conserved hypothetical protein 
gb|AE015451.1|:c3257150-3255870 -1.39 -2.63 0.02 
PP_1799 
GDP-mannose 4 6 dehydratase 
gb|AE015451.1|:2021899-2022966 -1.39 -2.63 0.01 
PP_4439 
ISPpu14  transposase Orf3 gb|AE015451.1|:5033959-
5035494 -1.39 -2.62 0.02 
PP_3402 
hypothetical protein gb|AE015451.1|:c3854191-
3853796 -1.37 -2.59 0.01 
PP_2874 hypothetical protein gb|AE015451.1|:3275984-3276295 -1.37 -2.59 0.01 
PP_3557 
methyl-accepting chemotaxis transducer 
gb|AE015451.1|:4034947-4037091 -1.36 -2.56 0.04 
PP_5067 potassium efflux system protein KefA  putative -1.35 -2.56 0.04 
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gb|AE015451.1|:5781517-5784825 
PP_5124 ferredoxin  4Fe-4S gb|AE015451.1|:5845668-5845919 -1.35 -2.55 0.04 
PP_3319 
sensory box protein/GGDEF domain protein 
gb|AE015451.1|:3754557-3756758 -1.35 -2.55 0.02 
PP_4945 
conserved hypothetical protein 
gb|AE015451.1|:c5628525-5627689 -1.35 -2.55 0.02 
PP_0957 
KpsF/GutQ family protein gb|AE015451.1|:c1099563-
1098589 -1.35 -2.55 0.01 
PP_1100 
deoxycytidine triphosphate deaminase 
gb|AE015451.1|:1257456-1258022 -1.34 -2.54 0.01 
PP_2006 
hypothetical protein gb|AE015451.1|:c2277453-
2275675 -1.34 -2.53 0.01 
PP_4933 
conserved hypothetical protein 
gb|AE015451.1|:5613045-5614013 -1.34 -2.53 0.01 
PP_4938 
glycosyl transferase  putative 
gb|AE015451.1|:c5620495-5619356 -1.33 -2.51 0.01 
PP_0441 
preprotein translocase  SecE subunit 
gb|AE015451.1|:534102-534470 -1.32 -2.50 0.04 
PP_5392 
conserved hypothetical protein 
gb|AE015451.1|:c6147451-6146318 -1.32 -2.50 0.01 
PP_5391 
hypothetical protein gb|AE015451.1|:c6146308-
6145727 -1.32 -2.49 0.01 
PP_3564 
transcriptional regulator  AraC family 
gb|AE015451.1|:c4043740-4042763 -1.31 -2.49 0.02 
PP_5027 
D-tyrosyl-tRNA(Tyr) deacylase 
gb|AE015451.1|:c5729389-5728952 -1.31 -2.47 0.01 
PP_4852 
transcriptional regulator  AraC family 
gb|AE015451.1|:c5519726-5518938 -1.30 -2.47 0.01 
PP_4736 
L-lactate dehydrogenase gb|AE015451.1|:5385268-
5386413 -1.30 -2.47 0.01 
PP_4547 
glutamine synthetase  putative 
gb|AE015451.1|:5168381-5169745 -1.30 -2.46 0.04 
PP_0559 
acetyl-CoA carboxylase  biotin carboxyl carrier prote 
gb|AE015451.1|:c650154-649693 -1.30 -2.45 0.01 
PP_1073 
glycerol-3-phosphate dehydrogenase 
gb|AE015451.1|:c1232710-1231166 -1.29 -2.45 0.04 
PP_1659 
conserved hypothetical protein 
gb|AE015451.1|:1854985-1856325 -1.29 -2.44 0.03 
PP_3321 
conserved hypothetical protein 
gb|AE015451.1|:3757176-3757688 -1.27 -2.41 0.02 
PP_4636 beta-ketothiolase gb|AE015451.1|:5259457-5260635 -1.25 -2.39 0.03 
PP_0453 ribosomal protein S10 gb|AE015451.1|:550659-550970 -1.25 -2.38 0.01 
PP_1773 
integration host factor  beta subunit 
gb|AE015451.1|:1981358-1981660 -1.24 -2.36 0.01 
PP_4192 
succinate dehydrogenase  hydrophobic membrane 
anchor gb|AE015451.1|:c4738740-4738372 -1.23 -2.35 0.04 
PP_5091 
conserved hypothetical protein 
gb|AE015451.1|:c5816017-5815598 -1.22 -2.33 0.01 
nonsymbol 
RNA polymerase sigma-54 factor 
gb|AE015451.1|:c1096058-1094565 -1.22 -2.33 0.02 
PP_3981 
ISPpu14  transposase Orf3 gb|AE015451.1|:4487111-
4488646 -1.20 -2.30 0.01 
PP_1661 
dehydrogenase subunit  putative 
gb|AE015451.1|:1856818-1859076 -1.20 -2.30 0.04 
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PP_5350 
transcriptional regulator  RpiR family 
gb|AE015451.1|:c6099078-6098212 -1.19 -2.27 0.03 
PP_3693 
transcriptional regulator MvaT  P16 subunit  putative 
gb|AE015451.1|:c4211487-4211122 -1.18 -2.27 0.01 
PP_1609 hypothetical protein gb|AE015451.1|:1806092-1806232 -1.18 -2.26 0.04 
PP_4731 
outer membrane lipoprotein OmlA 
gb|AE015451.1|:5380697-5381233 -1.18 -2.26 0.02 
PP_4958 
conserved hypothetical protein 
gb|AE015451.1|:c5649060-5648521 -1.17 -2.25 0.01 
PP_3663 
GGDEF domain protein gb|AE015451.1|:c4162052-
4160751 -1.16 -2.23 0.01 
PP_4870 azurin gb|AE015451.1|:c5537572-5537123 -1.15 -2.22 0.04 
PP_4193 
succinate dehydrogenase  cytochrome b556 subunit 
gb|AE015451.1|:c4739120-4738734 -1.15 -2.22 0.04 
PP_4708 
polyribonucleotide nucleotidyltransferase 
gb|AE015451.1|:c5354114-5352009 -1.15 -2.22 0.02 
PP_3698 
conserved hypothetical protein 
gb|AE015451.1|:c4219292-4217793 -1.15 -2.21 0.03 
PP_1146 hypothetical protein gb|AE015451.1|:1314805-1315500 -1.15 -2.21 0.02 
PP_3908 hypothetical protein gb|AE015451.1|:4418483-4418833 -1.14 -2.21 0.03 
PP_5396 
ISPpu14  transposase Orf3 gb|AE015451.1|:c6154464-
6152929 -1.14 -2.20 0.03 
PP_4476 
conserved hypothetical protein 
gb|AE015451.1|:c5085956-5085666 -1.13 -2.19 0.05 
PP_2313 
conserved hypothetical protein 
gb|AE015451.1|:2643254-2643691 -1.13 -2.19 0.02 
PP_4648 
nucleotide methyltransferase  putative 
gb|AE015451.1|:5272852-5273976 -1.13 -2.19 0.04 
PP_3598 
conserved hypothetical protein 
gb|AE015451.1|:4087773-4088582 -1.13 -2.18 0.02 
PP_1714 
peptidyl-prolyl cis-trans isomerase  FKBP-type 
gb|AE015451.1|:1914817-1915569 -1.13 -2.18 0.03 
PP_4839 
membrane protein  putative gb|AE015451.1|:5505171-
5506538 -1.11 -2.15 0.04 
PP_3747 
glycolate oxidase  iron-sulfur subunit 
gb|AE015451.1|:4276603-4277838 -1.11 -2.15 0.02 
PP_0477 ribosomal protein S11 gb|AE015451.1|:561868-562257 -1.10 -2.15 0.01 
PP_0468 ribosomal protein S8 gb|AE015451.1|:557464-557856 -1.10 -2.14 0.02 
PP_0476 ribosomal protein S13 gb|AE015451.1|:561493-561849 -1.09 -2.13 0.01 
PP_1642 
conserved hypothetical protein 
gb|AE015451.1|:1837378-1838049 -1.09 -2.12 0.03 
PP_0450 ribosomal protein S7 gb|AE015451.1|:546648-547118 -1.07 -2.10 0.04 
PP_4346 
D-alanine--D-alanine ligase A 
gb|AE015451.1|:c4938751-4937693 -1.07 -2.10 0.05 
PP_0339 
pyruvate dehydrogenase  E1 component 
gb|AE015451.1|:c410662-408017 -1.07 -2.09 0.04 
PP_5088 
primosomal protein N` gb|AE015451.1|:5810664-
5812883 -1.06 -2.09 0.03 
PP_4624 
hydrolase  alpha/beta fold family 
gb|AE015451.1|:c5249813-5248914 -1.06 -2.09 0.02 
PP_5054 glutaredoxin gb|AE015451.1|:c5760317-5760063 -1.06 -2.09 0.04 
PP_5418 
ATP synthase F0  C subunit gb|AE015451.1|:c6180422-
6180165 -1.05 -2.07 0.03 
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PP_1212 
conserved domain protein gb|AE015451.1|:1389877-
1390098 -1.05 -2.07 0.04 
PP_3839 
alcohol dehydrogenase  zinc-containing 
gb|AE015451.1|:4362913-4363923 -1.05 -2.07 0.02 
PP_4714 
conserved hypothetical protein 
gb|AE015451.1|:c5360836-5360327 -1.04 -2.06 0.01 
PP_4724 
carbamoyl-phosphate synthase  small subunit 
gb|AE015451.1|:c5373167-5372031 -1.04 -2.06 0.02 
PP_4652 
membrane protein  putative gb|AE015451.1|:5277038-
5278258 -1.04 -2.05 0.02 
PP_1749 
acetyltransferase  GNAT family 
gb|AE015451.1|:c1949651-1947906 -1.03 -2.04 0.02 
PP_5324 response regulator gb|AE015451.1|:c6070635-6069745 -1.03 -2.04 0.02 
PP_3043 hypothetical protein gb|AE015451.1|:3428087-3428293 -1.03 -2.04 0.02 
PP_4811 
gamma-glutamyl phosphate reductase 
gb|AE015451.1|:c5474791-5473520 -1.02 -2.03 0.04 
PP_2324 
phospho-2-dehydro-3-deoxyheptonate aldolase  class I 
gb|AE015451.1|:c2652414-2651302 -1.02 -2.03 0.04 
PP_1876 
conserved hypothetical protein 
gb|AE015451.1|:2099932-2100978 -1.01 -2.02 0.05 
PP_4788 
conserved hypothetical protein TIGR00043 
gb|AE015451.1|:5450121-5450594 -1.01 -2.02 0.04 
PP_1365 
exodeoxyribonuclease I gb|AE015451.1|:1553925-
1555358 -1.01 -2.01 0.03 
PP_1914 
3-oxoacyl-(acyl-carrier-protein) reductase 
gb|AE015451.1|:2157648-2158388 -1.00 -2.01 0.02 
PP_4283 
transcriptional regulator  GntR family 
gb|AE015451.1|:c4874531-4873776 -1.00 -2.00 0.03 
PP_5298 
conserved hypothetical protein 
gb|AE015451.1|:c6046101-6045334 1.01 2.01 0.02 
PP_3513 
transcriptional regulator  LysR family 
gb|AE015451.1|:3984714-3985568 1.04 2.05 0.03 
PP_0369 
GGDEF domain protein gb|AE015451.1|:447502-
448704 1.10 2.14 0.01 
PP_4137 
outer membrane siderophore receptor  putative 
gb|AE015451.1|:4673226-4675298 1.10 2.14 0.02 
PP_2843 
urease  gamma subunit gb|AE015451.1|:3247742-
3248044 1.11 2.15 0.04 
PP_3951 
3-oxoadipate CoA-transferase  subunit A 
gb|AE015451.1|:4457362-4458057 1.11 2.16 0.02 
PP_3021 
transporter  LysE family gb|AE015451.1|:c3408540-
3407926 1.12 2.18 0.02 
PP_1408 acyl-transferase gb|AE015451.1|:c1607529-1606642 1.13 2.18 0.04 
PP_2093 
response regulator NasT gb|AE015451.1|:c2385874-
2385299 1.16 2.23 0.05 
PP_4311 
D-amino acid dehydrogenase  small subunit  putative 
gb|AE015451.1|:c4904125-4902932 1.16 2.23 0.04 
PP_5007 
polyhydroxyalkanoate granule-associated protein GA2 
gb|AE015451.1|:c5705363-5704578 1.20 2.30 0.01 
PP_0759 
conserved hypothetical protein 
gb|AE015451.1|:874420-875259 1.21 2.31 0.05 
PP_4069 hypothetical protein gb|AE015451.1|:4594782-4595081 1.22 2.33 0.03 
PP_2850 hypothetical protein gb|AE015451.1|:3252514-3252627 1.29 2.44 0.01 
PP_2847 urease accessory protein UreJ 1.29 2.44 0.02 
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gb|AE015451.1|:3250613-3251158 
PP_2689 
endoribonuclease  putative gb|AE015451.1|:c3080067-
3079696 1.29 2.45 0.04 
PP_3902 
hypothetical protein gb|AE015451.1|:c4416483-
4416175 1.33 2.51 0.02 
PP_5008 
polyhydroxyalkanoate granule-associated protein GA1 
gb|AE015451.1|:c5705793-5705374 1.34 2.54 0.01 
PP_2687 
conserved hypothetical protein 
gb|AE015451.1|:c3077849-3076899 1.37 2.58 0.04 
PP_2094 
nitrate-binding protein NasS  putative 
gb|AE015451.1|:c2387100-2385886 1.37 2.58 0.03 
PP_5233 
ammonium transporter gb|AE015451.1|:c5967683-
5966352 1.38 2.60 0.01 
PP_2846 
urease accessory protein UreE 
gb|AE015451.1|:3250091-3250594 1.45 2.74 0.02 
PP_1703 
assimilatory nitrate reductase/sulfite reductase  put 
gb|AE015451.1|:1899399-1903472 1.85 3.61 0.01 
PP_2092 nitrate transporter gb|AE015451.1|:c2385138-2383903 1.85 3.61 0.01 
PP_2685 
conserved hypothetical protein 
gb|AE015451.1|:c3076049-3075327 1.99 3.96 0.01 
PP_2638 
cellulose synthase operon C protein  putative 
gb|AE015451.1|:3019460-3022978 2.09 4.26 0.00 
PP_4841 
branched-chain amino acid ABC transporter  periplasmi 
gb|AE015451.1|:5508393-5509658 2.16 4.46 0.02 
PP_2686 
transglutaminase-like superfamily domain protein 
gb|AE015451.1|:c3076902-3076123 2.19 4.58 0.01 
PP_1705 nitrite reductase gb|AE015451.1|:1903743-1906295 2.38 5.20 0.04 
PP_4842 
branched-chain amino acid ABC transporter  permease 
p gb|AE015451.1|:5510246-5511286 2.54 5.82 0.02 
PP_5234 
nitrogen regulatory protein P-II 
gb|AE015451.1|:c5968068-5967730 3.61 12.22 0.01 
 
Comparison 2 
Locus name Gene Name Log change Fold change P-value 
PP_0555 
acetoin dehydrogenase  alpha subunit 
gb|AE015451.1|:c645014-644037 -3.98 -15.76 0.00 
PP_0553 
acetoin dehydrogenase  dihydrolipoamide 
acetyltransfe gb|AE015451.1|:c642984-
641878 -3.65 -12.58 0.00 
PP_0556 
acetoin catabolism protein 
gb|AE015451.1|:c646092-645037 -3.20 -9.19 0.01 
PP_3504 
conserved hypothetical protein 
gb|AE015451.1|:3974810-3975076 -3.08 -8.48 0.02 
PP_0554 
acetoin dehydrogenase  beta subunit 
gb|AE015451.1|:c644003-642981 -2.86 -7.27 0.01 
PP_0557 
acetoin catabolism regulatory protein 
gb|AE015451.1|:646376-648229 -2.82 -7.06 0.00 
PP_0765 
conserved hypothetical protein 
gb|AE015451.1|:880484-882370 -2.79 -6.94 0.00 
PP_4794 
leucyl-tRNA synthetase 
gb|AE015451.1|:5456267-5458873 -2.63 -6.20 0.01 
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PP_1743 
sodium:solute symporter family protein 
gb|AE015451.1|:1942832-1944496 -2.51 -5.71 0.03 
PP_5324 
response regulator 
gb|AE015451.1|:c6070635-6069745 -2.50 -5.64 0.00 
PP_0765 
conserved hypothetical protein 
gb|AE015451.1|:880484-882370 -2.49 -5.62 0.00 
PP_1659 
conserved hypothetical protein 
gb|AE015451.1|:1854985-1856325 -2.28 -4.85 0.05 
PP_2437 
acyl-CoA dehydrogenase  putative 
gb|AE015451.1|:2783545-2784789 -2.15 -4.43 0.02 
PP_0545 
aldehyde dehydrogenase family protein 
gb|AE015451.1|:c633438-631918 -2.13 -4.39 0.04 
PP_2141 
conserved hypothetical protein 
gb|AE015451.1|:2444126-2444359 -1.98 -3.96 0.02 
PP_4454 
opine ABC transporter  permease protein  
putative gb|AE015451.1|:c5055386-
5054514 -1.80 -3.49 0.02 
PP_2569 
metabolite MFS transporter  MHS family 
gb|AE015451.1|:2935964-2937640 -1.62 -3.07 0.05 
PP_0469 
ribosomal protein L6 
gb|AE015451.1|:557869-558402 1.54 2.91 0.05 
PP_4050 
glycogen synthase 
gb|AE015451.1|:4564755-4566314 1.64 3.12 0.04 
PP_5075 
glutamate synthase  small subunit 
gb|AE015451.1|:c5793321-5791903 1.76 3.39 0.04 
PP_1360 
chaperonin  10 kDa 
gb|AE015451.1|:1549256-1549549 1.78 3.44 0.04 
PP_3951 
3-oxoadipate CoA-transferase  subunit A 
gb|AE015451.1|:4457362-4458057 1.87 3.67 0.04 
PP_3105 
hypothetical protein 
gb|AE015451.1|:3507649-3508344 1.96 3.89 0.05 
PP_4573 
ATPase  AAA family 
gb|AE015451.1|:5192819-5193664 1.98 3.95 0.05 
PP_1385 
multidrug/solvent RND transporter TtgB 
gb|AE015451.1|:c1581392-1578240 2.01 4.02 0.01 
PP_4550 
long-chain-fatty-acid--CoA ligase 
gb|AE015451.1|:c5174977-5173289 2.07 4.19 0.04 
PP_2074 
transcriptional regulator  LysR family 
gb|AE015451.1|:2359040-2359963 2.11 4.33 0.01 
PP_0814 
cytochrome o ubiquinol oxidase  subunit 
III gb|AE015451.1|:953190-953813 2.12 4.35 0.05 
PP_2688 
conserved hypothetical protein 
gb|AE015451.1|:c3079262-3077853 2.14 4.40 0.00 
PP_2094 
nitrate-binding protein NasS  putative 
gb|AE015451.1|:c2387100-2385886 2.16 4.48 0.00 
PP_4308 
transcriptional regulator  AsnC family 
gb|AE015451.1|:4899601-4900038 2.19 4.56 0.02 
PP_0153 
conserved hypothetical protein 
gb|AE015451.1|:c161965-161750 2.23 4.69 0.04 
PP_4054 
conserved hypothetical protein 
gb|AE015451.1|:4572905-4573189 2.26 4.80 0.01 
PP_1794 
hypothetical protein 
gb|AE015451.1|:c2015484-2014042 2.27 4.83 0.04 
PP_0813 
cytochrome o ubiquinol oxidase  subunit I 
gb|AE015451.1|:951168-953186 2.31 4.95 0.03 
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PP_1795 
hypothetical protein 
gb|AE015451.1|:c2016389-2015502 2.32 5.00 0.04 
PP_5008 
polyhydroxyalkanoate granule-associated 
protein GA1 gb|AE015451.1|:c5705793-
5705374 2.62 6.14 0.00 
PP_0811 
cyoups2 protein gb|AE015451.1|:949961-
950197 2.63 6.18 0.00 
PP_4204 
transcriptional regulator  Cro/CI family 
gb|AE015451.1|:c4750452-4750051 2.65 6.29 0.01 
PP_3213 
ABC transporter  periplasmic binding 
component-relate 
gb|AE015451.1|:c3647060-3646032 2.66 6.33 0.05 
PP_1185 
outer membrane protein H1 
gb|AE015451.1|:1360133-1360738 2.72 6.57 0.01 
PP_2686 
transglutaminase-like superfamily domain 
protein gb|AE015451.1|:c3076902-
3076123 2.72 6.57 0.00 
PP_2687 
conserved hypothetical protein 
gb|AE015451.1|:c3077849-3076899 2.82 7.07 0.00 
PP_4841 
branched-chain amino acid ABC 
transporter  periplasmi 
gb|AE015451.1|:5508393-5509658 2.87 7.30 0.00 
PP_2638 
cellulose synthase operon C protein  
putative gb|AE015451.1|:3019460-
3022978 2.90 7.45 0.02 
PP_3781 
oxygen-independent Coproporphyrinogen 
III oxidase fam gb|AE015451.1|:4308593-
4310008 2.91 7.53 0.00 
PP_1690 
conserved hypothetical protein 
gb|AE015451.1|:c1883189-1882707 3.10 8.56 0.00 
PP_2051 
acetyl-CoA acetyltransferase 
gb|AE015451.1|:2333066-2334250 3.27 9.64 0.04 
PP_2685 
conserved hypothetical protein 
gb|AE015451.1|:c3076049-3075327 3.48 11.14 0.00 
PP_5233 
ammonium transporter 
gb|AE015451.1|:c5967683-5966352 3.77 13.67 0.00 
PP_0367 
conserved hypothetical protein 
gb|AE015451.1|:444691-445026 3.78 13.74 0.00 
PP_4842 
branched-chain amino acid ABC 
transporter  permease p 
gb|AE015451.1|:5510246-5511286 3.99 15.91 0.00 
PP_2048 
acyl-CoA dehydrogenase  putative 
gb|AE015451.1|:2329570-2331420 4.31 19.87 0.00 
PP_2047 
3-hydroxyacyl-CoA dehydrogenase family 
protein gb|AE015451.1|:2328410-2329648 4.39 20.91 0.00 
PP_5234 
nitrogen regulatory protein P-II 
gb|AE015451.1|:c5968068-5967730 4.65 25.10 0.00 
PP_2051 
acetyl-CoA acetyltransferase 
gb|AE015451.1|:2333066-2334250 4.80 27.95 0.00 
PP_2049 
alcohol dehydrogenase  iron-containing 
gb|AE015451.1|:2331454-2332617 4.82 28.31 0.00 
PP_2050 
conserved hypothetical protein 
TIGR00051 gb|AE015451.1|:2332617-
2333069 4.83 28.42 0.00 
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Supplementary Table S2. Proteomics data of proteins that were differentially expressed. 
SPOT NUMBER ID Enzyme name Fold change 
1 gi|26992090  F0F1 ATP synthase subunit alpha 91.70 
2 gi|26991521  
branched-chain amino acid ABC transporter, periplasmic amino 
acid-binding protein, putative 35.15 
5  gi|26987038  
glycine betaine/L-proline ABC transporter, periplasmic binding 
protein 4.88 
6 gi|26991724  nitrogen metabolism transcriptional regulator NtrC  6.70 
7 gi|26990756  glycogen debranching protein GlgX  4.48 
8  gi|26990172  hypothetical protein PP_3459  5.47 
9 gi|26987893  acetolactate synthase 3.46 
10 gi|26988814  OmpF family protein  2.60 
11 gi|26987941  outer membrane porin  2.68 
12 gi|26991722   glutamine synthetase, type I 2.20 
22 gi|26987192  elongation factor G 20.03 
23 gi|26991722  glutamine synthetase, type I 15.80 
24 gi|26990756  glycogen debranching protein GlgX  11.70 
26 gi|26988775  hypothetical protein PP_2050  9.38 
27 gi|26991001  hydantoin racemase, putative  8.77 
28 gi|26991724  nitrogen metabolism transcriptional regulator NtrC  4.87 
29 gi|26988814  OmpF family protein  5.43 
30 gi|26987296  acetyl-CoA carboxylase biotin carboxylase subunit  8.34 
  
 161 
 Chapter VII 
31 gi|26987458  ribose-phosphate pyrophosphokinase  6.55 
32 gi|26989406  hypothetical protein PP_2687  5.59 
33 gi|26988830  hypothetical protein PP_2105  5.51 
34 gi|26990895  electron-transferring-flavoprotein dehydrogenase  4.52 
35 gi|26989812  hypothetical protein PP_3093  4.85 
36 gi|26988035  general amino acid ABC transporter, ATP-binding protein  4.07 
37 gi|26988772   3-hydroxyacyl-CoA dehydrogenase family protein 3.97 
38 gi|26988860  multifunctional fatty acid oxidation complex subunit alpha  3.06 
39 gi|26989257 hypothetical protein PP_2537  3.17 
40 gi|26988861 3-ketoacyl-CoA thiolase  2.95 
41 gi|26990883  succinate dehydrogenase flavoprotein subunit  3.93 
43 gi|26988860  multifunctional fatty acid oxidation complex subunit alpha  3.06 
44 gi|26990817  NADH dehydrogenase I subunit F 2.89 
45 gi|26990754 malto-oligosyltrehalose synthase 2.56 
46 gi|26988807 phosphoenolpyruvate synthase  2.35 
13 gi|26991567  adenylosuccinate synthetase  0.23 
14 gi|26990716  isocitrate dehydrogenase, NADP-dependent  0.20 
15 gi|26987293  pyruvate dehydrogenase (acetyl-transferring) 0.25 
16 gi|26987292  acetoin dehydrogenase, beta subunit  0.18 
17 gi|26987291  branched-chain alpha-keto acid dehydrogenase subunit E2  0.27 
18 gi|26989108  branched chain amino acid ABC transporter  0.36 
19 gi|26987716  leucyl aminopeptidase  0.44 
47 gi|26987024  
amino acid ABC transporter, periplasmic amino acid-binding 
protein 0.03 
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48 gi|26988458  ABC transporter, periplasmic binding protein  0.04 
49 gi|26991547  extracellular ligand-binding receptor  0.06 
50 gi|26987651  superoxide dismutase  0.05 
51 gi|26992051  LysR family transcriptional regulator  0.08 
52 gi|26991377  C4-type zinc finger DksA/TraR family protein  0.09 
54 gi|26991067 flagellin FliC  0.17 
55 gi|26988588  elongation factor P 0.12 
56 gi|26988743  BNR domain-containing protein  0.13 
57 gi|26987098  malate synthase G 0.11 
58 gi|26988076  cell division protein FtsZ  0.14 
59 gi|26986857  metal ABC transporter periplasmic-binding protein  0.13 
60 gi|26991413  ferric uptake regulator, Fur family  0.16 
62 gi|26987621  dipeptide ABC transporter, periplasmic peptide-binding protein  0.20 
63 gi|26987283  aldehyde dehydrogenase family protein  0.17 
64 gi|26990223  branched-chain amino acid aminotransferase  0.32 
65 gi|26991067  flagellin FliC  0.18 
67 gi|26988032  general amino acid ABC transporter, periplasmic binding protein  0.16 
68 gi|26990810  isocitrate lyase 0.24 
69 gi|26990740  dihydropyrimidine dehydrogenase  0.29 
70 gi|26990737  allantoate amidohydrolase  0.22 
71 gi|26987501  hypothetical protein PP_0765  0.22 
        
72 gi|26988094  co-chaperonin GroES  0.36 
73 gi|26990893  electron transfer flavoprotein, alpha subunit  0.27 
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74 gi|26987098  malate synthase G 0.25 
76 gi|26991857  
putrescine ABC transporter, periplasmic putrescine-binding 
protein 0.33 
77 gi|26991502  
bifunctional phosphoribosylaminoimidazolecarboxamide 
formyltransferase/IMP cyclohydrolase 0.22 
78  gi|26987250 hypothetical protein PP_0512  0.35 
79 gi|26987499  acyl-CoA synthetase  0.27 
80 gi|26987501  hypothetical protein PP_0765  0.37 
81 gi|26987585  nucleoside-diphosphate kinase  0.30 
83 gi|26987407  serine hydroxymethyltransferase  0.28 
84 gi|161378124  flagellum-specific ATP synthase  0.44 
85 gi|26987578  cysteine desulfurase IscS  0.35 
86 gi|26990716  isocitrate dehydrogenase, NADP-dependent  0.48 
20 gi|26987193  elongation factor Tu  
Novo C/N-C 
(UP)  
21 gi|26991910  nitrogen regulatory protein P-II  
 Novo C/N-C 
(UP)  
87 gi|26988772  3-hydroxyacyl-CoA dehydrogenase family protein 
Novo N-C (UP)  
88 gi|26987920  outer membrane protein H1  Novo N-C (UP)  
89 gi|26988776  acetyl-CoA acetyltransferase  Novo N-C (UP)  
90 gi|26992090 F0F1 ATP synthase subunit alpha  Novo N-C (UP)  
91 gi|26990877  succinyl-CoA synthetase subunit alpha Novo N-C (UP)  
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92 gi|26989024  ATP-dependent Clp protease proteolytic subunit  Novo N-C (UP)  
93 gi|26991544  branched chain amino acid ABC transporter ATP-binding protein Novo N-C (UP)  
94 gi|26987502 hypothetical protein PP_0766  
Novo N-C 
(DOWN)   
95 gi|26987877  extracellular ligand-binding receptor  
Novo N-C 
(DOWN)   
96 gi|26987807  
amino acid ABC transporter, periplasmic amino acid-binding 
protein  
Novo N-C 
(DOWN)   
98 gi|26987292  acetoin dehydrogenase, beta subunit  
Novo N-C 
(DOWN)   
99 gi|26987291  branched-chain alpha-keto acid dehydrogenase subunit E2  
Novo N-C 
(DOWN)   
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Supplementary Table S3. Transcriptomic data of genes differentially expressed with a fold change 
above 3 and a P value below 0.02. Nitrogen- vs. dual-nutrient-limited cultures. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Locus 
Name Gene Name 
Log 
change 
Fold 
change p-value 
PP_0389 
ribosomal protein S21 
gb|AE015451.1|:c475503-475288 1.85 3.62 0.00 
PP_1099 
cold-shock domain family protein 
gb|AE015451.1|:c1257128-1256919 1.89 3.72 0.02 
PP_0008 
ribonuclease P protein component 
gb|AE015451.1|:c8798-8394 1.99 3.98 0.02 
PP_1083 
bacterioferritin-associated ferredoxin  
putative gb|AE015451.1|:c1242882-
1242664 2.03 4.09 0.02 
PP_2048 
acyl-CoA dehydrogenase  putative 
gb|AE015451.1|:2329570-2331420 3.32 10.01 0.00 
PP_2051 
acetyl-CoA acetyltransferase 
gb|AE015451.1|:2333066-2334250 3.37 10.36 0.01 
PP_2050 
conserved hypothetical protein TIGR00051 
gb|AE015451.1|:2332617-2333069 3.64 12.45 0.00 
PP_2049 
alcohol dehydrogenase  iron-containing 
gb|AE015451.1|:2331454-2332617 4.00 16.05 0.00 
PP_2047 
3-hydroxyacyl-CoA dehydrogenase family 
protein gb|AE015451.1|:2328410-2329648 4.69 25.84 0.00 
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